Sentence,class,file
http://www.ejomr.org/JOMR/archives/2016/4/e4/v7n4e4ht.htm J Oral Maxillofac Res 2016 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ba/f8/jomr-07-e4.PMC5279770.pdf
http://www.ejomr.org/JOMR/archives/2016/4/e4/v7n4e4ht.htm J Oral Maxillofac Res 2016 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ba/f8/jomr-07-e4.PMC5279770.pdf
http://www.ejomr.org/JOMR/archives/2016/4/e4/v7n4e4ht.htm J Oral Maxillofac Res 2016 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ba/f8/jomr-07-e4.PMC5279770.pdf
http://www.ejomr.org/JOMR/archives/2016/4/e4/v7n4e4ht.htm J Oral Maxillofac Res 2016 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ba/f8/jomr-07-e4.PMC5279770.pdf
http://www.ejomr.org/JOMR/archives/2016/4/e4/v7n4e4ht.htm J Oral Maxillofac Res 2016 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ba/f8/jomr-07-e4.PMC5279770.pdf
http://www.ejomr.org/JOMR/archives/2016/4/e4/v7n4e4ht.htm J Oral Maxillofac Res 2016 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ba/f8/jomr-07-e4.PMC5279770.pdf
http://www.ejomr.org/JOMR/archives/2016/4/e4/v7n4e4ht.htm J Oral Maxillofac Res 2016 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ba/f8/jomr-07-e4.PMC5279770.pdf
http://www.ejomr.org/JOMR/archives/2016/4/e4/v7n4e4ht.htm J Oral Maxillofac Res 2016 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ba/f8/jomr-07-e4.PMC5279770.pdf
[URL: http://www.eva-berlin.de ] 21.,Non-OADS,/arxiv_data1/oa_pdf/ba/f8/jomr-07-e4.PMC5279770.pdf
[URL: http://mds.marshall.edu/etd/903 ] 22.,Non-OADS,/arxiv_data1/oa_pdf/ba/f8/jomr-07-e4.PMC5279770.pdf
http://www.ejomr.org/JOMR/archives/2016/4/e4/v7n4e4ht.htm J Oral Maxillofac Res 2016 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ba/f8/jomr-07-e4.PMC5279770.pdf
"Influence of Connecting Two Standalone Mobile Three-Dimensional Scanners on Accuracy Comparing with a Standard  Device in Facial Scanning J Oral Maxillofac Res 2016;7(4):e4 URL: http://www.ejomr.org/JOMR/archives/2016/4/e4/v7n4e4.pdf doi: 10.5037/jomr.2016.7404 Copyright ©  Modabber A, Peters F, Brokmeier A, Goloborodko E, Ghassemi A, Lethaus B, Hölzle F, Möhlhenrich SC.",Non-OADS,/arxiv_data1/oa_pdf/ba/f8/jomr-07-e4.PMC5279770.pdf
"Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 28 December 2016.",Non-OADS,/arxiv_data1/oa_pdf/ba/f8/jomr-07-e4.PMC5279770.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.24.",Non-OADS,/arxiv_data1/oa_pdf/ba/f8/jomr-07-e4.PMC5279770.pdf
"Accepted for publication: 25 November 2016 To cite this article: Gambarini G, Piasecki L, Di Nardo D, Miccoli G, Di Giorgio G, Carneiro E, Al-Sudani D, Testarelli L. Incidence of Deformation and Fracture of Twisted File Adaptive Instruments after Repeated Clinical Use J Oral Maxillofac Res 2016;7(4):e5 URL: http://www.ejomr.org/JOMR/archives/2016/4/e5/v7n4e5.pdf doi: 10.5037/jomr.2016.7405 http://www.ejomr.org/JOMR/archives/2016/4/e5/v7n4e5ht.htm J Oral Maxillofac Res 2016 (Oct-Dec) | vol.",Non-OADS,/arxiv_data1/oa_pdf/49/b4/jomr-07-e5.PMC5279771.pdf
http://www.ejomr.org/JOMR/archives/2016/4/e5/v7n4e5ht.htm J Oral Maxillofac Res 2016 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/49/b4/jomr-07-e5.PMC5279771.pdf
http://www.ejomr.org/JOMR/archives/2016/4/e5/v7n4e5ht.htm J Oral Maxillofac Res 2016 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/49/b4/jomr-07-e5.PMC5279771.pdf
http://www.ejomr.org/JOMR/archives/2016/4/e5/v7n4e5ht.htm J Oral Maxillofac Res 2016 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/49/b4/jomr-07-e5.PMC5279771.pdf
http://www.ejomr.org/JOMR/archives/2016/4/e5/v7n4e5ht.htm J Oral Maxillofac Res 2016 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/49/b4/jomr-07-e5.PMC5279771.pdf
http://www.ejomr.org/JOMR/archives/2016/4/e5/v7n4e5ht.htm J Oral Maxillofac Res 2016 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/49/b4/jomr-07-e5.PMC5279771.pdf
[URL: http://www.oralhealthgroup.com ] 7.,Non-OADS,/arxiv_data1/oa_pdf/49/b4/jomr-07-e5.PMC5279771.pdf
[URL: http://oemus.com/publication/roots/ ] 8.,Non-OADS,/arxiv_data1/oa_pdf/49/b4/jomr-07-e5.PMC5279771.pdf
http://www.ejomr.org/JOMR/archives/2016/4/e5/v7n4e5ht.htm J Oral Maxillofac Res 2016 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/49/b4/jomr-07-e5.PMC5279771.pdf
"[Medline: 25771139 ]  [doi: 10.1016/j.joen.2015.01.023 ] To cite this article: Gambarini G, Piasecki L, Di Nardo D, Miccoli G, Di Giorgio G, Carneiro E, Al-Sudani D, Testarelli L. Incidence of Deformation and Fracture of Twisted File Adaptive Instruments after Repeated Clinical Use J Oral Maxillofac Res 2016;7(4):e5 URL: http://www.ejomr.org/JOMR/archives/2016/4/e5/v7n4e5.pdf doi: 10.5037/jomr.2016.7405 Copyright ©  Gambarini G, Piasecki L, Di Nardo D, Miccoli G, Di Giorgio G, Carneiro E, Al-Sudani D, Testarelli L.   Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 28 December 2016.",Non-OADS,/arxiv_data1/oa_pdf/49/b4/jomr-07-e5.PMC5279771.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/49/b4/jomr-07-e5.PMC5279771.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/35/0d/jpr-10-241.PMC5279814.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/35/0d/jpr-10-241.PMC5279814.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 241–248Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  241 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S122861Therapeutic effect of epidural hyaluronic acid in a  rat model of foraminal stenosis Francis Sahngun Nahm1  Pyung Bok Lee1  Ghee Y oung Choe2  Y oung Jin Lim3  Y ong Chul Kim3 1Department of Anesthesiology  and Pain Medicine, 2Department of  Pathology, Seoul National University  Bundang Hospital, Seongnam-si,   3Department of Anesthesiology  and Pain Medicine, Seoul National University Hospital, Seoul, Republic of KoreaPurpose: Since receiving a warning from the US Food and Drug Administration (FDA) about  injection of corticosteroids into the epidural space having serious adverse events, we have  sought alternative medications for injection at this site.",Non-OADS,/arxiv_data1/oa_pdf/35/0d/jpr-10-241.PMC5279814.pdf
"Moreover, HA is known to inhibit proliferation of  macrophages Correspondence: Pyung Bok Lee Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Gumi-dong 300, Bundang-gu, Seongnam-si, 13620, Republic of Korea   Tel +82 31 787 7499   Fax +82 31 787 4063   Email painfree@snubh.orgJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Nahm et alRunning head recto: Epidural hyaluronic acid for foraminal stenosisDOI: http://dx.doi.org/10.2147/JPR.S122861",Non-OADS,/arxiv_data1/oa_pdf/35/0d/jpr-10-241.PMC5279814.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/ucm394280.htm.,Non-OADS,/arxiv_data1/oa_pdf/35/0d/jpr-10-241.PMC5279814.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/35/0d/jpr-10-241.PMC5279814.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 248 Nahm et al,Non-OADS,/arxiv_data1/oa_pdf/35/0d/jpr-10-241.PMC5279814.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c4/5c/ndt-13-177.PMC5279815.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 177–190Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  177OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12242 3 a preliminary study of Patient Dignity inventory  validation among patients hospitalized in an acute  psychiatric ward rosaria Di lorenzo1 giulio cabri2 eleonora carretti3 giacomo galli4 Nina giambalvo4 giulia rioli4 serena saraceni4 giulia spiga4 cinzia Del giovane5 Paola Ferri6 1Mental health Department,   service of Psychiatric Diagnosis  and Treatment in NOcsae general  hospital, 2Private accredited  Psychiatric hospital villa igea,   Modena, 3Nursing home of rubiera,   reggio emilia, 4Department of  Diagnostic, clinical and Public health  Medicine, University of Modena  and reggio emilia, 5PhD statistics  Unit, Department of Diagnostic,   clinical and Public health Medicine,   6Department of Diagnostic, clinical  and Public health Medicine,   University  of Modena and reggio  emilia, Modena, italyPurpose:  To investigate the perception of dignity among patients hospitalized in a psychiatric  setting using the Patient Dignity Inventory (PDI), which had been first validated in oncologic  field among terminally ill patients.",Non-OADS,/arxiv_data1/oa_pdf/c4/5c/ndt-13-177.PMC5279815.pdf
"Keywords:  dignity experience, Patient Dignity Inventory, patients hospitalized in a psychiatric  ward, factor analysis, validation study, dignity distress measurement Introduction Dignity in health care setting Dignity is a complex concept that belongs not only to many fields of knowledge such  as philosophy, religion, medicine, law, social sciences and ethics but also to common  sense.1,2 The meaning of dignity has changed in accordance with historical and cultural  evolution of human societies.3,4 In the contemporary age, dignity is considered as  a fundamental and universal human right, as the Universal Declaration of Human  Rights (ONU 1948) states: “All human beings are born free and equal in dignity and correspondence: rosaria Di lorenzo Mental health Department, service of  Psychiatric Diagnosis and Treatment  in NOcsae general hospital, via  P. giardini, 1355, 41126 Baggiovara  (Modena), az-Usl, Modena, italy email saradilorenzo1@alice.i tJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Di Lorenzo et al Running head recto: A preliminary study of Patient Dignity Inventory validation in Psychiatry DOI: http://dx.doi.org/10.2147/NDT.S122423",Non-OADS,/arxiv_data1/oa_pdf/c4/5c/ndt-13-177.PMC5279815.pdf
Available from:  http://www.who.int/mental_health/world-mental-health-day/2015/en /.,Non-OADS,/arxiv_data1/oa_pdf/c4/5c/ndt-13-177.PMC5279815.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c4/5c/ndt-13-177.PMC5279815.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/5c/ndt-13-177.PMC5279815.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2c/70/ijn-12-839.PMC5279816.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 839–854International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  839OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12879 2 Biodegradable mesoporous delivery system  for biomineralization precursors hong-ye Yang,1 li-na Niu,2  Jin-long sun,2 Xue-qing  huang,3 Dan-dan Pei,4 cui  huang,1 Franklin r Tay5 1The state Key laboratory Breeding  Base of Basic science of stomatology,   Key laboratory for Oral Biomedicine  Ministry of education, school and  hospital of stomatology, Wuhan  University, Wuhan, hubei, People’s  republic of china; 2state Key  laboratory of Military stomatology,   National clinical research center  for Oral Diseases, shaanxi Key  laboratory of Oral Diseases,   Department of Prosthodontics,   school of stomatology, The Fourth  Military Medical University, Xi’an,   shaanxi, People’s republic of china;   3Department of Prosthodontics,   guanghua school and hospital  of stomatology, guangdong Key  laboratory of stomatology, Yat-sen  University, guangzhou, guangdong,   People’s republic of china;   4Department of Prosthodontics,   college of stomatology, Xi’an Jiaotong  University, Xi’an, shaanxi, People’s  republic of china; 5Department  of endodontics, college of Dental  Medicine, augusta University, augusta,   ga, UsaAbstract:  Scaffold supplements such as nanoparticles, components of the extracellular matrix,  or growth factors have been incorporated in conventional scaffold materials to produce smart  scaffolds for tissue engineering of damaged hard tissues.",Non-OADS,/arxiv_data1/oa_pdf/2c/70/ijn-12-839.PMC5279816.pdf
"Contemporary regenerative medicine principles, as epitomized by  the “diamond concept”, require the utilization of scaffolds, mesenchymal stem cells,  growth factors, and the establishment of mechanical competence to optimize bone  regeneration in non-self-healing large bone defects.2 From a tissue engineering per - spective, scaffolds provide the 3-D environment for filling of bone defects, the matrix  for cell seeding and proliferation, the spaces for angiogenesis, and the framework to  achieve mechanical competency during bone regeneration.3 Calcium phosphate-based ceramics have been intensively studied over the past  four decades as load-bearing bone graft substitutes.4 Nevertheless, they fall short of correspondence: Franklin r Tay Department of endodontics, college of  Dental Medicine, augusta University,  1430 John Wesley gilbert Drive,  augusta, ga 30912, Usa Tel +1 706 721 2606 Fax +1 706 723 0218 email ftay@augusta.ed u  cui huang The state Key laboratory Breeding Base  of Basic science of stomatology, Key  laboratory for Oral Biomedicine Ministry  of education, school and hospital of  stomatology, Wuhan University, 237 luoyu  road, hongshan District, Wuhan, hubei  430079, People’s republic of china email huangcui@whu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Y ang et al Running head recto: Biodegradable mesoporous delivery system DOI: http://dx.doi.org/10.2147/IJN.S128792",Non-OADS,/arxiv_data1/oa_pdf/2c/70/ijn-12-839.PMC5279816.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2c/70/ijn-12-839.PMC5279816.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/70/ijn-12-839.PMC5279816.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6d/df/jpr-10-233.PMC5279817.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6d/df/jpr-10-233.PMC5279817.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 233–240Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  233 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S120170Long-term safety and analgesic efficacy of  buprenorphine buccal film in patients with  moderate-to-severe chronic pain requiring  around-the-clock opioids Martin Hale1 Veronica Urdaneta2 M T odd Kirby3 Qinfang Xiang4 Richard Rauck5 1Gold Coast Research, LLC, Plantation,   FL, USA; 2Pharmacovigilance and Risk  Management, 3Clinical Development,   4Biometrics, Endo Pharmaceuticals  Inc., Malvern, PA, USA; 5Carolinas Pain  Institute, Wake Forest Baptist Health,   Winston Salem, NC, USABackground: This open-label, single-arm study was conducted to evaluate the long-term safety  and efficacy of a novel buprenorphine formulation, buprenorphine buccal film, in the treatment  of moderate-to-severe chronic pain requiring around-the-clock opioids.",Non-OADS,/arxiv_data1/oa_pdf/6d/df/jpr-10-233.PMC5279817.pdf
"1 In this survey, Journal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Hale et alRunning head recto: Safety and efficacy of buprenorphine buccal filmDOI: http://dx.doi.org/10.2147/JPR.S120170 Correspondence: Martin Hale Gold Coast Research, LLC, 499 NW 70th Ave, Ste 200, Plantation, FL 33317, USATel +954 659 3399Fax +954 659 3400Email Goldcoast@HaleMD.com",Non-OADS,/arxiv_data1/oa_pdf/6d/df/jpr-10-233.PMC5279817.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/6d/df/jpr-10-233.PMC5279817.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 240 Hale et al Sciences International, Inc., Biogen, Boston Scientific Cor - poration, Endo Pharmaceuticals Inc., Nektar Therapeutics,  and Pfizer Inc.",Non-OADS,/arxiv_data1/oa_pdf/6d/df/jpr-10-233.PMC5279817.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d1/6d/clep-9-063.PMC5279818.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d1/6d/clep-9-063.PMC5279818.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2017:9 63–65Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 63 LEttEr open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S130096 Comment on “An algorithm for identification  and classification of individuals with type 1 and  type 2 diabetes mellitus in a large primary care  database”, written by Sharma et al Valéry Bocquet Competence Center for Methodology  and Statistics, Luxembourg Institute of Health, LuxembourgDear editor Diabetes is a disease whose global prevalence has been rising year after year, and by 2014  more than 400 million individuals were diagnosed with diabetes.1 As a consequence,  screening of patients with type 1 or type 2 diabetes has become important, both to estimate the prevalence of diabetes and to treat affected individuals.",Non-OADS,/arxiv_data1/oa_pdf/d1/6d/clep-9-063.PMC5279818.pdf
"2016;387(10027):1513–1530.Correspondence: Valéry Bocquet Competence Center for Methodology and Statistics, Luxembourg Institute of Health, 1A–B Rue Thomas Edison, L-1445 Strassen, Luxembourgtel +352 26 970 763Fax +352 26 970 717Email valery.bocquet@lih.luJournal name: Clinical Epidemiology Article Designation: LetterY ear: 2017V olume: 9Running head verso: BocquetRunning head recto: Comment in response to Sharma et al’ s paperDOI: http://dx.doi.org/10.2147/CLEP .S130096",Non-OADS,/arxiv_data1/oa_pdf/d1/6d/clep-9-063.PMC5279818.pdf
"Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/d1/6d/clep-9-063.PMC5279818.pdf
Available from: http://www.sdrn.org.uk/sites/sdrn.org.uk/files/nhs%20diagnosis%20classification%20report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d1/6d/clep-9-063.PMC5279818.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ac/42/dddt-11-305.PMC5279819.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 305–312Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  305Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12449 7 impact of metoprolol treatment on mental  status of chronic heart failure patients with  neuropsychiatric disorders Xuelu liu1 Xueming lou1 Xianliang cheng2 Y ong Meng1 1Department of cardiology,   2Department of endocrinology, The  second affiliated hospital of Kunming  Medical University, Kunming, Yunnan,   People’s republic of chinaBackground:  Metoprolol treatment is well established for chronic heart failure (CHF) patients,  but the central nervous system side effects are often a potential drawback.",Non-OADS,/arxiv_data1/oa_pdf/ac/42/dddt-11-305.PMC5279819.pdf
"According to a literature review over the past decade, the prevalence rates of depression  and anxiety among chronic heart failure (CHF) patients were 10%–60% and 11%–45%,  respectively.1 β blockers are widely used to treat CHF as several randomized clinical  trials report their use to decrease hospitalizations and to enhance survival and well- being of heart failure (HF) patients.2–7 However, earlier reports on the possible side  effects of β blockers on the central nervous system (CNS), including the manifestation correspondence: Yong Meng Department of cardiology, The second  Affiliated Hospital of Kunming Medical  University, no 374, Dianmian road,  Kunming 650101, Yunnan, People’s  republic of china Tel +86 153 6813 7676 Fax +86 153 6813 7678 email mengyong76@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Liu et al Running head recto: Metoprolol effect on mental status of CHF patients DOI: http://dx.doi.org/10.2147/DDDT.S124497",Non-OADS,/arxiv_data1/oa_pdf/ac/42/dddt-11-305.PMC5279819.pdf
Available from: https://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/ac/42/dddt-11-305.PMC5279819.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ac/42/dddt-11-305.PMC5279819.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/42/dddt-11-305.PMC5279819.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/77/34/ijn-12-779.PMC5279820.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 779–793International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  779RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S12653 0 Tracking stem cells with superparamagnetic iron   oxide nanoparticles: perspectives and  considerations Jasmin1,* Gustavo T orres de Souza2,3,* Ruy Andrade Louzada4 Paulo Henrique Rosado-de- Castro5 Rosalia Mendez-Otero6 Antonio Carlos Campos de  Carvalho6 1NUMP eX-Bio, Federal University  of Rio de Janeiro, Duque de Caxias, RJ,  2Laboratory of Animal Reproduction,  embrapa Dairy Cattle, Juiz de Fora,  MG, 3Laboratory of Genetics, Federal  University of Juiz de Fora, Juiz de  Fora, MG, Brazil; 4Institute Gustave- Roussy of Oncology, Paris-Sud  University, villejuif, France; 5Institute of  Biomedical Sciences, Federal University  of Rio de Janeiro, Rio de Janeiro, RJ,  6Institute Carlos Chagas Filho of  Biophysics, Federal University of Rio  de Janeiro, Rio de Janeiro, RJ, Brazil *These authors contributed equally  to this workAbstract:  Superparamagnetic iron oxide nanoparticles (SPIONs) have been used for diagnoses  in biomedical applications, due to their unique properties and their apparent safety for humans.",Non-OADS,/arxiv_data1/oa_pdf/77/34/ijn-12-779.PMC5279820.pdf
"The outcomes of clinical trials using stem cells are less assessable by invasive  methods, which are usually used in experiments with animal models and include  postmortem analyses, such as histologic analysis of tissues and organs.7,8 Currently,  there are active efforts to develop and standardize suitable noninvasive methods for  long-term tracking of cells after transplantation.9 Magnetic resonance imaging (MRI) offers an imaging modality that allows high- resolution visualization of cell biodistribution.10–14 Several types of contrast agents have  been used for MRI in vivo imaging, including superparamagnetic iron oxide nanopar - ticles (SPIONs), which successfully label different mammalian cell types.15–19Correspondence: Jasmin estrada de Xerém, 27, NUMPeX- Bio – UFRJ, Xerém, Duque de Caxias,   RJ, 25245-390, Brazil Tel +55 21 2679 1018 email jasmin@biof.ufrj.b r Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Jasmin et al Running head recto: Tracking stem cells with superparamagnetic iron oxide nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S126530",Non-OADS,/arxiv_data1/oa_pdf/77/34/ijn-12-779.PMC5279820.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/77/34/ijn-12-779.PMC5279820.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/34/ijn-12-779.PMC5279820.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/12/dc/ott-10-521.PMC5279823.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 521–526OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  521Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12161 5 effective BraF inhibitor vemurafenib therapy   in a 2-year-old patient with sequentially   diagnosed Langerhans cell histiocytosis  and erdheim–Chester disease Zsófia Váradi1 rita Bánusz1 Judit Csomor2 Krisztián Kállay3 edit Varga1 Gabriella Kertész1 Monika Csóka1 1second Department of pediatrics,   2First Department of pathology  and experimental Cancer research,   semmelweis University, 3pediatric  Hematology and stem Cell  Transplantation Unit, United st István  and st László Hospital, Budapest,   HungaryAbstract:  Erdheim–Chester disease (ECD) is a rare histiocytic disorder, characterized by  the xanthomatous infiltration of tissues by CD68-positive and CD1a-/CD100-negative foamy  histiocytes.",Non-OADS,/arxiv_data1/oa_pdf/12/dc/ott-10-521.PMC5279823.pdf
Volume: 10 Running head verso: Váradi et al Running head recto: Vemurafenib therapy in a 2-year-old patient DOI: http://dx.doi.org/10.2147/OTT.S121615,Non-OADS,/arxiv_data1/oa_pdf/12/dc/ott-10-521.PMC5279823.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/12/dc/ott-10-521.PMC5279823.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/dc/ott-10-521.PMC5279823.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c5/8f/ndt-13-205.PMC5279824.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 205–211Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  205OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11882 5 construct validity of the Depression and somatic  symptoms scale: evaluation by Mokken scale  analysis Ya-hsin chou1 chin-Pang lee1,2 chia-Yih liu1,2 ching-i hung1,2 1Department of Psychiatry, chang- gung Memorial hospital at linkou,   2school of Medicine, chang gung  University college of Medicine,   Taoyuan, TaiwanObjective:  Previous studies of the Depression and Somatic Symptoms Scale (DSSS), a free  scale, have been based on the classical test theory, and the construct validity and dimensionality  of the DSSS are as yet uncertain.",Non-OADS,/arxiv_data1/oa_pdf/c5/8f/ndt-13-205.PMC5279824.pdf
"The DSSS and its subscales are significantly  correlated with the Hamilton Depression Rating Scale (HAMD) as well as the mental  and physical subscale scores of a health-related quality of life scale.9 It is also sensitive  to pharmacotherapy.9 Moreover, the predictive ability of the DSSS for the prognosis  of depression is not inferior to that of the HAMD.10 Furthermore, previous studies correspondence: ching-i hung Department of Psychiatry, chang-gung  Memorial hospital–linkou, 5, Fuxing  street, Taoyuan, guishan District 333,  Taiwan Tel +886 3 328 1200 Fax +886 3 328 0267 email a36250@cgmh.org.t w Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Chou et al Running head recto: Mokken scaling analysis of DSSS DOI: http://dx.doi.org/10.2147/NDT.S118825",Non-OADS,/arxiv_data1/oa_pdf/c5/8f/ndt-13-205.PMC5279824.pdf
Available  from https://pure.uvt.nl/portal/files/1459839/Straat_using_23-11-2012.,OADS,/arxiv_data1/oa_pdf/c5/8f/ndt-13-205.PMC5279824.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c5/8f/ndt-13-205.PMC5279824.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/8f/ndt-13-205.PMC5279824.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4f/94/ott-10-515.PMC5279825.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 515–520OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  515Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9771 3 Differential pharmacology and clinical utility of  sonidegib in advanced basal cell carcinoma Mohd wahid Arshad Jawed Sajad Ahmad Dar Raju K Mandal Shafiul Haque Research and Scientific Studies Unit,   College of Nursing and Allied Health  Sciences, Jazan University, Jazan,   Kingdom of Saudi ArabiaAbstract:  Patients suffering from advanced basal cell carcinoma (BCC) have very limited  treatment options.",Non-OADS,/arxiv_data1/oa_pdf/4f/94/ott-10-515.PMC5279825.pdf
"It is indicated for  the treatment of adults with locally advanced BCC (laBCC) not suitable for surgery  or radiation therapy or adults with recurrent laBCC following surgery or radiation  therapy.4Correspondence: Shafiul Haque Research and Scientific Studies Unit,  College of Nursing and Allied Health  Sciences, Jazan University, Jazan 45142,  Kingdom of Saudi Arabia Tel/fax +966 17 317 4383 email shafiul.haque@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: Wahid et al Running head recto: Comparative utility of sonidegib in advanced basal cell carcinoma DOI: http://dx.doi.org/10.2147/OTT.S97713",Non-OADS,/arxiv_data1/oa_pdf/4f/94/ott-10-515.PMC5279825.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/4f/94/ott-10-515.PMC5279825.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/94/ott-10-515.PMC5279825.pdf
"Available from: https://evs.nci.nih.gov/ftp1/CTCAE/ CTCAE_4.03_2010-06-14_QuickReference_5 ×7.pd f. Accessed  November 14, 2016.",OADS,/arxiv_data1/oa_pdf/4f/94/ott-10-515.PMC5279825.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9b/ac/tcrm-13-111.PMC5279826.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 111–115Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  111ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12513 0 Fibrin sheaths in central venous port catheters:  treatment with low-dose, single injection of  urokinase on an outpatient basis De-hua Chang1 Kamal Mammadov1 Tilman hickethier1 Jan Borggrefe1 Martin hellmich2 David Maintz1 Christoph Kabbasch1 1Department of Diagnostic and  interventional Radiology, University  hospital of Cologne, nRW, germany;   2institute of Medical statistics,   informatics and epidemiology,   University hospital of Cologne, nRW,   germanyPurpose:  Evaluation of the efficacy of single-shot, low-dose urokinase administration for the  treatment of port catheter-associated fibrin sheaths.",Non-OADS,/arxiv_data1/oa_pdf/9b/ac/tcrm-13-111.PMC5279826.pdf
"Different approaches to resolve the fibrin sheath  have been described, including exchange of the impaired catheter,3 the use of a loop  snare from a transfemoral venous approach to pull off the sheath from the catheter4,5  and thrombolysis.6–9 In the latter case, the reported application regimens (single injec - tions vs continuous infusions, local lysis through the catheter vs intravenous systemic  application) as well as the thrombolytic agents (streptokinase, urokinase, recombinant Correspondence: De-hua Chang Department of Diagnostic and  interventional Radiology, University  hospital of Cologne, Kerpener street 62,  50937 Cologne, germany Tel +49 221 4788 2035 email de-hua.chang@uk-koeln.d e Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Chang et al Running head recto: Treatment with urokinase for port catheter-associated fibrin sheaths DOI: http://dx.doi.org/10.2147/TCRM.S125130",Non-OADS,/arxiv_data1/oa_pdf/9b/ac/tcrm-13-111.PMC5279826.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/9b/ac/tcrm-13-111.PMC5279826.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/ac/tcrm-13-111.PMC5279826.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2017:10 41–47Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 41 PERSPECTIVES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S118706Enhancing health and independent living for  veterans with disabilities by leveraging  community-based resources Jennifer Hale-Gallardo1  Huanguang Jia1  T ony Delisle2  Charles E Levy1,3–5  Valentina Osorio1  Jennifer A Smith1  Elizabeth M Hannold1,† 1Center of Innovation on Disability  and Rehabilitation Research, North  Florida/South Georgia Veterans Health System,  2Center for Independent Living  of North Central Florida, 3Physical  Medicine and Rehabilitation Service, North Florida/South Georgia Veterans Health Service,  4The Department  of Occupational Therapy, College of Public Health and Health Professions,  5The Center for the Arts in Medicine,  College of the Arts, University of Florida, Gainesville, FL, USA †Elizabeth M Hannold passed away on  September 28, 2015.Abstract:  The number of US veterans with disabilities has increased in recent years as ser - vice members have returned home with extensive injuries and veterans from previous wars  acquire functional limitations as a consequence of aging with chronic diseases.",Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
"The Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF) and  Operation New Dawn (OND) conflicts have been called the wars of disabilities due to the higher survival rate of troops exposed to explosive munitions and blasts  resulting Correspondence: Jennifer Hale-Gallardo   Center of Innovation on Disability and  Rehabilitation Research, North Florida/South Georgia Veterans Health System, 1601 SW Archer Road 151-B, Gainesville, FL 32608, USA Tel +1 352 376 1611 ext 4947   Fax +1 352 381 5750   Email Jennifer.Hale-Gallardo@va.govJournal name: Journal of Multidisciplinary Healthcare Article Designation: PERSPECTIVESY ear: 2017V olume: 10Running head verso: Hale-Gallardo et alRunning head recto: Enhancing health and independent living of veterans with disabilitiesDOI: http://dx.doi.org/10.2147/JMDH.S118706",Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from: https://www.va.gov/vetdata/report.asp.,Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from: https://www.dmdc.osd.mil/dcas/pages/report_oif_type.xhtml.,OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from: http://www.va.gov/opa/publications/factsheets/April-2016-Mental-Health-Fact-Sheet.pdf.,Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from: http://www.va.gov/ opa/publications/factsheets/April-2016-Mental-Health-Fact-Sheet.pdf.,Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from: http://www.blogs.va.gov/V Antage/wp-content/uploads/2016/06/160606_MentalHealthSummaryofEfforts.pdf.,Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from: http://www.rehab.va.gov/factsheet/OT -FactSheet.pdf.,OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from:  http://www.queri.research.va.gov/about/factsheets/stroke_factsheet.pdf.,OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from: http://www.gao.gov/assets/660/655087.pdf.,OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from: http://www.benefits.va.gov/vocrehab/independent_living.asp.,Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from: https://www.hsdl.org/?view&did=706744.,Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from: https://www.clark.wa.gov/sites/all/files/public-health/veterans-assistance/Return-ingSoldiers.pdf.,Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from: http://www.acl.gov/About_ACL/StrategicPlan/docs/ACL_Stra-tegic_Plan.pdf.,Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from: http://www.mwcil.org/home/files/disc_edit_il_philosophy_1final_copy.pdf.,Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from: http://www.ncil.org/about/aboutil/.,Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from: https://apha.confex.com/apha/143am/web-program/Paper335924.html.,Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
"Journal of Multidisciplinary Healthcare 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 47 Enhancing health and independent living of veterans with disabilities  83.,Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from: http://www.mwcil.org/home/files/discconsumer_control_in_inde-pendent_living_manualedited.pdf.,Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
Available from: http://www.va.gov/health/docs/VHA_Blue-print_for_Excellence.pdf.,Non-OADS,/arxiv_data1/oa_pdf/03/9f/jmdh-10-041.PMC5279827.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d2/b7/copd-12-403.PMC5279828.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 403–415International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  403RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S12393 3 “what are my chances of developing COPD if  one of my parents has the disease?” A systematic  review and meta-analysis of prevalence of  co-occurrence of COPD diagnosis in parents  and offspring Lok Sze Katrina Li1 Catherine Paquet2 Kylie Johnston1 Marie T williams3 1School of Health Sciences, Sansom  Institute for Health Research,   University of South Australia,   Adelaide, South Australia, 2Center  for Population Health Research,   Sansom Institute for Health Research,   University of South Australia,   Adelaide, South Australia, 3Alliance for  Research in exercise, Nutrition and  Activity (AR eNA), Sansom Institute  for Health Research, University of  South Australia, Adelaide, South  Australia, AustraliaIntroduction:  Intergenerational associations in chronic obstructive pulmonary disease (COPD)  have been well recognized and may result from genetic, gene environment, or exposure to life  course factors.",Non-OADS,/arxiv_data1/oa_pdf/d2/b7/copd-12-403.PMC5279828.pdf
edu.a uJournal name: International Journal of COPD Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Li et al Running head recto: Prevalence of co-occurrence of COPD diagnosis in parents and offspring DOI: http://dx.doi.org/10.2147/COPD.S123933,Non-OADS,/arxiv_data1/oa_pdf/d2/b7/copd-12-403.PMC5279828.pdf
"Available from: http://www.goldcopd.org/uploads/users/files/GOLD_ Pocket_2015_Feb18.pd f. Accessed March 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d2/b7/copd-12-403.PMC5279828.pdf
"Avail - able from: http://www.who.int/gho/publications/world_health_statistics/ EN_WHS08_Full.pd f. Accessed March 30, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d2/b7/copd-12-403.PMC5279828.pdf
"Available from:  http://2014-new.copdx.org.au/wp-content/uploads/2011/08/COPDX- V2.39-October-2014_FINAL.pd f. Accessed July 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d2/b7/copd-12-403.PMC5279828.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/d2/b7/copd-12-403.PMC5279828.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/b7/copd-12-403.PMC5279828.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fd/0d/ijn-12-809.PMC5279829.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 809–825International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  809OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12359 6 silica nanoparticles induce autophagy dysfunction  via lysosomal impairment and inhibition of  autophagosome degradation in hepatocytes Ji Wang1,2 Y ongbo Yu1,2 Ke lu1 Man Yang1,2 Yang li1,2 Xianqing Zhou1,2 Zhiwei sun1,2 1Department of T oxicology and  sanitary chemistry, school of Public  health, 2Beijing Key laboratory of  environmental T oxicology, capital  Medical University, Beijing, People’s  republic of chinaAbstract:  Autophagy dysfunction is considered as a potential toxic mechanism of  nanomaterials.",Non-OADS,/arxiv_data1/oa_pdf/fd/0d/ijn-12-809.PMC5279829.pdf
"It is reported that SiNPs are retained in the liver  for up to 60 days by intravenous exposure, and liver fibrosis occurs in rats fed with  SiNPs.10,11 Previously, we have demonstrated that SiNPs are rapidly accumulated in  livers of mice after intravenous administration causing acute toxicity of lymphocytic correspondence: Zhiwei sun Department of Toxicology and sanitary  chemistry, school of Public health,  capital Medical University, No 10 Xi  Tou Tiao, You an Men, Beijing 100069,  People’s republic of china Tel +86 10 839 115 07 email zwsun@ccmu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Wang et al Running head recto: Silica nanoparticles induce autophagy dysfunction DOI: http://dx.doi.org/10.2147/IJN.S123596",Non-OADS,/arxiv_data1/oa_pdf/fd/0d/ijn-12-809.PMC5279829.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fd/0d/ijn-12-809.PMC5279829.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/0d/ijn-12-809.PMC5279829.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/11/6c/ndt-13-191.PMC5279831.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 191–200Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  191OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12306 6 a possible role of the infant/T oddler sensory  Profile in screening for autism: a proof-of-concept  study in the specific sample of prematurely born  children with birth weights ,1,500 g stepanka Beranova,1 Jan  stoklasa,2 iva Dudova,1  Daniela Markova,3  Martina Kasparova,4  Jana Zemankova,5 Tomas  Urbanek,6 T omas Talasek,2  Pasi luukka,7 Michal  hrdlicka1 1Department of child Psychiatry,   charles University second Faculty  of Medicine and University hospital  Motol, Prague, 2Department of  applied economics, Faculty of  arts, Palacky University, Olomouc,   3Department of Pediatrics and  adolescent Medicine, charles  University First Faculty of Medicine  and general University hospital,   Prague, 4Department of Pediatrics,   charles University second Faculty  of Medicine and University hospital  Motol, Prague, 5Department of  Pediatrics, charles University  Faculty of Medicine and University  hospital, hradec Kralove, 6institute  of Psychology, Academy of Sciences,   Brno, czech republic; 7laboratory of  applied Mathematics, lappeenranta  University of T echnology,   lappeenranta, FinlandObjective:  The objective of this study was to explore the potential of the Infant/Toddler Sen - sory Profile (ITSP) as a screening tool for autism spectrum disorders (ASD) in prematurely  born children.",Non-OADS,/arxiv_data1/oa_pdf/11/6c/ndt-13-191.PMC5279831.pdf
"It provides a standardized method to measure a child’s sensory processing abilities  and to profile the effect of sensory processing on functional performance in the daily  life of a child aged 0–36 months.1 The ITSP was created to extend the age range correspondence: stepanka Beranova Department of child Psychiatry, charles  University second Faculty of Medicine,  University hospital Motol, V Uvalu 84,  15006 Prague, Czech Republic Tel +420 224 433 467 Fax +420 224 433 420 email stepanka.beranova@fnmotol.c z Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Beranova et al Running head recto: The Infant/Toddler Sensory Profile in screening for autism DOI: http://dx.doi.org/10.2147/NDT.S123066",Non-OADS,/arxiv_data1/oa_pdf/11/6c/ndt-13-191.PMC5279831.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/11/6c/ndt-13-191.PMC5279831.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/6c/ndt-13-191.PMC5279831.pdf
Available  from: https://www.R-project.org /.,Non-OADS,/arxiv_data1/oa_pdf/11/6c/ndt-13-191.PMC5279831.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ae/07/opth-11-233.PMC5279832.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 233–235Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  233ShO rt repO rtopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S12410 1 Stereoacuity after small aperture corneal inlay  implantation Steven h Linn1 David F Skanchy2 tyler S Quist3 Jordan D Desautels4 Majid Moshirfar1,5 1Department of Clinical research,   hDr research Center, hoopes Vision,   Draper, Ut , 2McGovern Medical  School, the University of texas  health Science Center at houston,   tX, 3University of Utah School of  Medicine, Salt Lake City, Ut , 4tufts  University School of Medicine, Boston,   MA, 5John A Moran eye Center,   Department of Ophthalmology and  Visual Sciences, University of Utah  School of Medicine, Salt Lake City,   Ut, USAPurpose:  The aim of this study was to compare stereoacuity before and after KAMRA corneal  inlay implantation for the correction of presbyopia.",Non-OADS,/arxiv_data1/oa_pdf/ae/07/opth-11-233.PMC5279832.pdf
"An institutional review board approval was not Correspondence: Majid Moshirfar hDr research Center, hoopes Vision,  11820 S State Street Suite #200,   Draper, Ut 84020, USA tel +1 801 568 0200 Fax +1 801 563 0200 email cornea2020@me.co m Journal name: Clinical Ophthalmology Article Designation: Short Report Y ear: 2017 Volume: 11 Running head verso: Linn et al Running head recto: Stereoacuity after corneal inlay implantation DOI: http://dx.doi.org/10.2147/OPTH.S124101",Non-OADS,/arxiv_data1/oa_pdf/ae/07/opth-11-233.PMC5279832.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ae/07/opth-11-233.PMC5279832.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/07/opth-11-233.PMC5279832.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/87/de/prbm-10-039.PMC5279833.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/87/de/prbm-10-039.PMC5279833.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Psychology Research and Behavior Management 2017:10 39–45Psychology Research and Behavior Management Dovepress submit your manuscript | www.dovepress.com Dovepress 39 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S123224 Assessing behavioral patterns of Internet addiction  and drug abuse among high school students Zeinab Nemati   Hossein Matlabi Department of Health Education and  Promotion, Faculty of Health Sciences,  Tabriz University of Medical Sciences,  Tabriz, IranBackground: Internet addiction and drug abuse isolate adolescents from their family and friends  and cause damage to their health, relations, emotions, and spirit.",Non-OADS,/arxiv_data1/oa_pdf/87/de/prbm-10-039.PMC5279833.pdf
"10–12 The abuse of Correspondence: Hossein Matlabi Department of Health Education and Promotion, Faculty of Health Sciences, Tabriz University of Medical Sciences, Attar Neishabouri Street, Tabriz 5165665811, Iran Tel +98 91 4100 8927   Fax +98 41 3334 4731   Email hm1349@gmail.comJournal name: Psychology Research and Behavior Management Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Nemati and MatlabiRunning head recto: Behavioral patterns of Internet addictionDOI: http://dx.doi.org/10.2147/PRBM.S123224",Non-OADS,/arxiv_data1/oa_pdf/87/de/prbm-10-039.PMC5279833.pdf
Available from: http://www.who.int/maternal_child_adolescent/epidemiology/adolescence/en/.,Non-OADS,/arxiv_data1/oa_pdf/87/de/prbm-10-039.PMC5279833.pdf
"Psychology Research and Behavior Management 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/psychology-research-and-behavior-management-journalPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and its  application in behavior management to develop improved outcomes in the  clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/87/de/prbm-10-039.PMC5279833.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e6/f0/dddt-11-295.PMC5279834.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 295–304Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  295Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S10486 9 Obinutuzumab in chronic lymphocytic leukemia:  design, development and place in therapy Othman Al-Sawaf Kirsten Fischer Anja engelke Natali Pflug Michael Hallek valentin Goede German CLL Study Group,   Department i of internal Medicine,   University Hospital of Cologne,   Cologne, GermanyAbstract:  For decades, treatment of chronic lymphocytic leukemia (CLL) has been based on  chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/e6/f0/dddt-11-295.PMC5279834.pdf
"Obinutuzumab (formerly GA101) is the first of a new generation of  type II glycoengineered CD20 monoclonal antibodies that has been approved for the Correspondence: valentin Goede German CLL Study Group, Department i  of internal Medicine, University Hospital  of Cologne, Kerpener Straße 62,  Cologne, Germany email valentin.goede@uk-koeln.d e Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Al-Sawaf et al Running head recto: Obinutuzumab in CLL DOI: http://dx.doi.org/10.2147/DDDT.S104869",Non-OADS,/arxiv_data1/oa_pdf/e6/f0/dddt-11-295.PMC5279834.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e6/f0/dddt-11-295.PMC5279834.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/f0/dddt-11-295.PMC5279834.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/19/dd/idr-10-027.PMC5279835.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/19/dd/idr-10-027.PMC5279835.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance 2017:10 27–34Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 27 ORIg Inal ReseaRch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S127177extended-spectrum beta-lactamase- and  carbapenemase-producing Enterobacteriaceae  among ethiopian children Melese hailu legese1 gebru Mulugeta  Weldearegay1 Daniel asrat2 1Department of clinical laboratory  sciences, school of allied  health sciences, 2Department of  Microbiology, Immunology and  Parasitology, school of Medicine,  college of health sciences, addis  ababa University, addis ababa,   ethiopiaBackground: Infections by extended-spectrum beta-lactamase- (ESBL) and carbapenem- resistant Enterobacteriaceae (CRE) are an emerging problem in children nowadays.",Non-OADS,/arxiv_data1/oa_pdf/19/dd/idr-10-027.PMC5279835.pdf
"Keywords: ESBL, carbapenem resistance, Enterobacteriaceae, Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia Introduction Resistance of Gram-negative bacteria to antibiotics has increased at an alarming pace  over the last two decades, particularly the emergence of Enterobacteriaceae resistant to third-generation cephalosporins and aztreonam 1 which is commonly associated with the  expression of extended-spectrum beta-lactamases (ESBLs).2 These enzymes confer resis-correspondence: Melese hailu legese Department of clinical laboratory sciences, school of allied health sciences, college of health sciences, addis ababa University, PO Box 26970, 1000 addis ababa, ethiopiaTel +251 91 370 5279email melerose85@gmail.comJournal name: Infection and Drug Resistance  Article Designation: Original ResearchY ear: 2017V olume: 10Running head verso: Legese et alRunning head recto: ESBL & carbapenemase producing Enterobacteriaceae among Ethiopian childrenDOI: http://dx.doi.org/10.2147/IDR.S127177",Non-OADS,/arxiv_data1/oa_pdf/19/dd/idr-10-027.PMC5279835.pdf
"Infection and Drug Resistance 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/19/dd/idr-10-027.PMC5279835.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 34 legese et al,Non-OADS,/arxiv_data1/oa_pdf/19/dd/idr-10-027.PMC5279835.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/83/a1/copd-12-275.PMC5279836.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 275–284International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  275OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12194 3 Predicting high risk of exacerbations in   bronchiectasis: the e-F aCeD score Martinez-garcia M a,1,2  athanazio ra,3 girón r,4  Máiz-Carro l,5 de la rosa D,6   Olveira C,7 de gracia J,2,8   Vendrell M,9 Prados- sánchez C,10  gramblicka g,11 Corso  Pereira M,12 lundgren Fl,13  Fernandes De Figueiredo M,14  arancibia F ,15 rached sZ3 1Pulmonary service, Polytechnic and  University la Fe hospital, Valencia, spain;   2CIBeres, CIB er de enfermedades  respiratorias.",Non-OADS,/arxiv_data1/oa_pdf/83/a1/copd-12-275.PMC5279836.pdf
"The FACED score is easy to remember and to apply in clinical practice; it presents Correspondence: Martinez-garcia Ma Department of Pneumology, hospital  Universitario y Politécnico la Fe, Bulevar  sur s/n, 46012-Valencia, spain Tel +34 609865934 email mianmartinezgarcia@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Martinez-Garcia et al Running head recto: Exacerbations in bronchiectasis: the E-FACED score DOI: http://dx.doi.org/10.2147/COPD.S121943",Non-OADS,/arxiv_data1/oa_pdf/83/a1/copd-12-275.PMC5279836.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/83/a1/copd-12-275.PMC5279836.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/a1/copd-12-275.PMC5279836.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/14/fc/ppa-11-141.PMC5279837.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 141–150Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  141OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11739 6 getting patients in the door: medical appointment  reminder preferences Trisha M crutchfield1–3 christine e Kistler2–4 1University of north carolina center  for health Promotion and Disease  Prevention, 2University of north  carolina lineberger comprehensive  cancer center, 3cecil g. sheps  center for health services research,   4Department of Family Medicine,   University of north carolina at  chapel hill, chapel hill, nc, UsAPurpose:  Between 23% and 34% of outpatient appointments are missed annually.",Non-OADS,/arxiv_data1/oa_pdf/14/fc/ppa-11-141.PMC5279837.pdf
"Furthermore, individuals who frequently miss medical appointments have poorer  health outcomes4–9 and are less likely to utilize preventive health care services than Correspondence: Trisha M Crutchfield University of north carolina center  for health Promotion and Disease  Prevention, University of north carolina  at chapel hill, 1700 Martin luther King  Boulevard, campus Box 7426, chapel  hill, nc 27599-7426, UsA Tel +1 919 590 9532 email trisha@unc.ed u Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Crutchfield and Kistler Running head recto: Medical appointment reminder preferences DOI: http://dx.doi.org/10.2147/PPA.S117396",Non-OADS,/arxiv_data1/oa_pdf/14/fc/ppa-11-141.PMC5279837.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/14/fc/ppa-11-141.PMC5279837.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8a/ad/jpr-10-249.PMC5279838.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8a/ad/jpr-10-249.PMC5279838.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research 2017:10 249–257Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  249 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S122853Co-prescription of opioids with benzodiazepine  and other co-medications among opioid   users: differential in opioid doses Che Suraya Zin  Fadhilah Ismail Kulliyyah of Pharmacy, International  Islamic University Malaysia, Bandar Indera Mahkota, Kuantan, Pahang,  MalaysiaPurpose: This study investigated the patterns of opioid co-prescription with benzodiazepine and  other concomitant medications among opioid users.",Non-OADS,/arxiv_data1/oa_pdf/8a/ad/jpr-10-249.PMC5279838.pdf
"Antidepressants (e.g., venlafaxine and duloxetine) and anticonvulsants (e.g.,  pregabalin and gabapentin) are the adjuvant analgesics that had been found to be Correspondence: Che Suraya Zin   Kulliyyah of Pharmacy, International  Islamic University Malaysia, Kuantan Campus, Jalan Sultan Ahmad Shah, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia   Tel +60 9 570 4909   Fax +60 9 571 6775   Email chesuraya@iium.edu.myJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Zin and IsmailRunning head recto: Co-prescription of opioid with benzodiazepineDOI: http://dx.doi.org/10.2147/JPR.S122853",Non-OADS,/arxiv_data1/oa_pdf/8a/ad/jpr-10-249.PMC5279838.pdf
Available from: http://www.acadmed.org.my/.,OADS,/arxiv_data1/oa_pdf/8a/ad/jpr-10-249.PMC5279838.pdf
"Journal of Pain Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/8a/ad/jpr-10-249.PMC5279838.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 257 Co-prescription of opioid with benzodiazepine 18.,Non-OADS,/arxiv_data1/oa_pdf/8a/ad/jpr-10-249.PMC5279838.pdf
Available from: http://www.pharmacy.gov.my/v2/sites/default/files/document-upload/poisons-list-appendix-3-aug-2016_4.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8a/ad/jpr-10-249.PMC5279838.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/49/6c/ndt-13-201.PMC5279839.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 201–204Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  201OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12236 7 switching bipolar disorder patients treated with  clozapine to another antipsychotic medication:  a mirror image study Petru ifteni1,2 andreea T eodorescu1,2 Marius alexandru Moga1 alina Mihaela Pascu1 roxana steliana Miclaus1,2 1Faculty of Medicine, Transilvania  University of Brasov, Brasov, romania;   2clinical hospital of Psychiatry and  Neurology Brasov, Brasov, romaniaAbstract:  Bipolar disorder (BD) is associated with periodic symptom exacerbations, leading  to functional impairment, and increased risk of suicide.",Non-OADS,/arxiv_data1/oa_pdf/49/6c/ndt-13-201.PMC5279839.pdf
"Written informed consent has been obtained from  all patients for participation in this study.correspondence: andreea Teodorescu Faculty of Medicine, Transilvania  University of Brasov, 29 eroilor Bulevard,  Brasov, romania email andre_martie@yahoo.com Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Ifteni et al Running head recto: Switching from CLZ to another AP DOI: http://dx.doi.org/10.2147/NDT.S122367",Non-OADS,/arxiv_data1/oa_pdf/49/6c/ndt-13-201.PMC5279839.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/49/6c/ndt-13-201.PMC5279839.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/49/6c/ndt-13-201.PMC5279839.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cb/b2/ijn-12-795.PMC5279841.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 795–808International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  795OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12493 8 The role of surface charge in the desolvation  process of gelatin: implications in nanoparticle  synthesis and modulation of drug release saad M ahsan chintalagiri Mohan rao centre for cellular and Molecular  Biology, council of scientific and  Industrial research, hyderabad,   T elangana, IndiaAbstract:  The process of moving hydrophobic amino acids into the core of a protein by  desolvation is important in protein folding.",Non-OADS,/arxiv_data1/oa_pdf/cb/b2/ijn-12-795.PMC5279841.pdf
"Gelatin and albumin have been extensively used for nanoparticle preparation by the correspondence: chintalagiri Mohan rao centre for cellular and Molecular  Biology, Council of Scientific and  Industrial research, hyderabad 500007,   Telangana, India Tel +91 40 2719 5631 Fax +91 40 2719 5633 email mohan@ccmb.res.i n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Ahsan and Rao Running head recto: Role of surface charge in the desolvation process of gelatin DOI: http://dx.doi.org/10.2147/IJN.S124938",Non-OADS,/arxiv_data1/oa_pdf/cb/b2/ijn-12-795.PMC5279841.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/cb/b2/ijn-12-795.PMC5279841.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/b2/ijn-12-795.PMC5279841.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/18/6e/cia-12-189.PMC5279842.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 189–195Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  189OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12398 5 Multiple diabetic complications, as well as impaired  physical and mental function, are associated with  declining balance function in older persons   with diabetes mellitus Xiufang hong1,2 Xujiao Chen2 Jiaojiao Chu2 shanshan shen2 Qichen Chai2 gaobo lou2 lingyan Chen2 1Zhejiang Chinese Medical University,   2Department of geriatrics, Zhejiang  hospital, hangzhou, Zhejiang, People’s  republic of ChinaObjective:  To investigate whether there is a difference in balance function between older  persons with and without diabetes mellitus (DM), and to identify whether mediating factors, such  as diabetic complications, Instrumental Activities of Daily Living (IADL) score, Mini-Mental  State Examination (MMSE) score, as well as hemoglobin A1c (HbA1c), fasting plasma glucose  (FPG), serum total cholesterol (TC), triglycerides (TG), and low-density lipoprotein (LDL), are  associated with balance function in older persons with DM.",Non-OADS,/arxiv_data1/oa_pdf/18/6e/cia-12-189.PMC5279842.pdf
"Keywords:  diabetes mellitus, balance, POMA, fall, elderly, performance-oriented mobility  assessment Introduction Falls are the main cause of both fatal and nonfatal injuries in the elderly,1 such as  fractures and cerebral trauma, which increase morbidity and mortality and raise  health care costs.2,3 Diabetes mellitus (DM) affects .300 million individuals Correspondence: Xujiao Chen Department of geriatrics, Zhejiang  hospital, no 12, lingyin road, hangzhou  310013, People’s republic of China Tel +86 180 6989 7567 Fax +86 571 8798 0175 email lily197459@163.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Hong et al Running head recto: Balance function and associated mediating factors DOI: http://dx.doi.org/10.2147/CIA.S123985",Non-OADS,/arxiv_data1/oa_pdf/18/6e/cia-12-189.PMC5279842.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/18/6e/cia-12-189.PMC5279842.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/18/6e/cia-12-189.PMC5279842.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8e/ca/ijn-12-827.PMC5279843.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 827–837International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  827OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12194 8 Disulfiram-loaded porous PLGA microparticle  for inhibiting the proliferation and migration of  non-small-cell lung cancer chenhui Wang1,2,* Jiebing Yang1,3,* haobo han3 Jiawen chen3 Yudi Wang3 Quanshun li3 Yanbo Wang1 1Department of Urology, First  hospital of Jilin University, 2Innovative  Drug research centre, school of  Pharmacy, Chongqing University,   Chongqing, 3Key laboratory  for Molecular enzymology and  engineering of Ministry of education,   school of life sciences, Jilin  University, Changchun, People’s  republic of china *These authors contributed equally  to this workAbstract:  In this study, poly(lactic- co-glycolic acid) (PLGA) was used as a carrier to construct  disulfiram-loaded porous microparticle through the emulsion solvent evaporation method, using  ammonium bicarbonate as a porogen.",Non-OADS,/arxiv_data1/oa_pdf/8e/ca/ijn-12-827.PMC5279843.pdf
"Up to now, several reports have successfully entrapped disulfiram through shell- cross-linked micelle system or other formulations, which could achieve high in vitro  and in vivo antitumor efficacy.8,11,12 However, these systems could not realize the correspondence: Yanbo Wang Department of Urology, First hospital  of Jilin University, Qianjin street 2699,  Changchun 130012, People’s Republic of  china Tel +86 431 8515 5216 Fax +86 431 8515 5200 email doctorwyb@126.co m  Quanshun li Key laboratory for Molecular  enzymology and engineering of Ministry  of education, school of life sciences,  Jilin University, Qianjin street 2699,  Changchun 130012, People’s Republic of  china email quanshun@jlu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Wang et al Running head recto: Porous PLGA microparticle for disulfiram delivery DOI: http://dx.doi.org/10.2147/IJN.S121948",Non-OADS,/arxiv_data1/oa_pdf/8e/ca/ijn-12-827.PMC5279843.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/8e/ca/ijn-12-827.PMC5279843.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/ca/ijn-12-827.PMC5279843.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/73/e3/cia-12-175.PMC5279844.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 175–187Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  175RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11121 6 Reducing the risk of stroke in elderly patients  with non-valvular atrial fibrillation: a practical  guide for clinicians Joanne M Foody Department of Medicine, Harvard  Medical School, Boston, MA, USAAbstract:  Non-valvular atrial fibrillation (NVAF) significantly contributes to the burden of  stroke, particularly in elderly patients.",Non-OADS,/arxiv_data1/oa_pdf/73/e3/cia-12-175.PMC5279844.pdf
"Keywords:  aged, non-vitamin K antagonist oral anticoagulants, stroke, warfarin, bleeding Introduction The prevalence of atrial fibrillation (AF) in the US population (estimated at 5.2 million  in 2010) is projected to increase to 12.1 million by 2030.1 While age-adjusted inci - dence of clinically recognized AF has risen in recent decades, a 1993–2007 Medicare  sample found a steady incidence, indicative of the association of AF with an aging  population.2,3 AF, the most common cardiac arrhythmia, is a significant risk factor for  stroke, increasing the risk fivefold.4,5 In analysis of trial data from ~9,000 patients with AF, increasing age was found to  be associated with elevated stroke risk (hazard ratio [HR] per decade increase, 1.45;  95% confidence interval [CI] 1.26–1.66).6 Elderly patients with AF also often suffer  from impactful comorbidities, including hypertension, coronary heart disease, diabetes Correspondence: Joanne M Foody Merck & Co., 126 e Lincoln Ave,  Rahway, NJ 07065, USA Tel +1 732 594 5000 Fax +1 732 594 5100 email Joanne.foody@merck.co mJournal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Foody Running head recto: Stroke risk reduction in elderly NVAF patients DOI: http://dx.doi.org/10.2147/CIA.S111216",Non-OADS,/arxiv_data1/oa_pdf/73/e3/cia-12-175.PMC5279844.pdf
"Available  from: http://www.acc.org/tools-and-practice-support/clinical-toolkits/ atrial-fibrillation-afi b. Accessed June 8, 2016.",Non-OADS,/arxiv_data1/oa_pdf/73/e3/cia-12-175.PMC5279844.pdf
"Available from: http://packageinserts.bms.com/pi/pi_couma - din.pd f. Accessed June 8, 2016.",Non-OADS,/arxiv_data1/oa_pdf/73/e3/cia-12-175.PMC5279844.pdf
"Available from: http://www.xareltohcp.com/ shared/product/xarelto/prescribing-information.pd f. Accessed June 8,  2016.",OADS,/arxiv_data1/oa_pdf/73/e3/cia-12-175.PMC5279844.pdf
"Available from http://packageinserts.bms.com/pi/ pi_eliquis.pd f. Accessed June 8, 2016.",OADS,/arxiv_data1/oa_pdf/73/e3/cia-12-175.PMC5279844.pdf
"Available from: http://docs.boehringer- ingelheim.com/Prescribing%20Information/PIs/Pradaxa/Pradaxa.pd f.  Accessed June 8, 2016.",Non-OADS,/arxiv_data1/oa_pdf/73/e3/cia-12-175.PMC5279844.pdf
Available from: http://dsi.com/prescribing-information-portlet/getPI   Content?productName =Savaysa&inline =true.,Non-OADS,/arxiv_data1/oa_pdf/73/e3/cia-12-175.PMC5279844.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/73/e3/cia-12-175.PMC5279844.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/73/e3/cia-12-175.PMC5279844.pdf
Avail - able from: http://perosphere.com/content/research/#p7HGMpc_1_ 2.,Non-OADS,/arxiv_data1/oa_pdf/73/e3/cia-12-175.PMC5279844.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ad/7f/ijn-12-855.PMC5279845.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 855–869International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  855OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12267 8 curcumin-coordinated nanoparticles with  improved stability for reactive oxygen species- responsive drug delivery in lung cancer therapy cheng-Qiong luo1–3,* lei Xing1–3,* Peng-Fei cui1 Jian-Bin Qiao1 Yu-Jing he1 Bao-an chen4 liang Jin1,2,5 hu-lin Jiang1–3 1state Key laboratory of  Natural Medicines, Department  of Pharmaceutics, 2Jiangsu Key  laboratory of Drug screening,   3Jiangsu Key laboratory of Drug  Discovery for Metabolic Diseases,   china Pharmaceutical University,   4Department of hematology, The  affiliated Zhongda hospital of  southeast University, 5school of  life science and Technology, china  Pharmaceutical University, Nanjing,   china *These authors contributed equally  to this workBackground:  The natural compound curcumin (Cur) can regulate growth inhibition and  apoptosis in various cancer cell lines, although its clinical applications are restricted by extreme  water insolubility and instability.",Non-OADS,/arxiv_data1/oa_pdf/ad/7f/ijn-12-855.PMC5279845.pdf
"However, poor aqueous solubility and  extreme instability at physiological environment of Cur result in attenuated adsorption  and fast elimination, which impede its therapeutic use.8 These unfavorable properties correspondence: hu-lin Jiang state Key laboratory of Natural  Medicines, Department of Pharmaceutics,  china Pharmaceutical University, Tongjia  Xiang 24, Nanjing 210009, china Tel/fax +86 25 8327 1027 email jianghulin3@163.co m  liang Jin school of life science and Technology,  china Pharmaceutical University, Tongjia  Xiang 24, Nanjing 210009, china Tel/fax +86 25 8327 1242 email liangjin1975@cpu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Luo et al Running head recto: Curcumin-coordinated nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S122678",Non-OADS,/arxiv_data1/oa_pdf/ad/7f/ijn-12-855.PMC5279845.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ad/7f/ijn-12-855.PMC5279845.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/ijn-12-855.PMC5279845.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/13/28/opth-11-219.PMC5279846.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 219–222Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  219Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12315 0 Trypan blue-assisted posterior capsulorhexis in  pediatric cataract surgery ayman lotfy1,2 ayman abdelrahman1,2 1Ophthalmology Department, Zagazig  University hospital, 2alpha Vision  Center, Zagazig, egyptPurpose:  To evaluate the safety and efficacy of staining the posterior capsule with trypan blue  during capsulorhexis in pediatric cataract surgery.",Non-OADS,/arxiv_data1/oa_pdf/13/28/opth-11-219.PMC5279846.pdf
"Use of trypan blue allows better controlled posterior capsulorhexis and  facilitates optic capture of the IOL, thus providing better centration and consequently  better optical performance.8,9 Patients and methods This study, carried out at Alpha Vision Center, Zagazig, Egypt, was performed  according to the Declaration of Helsinki and was approved by the institutional review Correspondence: ayman lotfy Ophthalmology Department, Zagazig  University hospital, Koliat al Tob street,  shaibet an nakareyah, Markaz el-Zagazig,  ash sharqia governorate 44519, egypt Tel +20 102 220 4510 Fax +20 122 427 6447 email elnadyayman@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Lotfy and Abdelrahman Running head recto: Posterior capsule staining DOI: http://dx.doi.org/10.2147/OPTH.S123150",Non-OADS,/arxiv_data1/oa_pdf/13/28/opth-11-219.PMC5279846.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/13/28/opth-11-219.PMC5279846.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/28/opth-11-219.PMC5279846.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5e/94/jbm-8-005.PMC5279847.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5e/94/jbm-8-005.PMC5279847.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Blood Medicine 2017:8 5–12Journal of Blood Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  5 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S123374Evaluation of a biosimilar granulocyte   colony-stimulating factor (filgrastim XM02)  for peripheral blood stem cell mobilization  and transplantation: a single center experience in Japan Hideaki Y oshimura Masaaki Hotta Takahisa Nakanishi Shinya FujitaAya NakayaAtsushi Satake T omoki Ito Kazuyoshi IshiiShosaku Nomura First Department of Internal  Medicine, Kansai Medical University,  Hirakata, Osaka, JapanBackground: Biosimilar granulocyte colony-stimulating factor (G-CSF) has recently been  introduced into clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/5e/94/jbm-8-005.PMC5279847.pdf
"5,6 Correspondence: Shosaku Nomura  First Department of Internal Medicine, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka 573-1010, JapanTel +81 72 804 2754Fax +81 72 804 2041Email nomurash@hirakata.kmu.ac.jp Journal name: Journal of Blood Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Y oshimura et alRunning head recto: Biosimilar G-CSF in HSCH and HSCTDOI: http://dx.doi.org/10.2147/JBM.S123374",Non-OADS,/arxiv_data1/oa_pdf/5e/94/jbm-8-005.PMC5279847.pdf
"Journal of Blood Medicine 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Blood Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-blood-medicine-journalThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects   of all aspect pertaining to blood based medicine including but not limited to:   Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,   and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of blood related medicine; Legal aspects of blood medicine; Historical perspec-tives.",Non-OADS,/arxiv_data1/oa_pdf/5e/94/jbm-8-005.PMC5279847.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dovepress 12 Y oshimura et al 19.,Non-OADS,/arxiv_data1/oa_pdf/5e/94/jbm-8-005.PMC5279847.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/70/29/ndt-13-213.PMC5279848.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 213–219Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  213OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12036 8 Minimal invasive puncture and drainage versus  endoscopic surgery for spontaneous intracerebral  hemorrhage in basal ganglia Zhihong li1,* Yuqian li1,* Feifei Xu2,* Xi Zhang3 Qiang Tian4 lihong li1 1Department of Neurosurgery,   Tangdu hospital, 2Department of  Foreign languages, 3Department of  Biomedical engineering, 4Department  of radiology, Tangdu hospital, The  Fourth Military Medical University,   Xi’an, shaanxi Province, People’s  republic of china *These authors contributed equally  to this workAbstract:  Two prevalent therapies for the treatment of spontaneous intracerebral hemorrhage  (ICH) in basal ganglia are, minimally invasive puncture and drainage (MIPD), and endoscopic  surgery (ES).",Non-OADS,/arxiv_data1/oa_pdf/70/29/ndt-13-213.PMC5279848.pdf
"Surgical treatments available correspondence: lihong li Department of Neurosurgery, Tangdu  hospital, The Fourth Military Medical  University, 1 Xinyi road, Baqiao District,  Xi’an 710039, shaanxi Province, People’s  republic of china Tel +86 029 8477 8359 email lihongliaaa@126.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Li et al Running head recto: Minimal invasive surgery for ICH DOI: http://dx.doi.org/10.2147/NDT.S120368",Non-OADS,/arxiv_data1/oa_pdf/70/29/ndt-13-213.PMC5279848.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/70/29/ndt-13-213.PMC5279848.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/29/ndt-13-213.PMC5279848.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a8/88/dddt-11-273.PMC5279849.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 273–293Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  273Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6097 3 Drugs in development for toxoplasmosis:  advances, challenges, and current status P Holland Alday1 Joseph Stone Doggett1,2 1Division of infectious Diseases,   Oregon Health & Science University,   2Portland veterans Affairs Medical  Center, Portland, OR, USAAbstract:  Toxoplasma gondii causes fatal and debilitating brain and eye diseases.",Non-OADS,/arxiv_data1/oa_pdf/a8/88/dddt-11-273.PMC5279849.pdf
"Correspondence: Joseph Stone Doggett veterans Affairs Medical Center, 3710  Southwest US veterans Hospital Road,  Portland, OR 97239, USA Tel +1 503 220 8262 email doggettj@ohsu.ed u Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Alday and Doggett Running head recto: Preclinical drugs for Toxoplasma gondii DOI: http://dx.doi.org/10.2147/DDDT.S60973",Non-OADS,/arxiv_data1/oa_pdf/a8/88/dddt-11-273.PMC5279849.pdf
Available at http://aidsinfo.nih.,Non-OADS,/arxiv_data1/oa_pdf/a8/88/dddt-11-273.PMC5279849.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a8/88/dddt-11-273.PMC5279849.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/88/dddt-11-273.PMC5279849.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.01.008 2211-3355/© 2017 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/db/fe/main.PMC5279859.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/fe/main.PMC5279859.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/db/fe/main.PMC5279859.pdf
http://www.hc-sc.gc.ca/fn-an/nutrition/ ﬁche-nutri- data/cnf_aboutus-aproposdenous_fcen-eng.php .,Non-OADS,/arxiv_data1/oa_pdf/db/fe/main.PMC5279859.pdf
http://www.jcsh-cces.ca/index.,Non-OADS,/arxiv_data1/oa_pdf/db/fe/main.PMC5279859.pdf
http://www.tchps.ca/ .,Non-OADS,/arxiv_data1/oa_pdf/db/fe/main.PMC5279859.pdf
http://www.who.int/school_youth_health/gshi/hps/ en/# .,Non-OADS,/arxiv_data1/oa_pdf/db/fe/main.PMC5279859.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/53/main.PMC5279860.pdf
"Once  this was  done,  reduction  was  easily  obtained  using  the  “traction- http://dx.doi.org/10.1016/j.ijscr.2017.01.025 2210-2612/© 2017  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/61/53/main.PMC5279860.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).Keywords: Adult Sedentary lifestyle Sociological factorsMarital statusFamily characteristicsSocial support 1.,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.01.007 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1016/j.ehb.2008.07.,OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1016/j.ypmed.,OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
162 (2).http://dx.doi.org/10.7326/M14-1651 (123 –22).,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
J .P h y s .A c t .H e a l t h9 : 9 8 5 –995 ( http://www.ncbi.nlm.nih.gov/pubmed/21953281 ).,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
1:37 –67 ( http://www.researchgate.net/pro ﬁle/Daniel_ Russell4/publication/271507385_THE_PROVISIONS_OF_SOCIAL_RELATIONSHIPS_ AND_ADAPTATION_TO_STRESS/links/54c960b40cf2807dcc265ce2.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1016/j.amepre.,OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1371/ journal.pone.0105620 .,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1016/j.amepre.2010.03.,OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1249/MSS.0b013e31824ba87e .,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
"2014 (3):1 –5.http://dx.doi.org/10.1155/2014/287013 .273 S. Huffman, M. SzafronPreventive Medicine Reports 5 (2017) 268 –274",Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1186/ 1471-2458-14-1127 .,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://www.hc-sc.gc.ca/fn-an/nutrition/weights-poids/guide-ld-adult/ index-eng.php ).,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1016/j.ypmed.2015.01.030 .,OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
:1 –25http://dx.doi.org/10.1080/1369118X.2015.,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.2188/jea.,OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1177/1461444805052280 .,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
AMEPRE 38 (1):17–26.http://dx.doi.org/10.1016/j.amepre.2009.08.032 .,OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
31 (6):1 –10.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
10(1):p. 1. http://dx.doi.org/10.1186/1479-5868- 10-79 .,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1080/09720502.,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
BMC Public Health:1 –25http://dx.doi.org/10.1186/s12889-016-2841-3 (February).,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1016/j.amepre.,OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1136/ bjsports-2013-093107 .,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1093/aje/kwq155 .,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1038/oby.2006.209 .,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1016/j.amepre.2011.10.020 .,OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1007/s10865-013-9508-7 .,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
18 (4):490 –501 ( http://ssc.sagepub.,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
BMC Public Health:1 –10http://dx.doi.org/10.1186/s12889-015-1711-8 (April).,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1016/j.ypmed.2007.10.005 .,OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1007/s00484-010- 0319-z48 .,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
1 –100 (September http://sda.chass.utoronto.ca.cyber.usask.ca/ sdaweb/dli2/cchs/cchs2012/more_doc/cchs-escc2012_2011-2012gid-eng.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
1 –171 (October http://sda.chass.utoronto.ca.,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://www.statcan.gc.ca/pub/12-002-x/2014001/article/11901-eng.htm#a7 ).,OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
9 (1):3. http://dx.doi.org/10.1186/1479-5868-9-3 .,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1016/j.chb.2011.12.003 .,OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1186/1471- 2458-14-1067 .,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
AMEPRE 39 (1): 25–32.http://dx.doi.org/10.1016/j.amepre.2010.03.004 .,OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
32 (1):34 –35.http://dx.doi.org/10.1093/ije/dyg018 .,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
BMC Public Health 13 (1):1. http://dx.doi.org/10.1186/1471-2458-13-196 .,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
http://dx.doi.org/10.1089/cyber.2012.0557 .,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
23 (1):70 –77.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
"http://dx.doi.org/10.1371/journal.pone.0085440 .274 S. Huffman, M. SzafronPreventive Medicine Reports 5 (2017) 268 –274",Non-OADS,/arxiv_data1/oa_pdf/6f/0a/main.PMC5279861.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).Keywords: MortalityPhysical activityModerate-to-vigorous-intensity physical activitySedentary Type 2 diabetes mellitus Cox proportional hazards regression 1.,Non-OADS,/arxiv_data1/oa_pdf/db/48/main.PMC5279862.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.01.013 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/db/48/main.PMC5279862.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/48/main.PMC5279862.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/db/48/main.PMC5279862.pdf
https://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/db/48/main.PMC5279862.pdf
"By week 6, follow up visit revealed signi ﬁcant improve- http://dx.doi.org/10.1016/j.mmcr.2017.01.003 Received 1 December 2016; Received in revised form 12 January 2017; Accepted 17 January 2017⁎Corresponding author at: Niagara Falls Memorial Medical Center, 621 10th Street, Niagara Falls, NY 14302, USA.",Non-OADS,/arxiv_data1/oa_pdf/90/10/main.PMC5279863.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/10/main.PMC5279863.pdf
8 (5) (2015) (Available from) 〈http://www.jjmicrobiol.com/?,Non-OADS,/arxiv_data1/oa_pdf/90/10/main.PMC5279863.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/26/36/opth-11-223.PMC5279866.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 223–231Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  223Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11951 0 Combination verteporfin photodynamic therapy  ranibizumab-dexamethasone in choroidal  neovascularization due to age-related macular  degeneration: results of a phase ii randomized trial ron P gallemore1 Josh Wallsh1 henry l hudson2 allen C ho3 richard Chace4 Joel Pearlman5 On behalf of the raDiC al  Trial group 1retina Macula institute, T orrance,   Ca, 2retina Centers PC, T ucson, aZ,   3Wills eye institute, Philadelphia,   Pa, 4eyesight Ophthalmic services,   Portsmouth, nh, 5retinal Consultants  Medical group, sacramento, C a, UsaPurpose:  To assess whether combination therapy (CT) reduces retreatments when compared  to ranibizumab monotherapy (RM), while safely maintaining similar vision outcomes.",Non-OADS,/arxiv_data1/oa_pdf/26/36/opth-11-223.PMC5279866.pdf
"Keywords:  age-related macular degeneration (AMD), combination therapy, ranibizumab,  photodynamic therapy (PDT), verteporfin Introduction Intravitreal ranibizumab (IVR; Lucentis®; Genentech, South San Francisco, CA USA)  monotherapy is a proven effective treatment for choroidal neovascularization (CNV)  due to age-related macular degeneration (AMD),1–2 limitations include the need  for continued monthly injections for 1 year or longer to achieve the best outcomes,  cost, risk of infection, and the potential inability of patients to attend monthly treat - ment visits.1–4 Combination therapy (CT) with verteporfin photodynamic therapy (vPDT) and IVR  with or without intravitreal dexamethasone (IVD) for neovascular AMD may reduce the  number and frequency of treatments while preserving vision gains associated with anti- vascular endothelial growth factor (VEGF) alone.5–15 Multiple retrospective case series  of patients with CNV treated with double therapy (vPDT and intravitreal anti-VEGF)  have demonstrated fewer retreatments than would be expected with monotherapy with  stabilized or improved visual acuity (VA).5,8,12 Williams et al and Hatz et al both com - pared double therapy with IVR monotherapy in randomized, prospective 1-year studies Correspondence: ron P gallemore retina Macula institute, 4201 Torrance  Blvd ste 220, Torrance, Ca 90503, Usa Tel +1 310 944 9393 Fax +1 310 944 3393 email rongallemoremd@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Gallemore et al Running head recto: Combination therapy for AMD DOI: http://dx.doi.org/10.2147/OPTH.S119510",Non-OADS,/arxiv_data1/oa_pdf/26/36/opth-11-223.PMC5279866.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/26/36/opth-11-223.PMC5279866.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/36/opth-11-223.PMC5279866.pdf
"Available from:  http://www.bausch.com/Portals/77/-/m/BL/United%20States/Files/ Package%20Inserts/Pharma/visudyne-package-insert.pd f. Accessed  June 2, 2016.",Non-OADS,/arxiv_data1/oa_pdf/26/36/opth-11-223.PMC5279866.pdf
2016 Jul 6;7:12119; PMID: 27381418; http://dx.doi.org/10.1038/ncomms12119 .,OADS,/arxiv_data1/oa_pdf/7b/51/kchl-11-01-1222760.PMC5279874.pdf
"1, 8 –10 http://dx.doi.org/10.1080/19336950.2016.1222760",Non-OADS,/arxiv_data1/oa_pdf/7b/51/kchl-11-01-1222760.PMC5279874.pdf
J Mol Biol 2016; 428:3150 –65; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/7b/51/kchl-11-01-1222760.PMC5279874.pdf
"NatCommun 2016; 7:12119; PMID:27381418; http://dx.doi.org/10.1038/ncomms12119 [3] L €uhn K, Wild MK, Eckhardt M, Gerardy-Schahn R, Vestweber D. The gene defective in leukocyte adhesion deﬁciency II encodes a putative GDP-fucose transporter.",OADS,/arxiv_data1/oa_pdf/7b/51/kchl-11-01-1222760.PMC5279874.pdf
Nat Genet 2001; 28:69-72; PMID:11326279; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/51/kchl-11-01-1222760.PMC5279874.pdf
"org/10.1038/88289 [4] Baldwin TC, Handford MG, Yuseff MI, Orellana A, Dupree P. Identi ﬁcation and characterization of GONST1, a golgi-localized GDP-mannose transporter in Arabidopsis.Plant Cell 2001; 13:2283-95: PMID:11595802; http://dx.doi.org/10.1105/tpc.13.10.2283 [5] Utz D, Handford M. VvGONST-A and VvGONST-B are Golgi-localised GDP-sugar transporters in grapevine (Vitisvinifera L.).",Non-OADS,/arxiv_data1/oa_pdf/7b/51/kchl-11-01-1222760.PMC5279874.pdf
"Plant Sci 2015; 231:191-7; PMID:25576004;http://dx.doi.org/10.1016/j.plantsci.2014.11.009 [ 6 ] W a n gH ,Z h a n gC ,C h e nH ,Y a n gQ ,Z h o uX ,G uZ , Zhang H, Chen W, Chen YQ.",OADS,/arxiv_data1/oa_pdf/7b/51/kchl-11-01-1222760.PMC5279874.pdf
Glycobiology 2016; pii: cww032; PMID 26957583; http://dx.doi.org/10.1093/glycob/cww032.,OADS,/arxiv_data1/oa_pdf/7b/51/kchl-11-01-1222760.PMC5279874.pdf
J Biol Chem 2010;285:36245-54; PMID:20837470; http://dx.doi.org/10.1074/jbc.M110.12600310 B. EBERT ET AL.,OADS,/arxiv_data1/oa_pdf/7b/51/kchl-11-01-1222760.PMC5279874.pdf
"1, 34 –45 http://dx.doi.org/10.1080/19336950.2016.1207023",Non-OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
"Pharmacol Rev2005; 57:411-25; PMID:16382099; http://dx.doi.org/10.1124/pr.57.4.5 [2] Wu J, Yan Z, Li Z, Yan C, Lu S, Dong M, Yan N. Struc- ture of the voltage-gated calcium channel Cav1.1 complex.",OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
Science 2015; 350:aad2395-aad; PMID:26680202; http://dx.doi.org/10.1126/science.aad2395 [3] Catterall WA.,OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
"Annu Rev Cell Dev Biol 2000; 16:521- 55; PMID:11031246; http://dx.doi.org/10.1146/annurev.cellbio.16.1.521 [4] Tombola F, Pathak MM, Isacoff EY.",OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
Ann Rev Cell Dev Biol 2006; 22:23-52; PMID:16704338; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
"Nature 2008; 456:891-7; PMID:19092925; http://dx.doi.org/10.1038/nature07620 [6] Xu Y, Ramu Y, Lu Z.",Non-OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
"Structure2016; 24:261-71; PMID:26749449; http://dx.doi.org/10.1016/j.str.2015.11.011 [8] Mathur R, Zheng J, Yan Y, Sigworth FJ.",OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
J Gen Physiol 1997; 109:191-9; PMID:9041448; http://dx.doi.org/10.1085/jgp.109.2.191 [9] Bezanilla F. Voltage sensor movements.,OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
"J Gen Physiol 2002; 120:465-73; PMID:12356849; http://dx.doi.org/10.1085/jgp.20028660 [10] Tuluc P, Benedetti B, Coste de Bagneaux P, Grabner M, Flucher BE.",OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
"J Gen Physiol 2016; 147:437-49;PMID:27185857; http://dx.doi.org/10.1085/jgp.201611568 [11] Xu W, Lipscombe D. Neuronal CaV1.3 a1 L-type chan- nels activate at relatively hyperpolarized membranepotentials and are incompletely inhibited by dihydropyri-dines.",Non-OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
"J Biol Chem 2004; 279:44335-43; PMID:15299022; http://dx.doi.org/10.1074/jbc.M407023200 [13] Lin Z, Lin Y, Schorge S, Pan JQ, Beierlein M, Lipscombe D. Alternative splicing of a short cassette exon in a1B generates functionally distinct N-type calcium channels in central and peripheral neurons.",OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
"Biophys J 1999; 76:1384-400; PMID:10049321; http://dx.doi.org/10.1016/S0006- 3495(99)77300-5 [15] Bourinet E, Soong TW, Sutton K, Slaymaker S, Mathews E, Monteil A, Zamponi GW, Nargeot J, Snutch TP.",OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
"Nat Neurosci1999; 2:407-15; PMID:10321243; http://dx.doi.org/10.1038/8070 [16] Adams PJ, Ben-Johny M, Dick IE, Inoue T, Yue DT.",OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
Biophys J 2009;96:35-44; PMID:19134469; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
"Mol Cell Biol 2009; 29:4757-65; PMID:19564422;http://dx.doi.org/10.1128/MCB.00608-09 [19] Tan GMY, Yu D, Wang J, Soong TW.",OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
"J Biol Chem 2012; 287:832-47; PMID:22069316; http://dx.doi.org/10.1074/jbc.M111.268722 [20] Safa P, Boulter J, Hales TG.",OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
Functional properties of CaV1.3 ( a1D) L-type Ca2 CChannel Splice Variants Expressed by Rat Brain and Neuroendocrine GH3 Cells.J Biol Chem 2001; 276:38727-37; PMID:11514547; http://dx.doi.org/10.1074/jbc.M103724200[21] McRory JE.,Non-OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
"J Neurosci 2004; 24:1707-18; PMID:14973233; http://dx.doi.org/10.1523/JNEUROSCI.4846-03.2004 [22] Mori MX, Erickson MG, Yue DT.",OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
"Science 2004; 304:432-5; PMID:15087548; http://dx.doi.org/10.1126/science.1093490 [23] Xu S-Z, Zeng F, Lei M, Li J, Gao B, Xiong C, et al.",OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
"NatBiotechnol 2005; 23:1289-93; PMID:16170312; http://dx.doi.org/10.1038/nbt1148 [24] Liu X, Yang PS, Yang W, Yue DT.",OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
Nature 2010; 463:968-72; PMID:20139964; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/68/kchl-11-01-1207023.PMC5279877.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/d4/main.PMC5279888.pdf
The  postoperative  course  was http://dx.doi.org/10.1016/j.ijscr.2017.01.023 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/85/d4/main.PMC5279888.pdf
E-mail address: jan@metabol.su.se (J. Nedergaard) Available online 9 November 2016 DOI of original article: http://dx.doi.org/10.1016/j.molmet.2016.07.005 .,OADS,/arxiv_data1/oa_pdf/c4/e5/main.PMC5279901.pdf
http://dx.doi.org/10.1016/j.molmet.2016.10.012 MOLECULAR METABOLISM 6 (2017) 173 e173/C2112016 The Authors.,OADS,/arxiv_data1/oa_pdf/c4/e5/main.PMC5279901.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/e5/main.PMC5279901.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Language lateralisationRegionalSubcorticalLateralityStatistical powerPresurgical planning 1.,Non-OADS,/arxiv_data1/oa_pdf/bc/a1/main.PMC5279902.pdf
http://dx.doi.org/10.1016/j.nicl.2017.01.011 2213-1582/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/bc/a1/main.PMC5279902.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/a1/main.PMC5279902.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/51/main.PMC5279903.pdf
"Received November 9, 2016 /C15Revision received November 28, 2016 /C15Accepted December 2, 2016 /C15Available online 8 December 2016 http://dx.doi.org/10.1016/j.molmet.2016.12.001 Review 174MOLECULAR METABOLISM 6 (2017) 174 e184/C2112016 The Authors.",OADS,/arxiv_data1/oa_pdf/46/51/main.PMC5279903.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/51/main.PMC5279903.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/51/main.PMC5279903.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/51/main.PMC5279903.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/51/main.PMC5279903.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/51/main.PMC5279903.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/51/main.PMC5279903.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/51/main.PMC5279903.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/51/main.PMC5279903.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/51/main.PMC5279903.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/51/main.PMC5279903.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/51/main.PMC5279903.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.12.005,OADS,/arxiv_data1/oa_pdf/bd/bd/main.PMC5279904.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Social interactionEye-trackingFamiliarityFunctional magnetic resonance imagingTemporoparietal junctionSuperior temporal sulcus 1.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1016/j.nicl.2017.01.006 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1111/j.1467-7687.2005.00445.x .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1016/j.neubiorev.2016.02.024 .,OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1016/j.neubiorev.2016.02.001 .,OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
10:41 –50.http://dx.doi.org/10.1016/j.rasd.2014.10.015 .,OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1016/j.tics.,OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
1 (1):1 –11.http://dx.doi.org/10.1002/brb3.6 .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://www.ncbi.nlm.nih.gov/pubmed/11949896 .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1037/0012-1649.40.2.271 .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1177/1073858407304654 .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
:2259 –2266 http://dx.doi.org/10.1007/s10803-015-2369-x .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1038/9224 .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/ 10.1016/j.nicl.2013.08.014 .,OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
"http://dx.doi.org/ 10.1016/j.neuroimage.2009.07.057 .Grelotti, D.J., Gauthier, I., Schultz, R.T., 2002.",OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1002/dev.10028 .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1098/Rstb.2006.1934 .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1093/scan/nsn011 .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1093/brain/awp306 .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1016/j.neuroimage.2016.02.026 .,OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1162/jocn.2007.19.8.1323 .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
: 2 6 2 –268http://dx.doi.org/10.1007/s10803-014-2193-8 .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/ 10.1007/s10803-011-1197-x .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1007/s10803-013-2018-1 .120 E. Oberwelland et al.,OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1038/nn1223 .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1016/j.conb.2006.03.001 .,OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1093/scan/nsl034 .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1098/rstb.2015.0081 .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1159/000366134 .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.08.024 .,OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1016/j.jaac.,OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
:1118 –1126 http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
"http://dx.doi.org/10.1177/1073858410397208 .Shah, N.J., Marshall, J.C., Za ﬁris, O., Schwab, A., Zilles, K., Markowitsch, H.J., Fink, G.R., 2001.",Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
NeuroImage 29 (1):90 –98.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1097/ 00004583-200404000-00015 .,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
http://dx.doi.org/10.1016/j.tins.2006.06.004 .121 E. Oberwelland et al.,OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC5279905.pdf
This  is  an  open access article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/a3/main.PMC5279906.pdf
Initial  computed http://dx.doi.org/10.1016/j.ijscr.2017.01.027 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/fd/a3/main.PMC5279906.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2d/47/main.PMC5279907.pdf
A  physical  examination  showed  hemorrhagic  ane- http://dx.doi.org/10.1016/j.ijscr.2017.01.030 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/2d/47/main.PMC5279907.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).Keywords: Migraine Magnetic resonance imaging Grey matter changesMeta-analysisDisease progression 1.,Non-OADS,/arxiv_data1/oa_pdf/db/39/main.PMC5279908.pdf
http://dx.doi.org/10.1016/j.nicl.2017.01.019 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/db/39/main.PMC5279908.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/39/main.PMC5279908.pdf
Statistical analysis We used Ginger ALE 2.3.5 ( http://www.brainmap.org/ )t oe v a l u a t e the presence of common patterns of GM alterations.,Non-OADS,/arxiv_data1/oa_pdf/db/39/main.PMC5279908.pdf
This is an ope n access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Transcutaneous vagus nerve stimulation tVNS Major depressive disorder (MDD)Functional magnetic resonance imaging (fMRI) 1.,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1016/j.nicl.2016.12.016 2213-1582/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
"In addition, head motion analysis was performed using the artifact detection toolbox (ART) ( https://www.nitrc.org/projects/ artifact_detect/ ).",OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
"http://dx.doi.org/10.1016/S0022-3956(03)00074-8 .Cohen, J.D., Nichols, T., Keller, J., Gomez, R.G., Schatzberg, A.F., Reiss, A.L., 2013.",OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1016/j.neures.2013.02.,OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1016/j.pscychresns.2005.12.007 (S0925- 4927(05)00207-6 [pii]).,OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1016/j.comppsych.2009.08.006 (S0010- 440X(09)00092-3 [pii]).,OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1515/BMT.2008.022 .,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.17925/ENR.2011.06.04.254 .,OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1016/j.brs.2014.11.018 .,OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1016/j.neuroimage.2015.03.015 .,OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.3155-13.2014 .,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
BMC Psychiatry 12:45. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
303:49 –52.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1007/s40473-014-0010-5 .,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
14:203. http://dx.doi.org/10.1186/1472-6882-14-203 .,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1038/tp.2015.174 .,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
1344:50 –65.http://dx.doi.org/10.1111/nyas.12759 .,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1016/j.jad.2016.08.003 .,OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/ 10.1001/jamapsychiatry.2013.143 .,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1007/s11920-006- 0049-4 .,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
12:255. http://dx.doi.org/10.1186/1472- 6882-12-255 (1472-6882-12-255 [pii]).,OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1016/j.jad.2016.02.,OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
219:36 –43.http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
62:60 –73.http://dx.doi.org/10.1016/j.brat.,OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1016/j.jad.2011.04.004 .,OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1038/nm.,OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1002/hbm.22807 .,Non-OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
http://dx.doi.org/10.1371/journal.pone.0069809 .111 J. Fang et al.,OADS,/arxiv_data1/oa_pdf/73/47/main.PMC5279909.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
"Abbreviations: AKT, Protein kinase B; ATF6, activating transcription factor 6; ER, endoplasmic reticulum; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GTT , glucose tolerance test; HFD, high-fat diet; IKK, kappa a/bkinase; iNOS, inducible nitric oxide synthase; IRE1, inositol requiring enzyme 1; ITT, insulin tolerance test; JNK, c-JunN- terminal kinase; NO, nitric oxide; PERK, protein kinase RNA-like ER kinase; qPCR, real time PCR; UPR, unfolded protein response Received October 7, 2016 /C15Revision received December 2, 2016 /C15Accepted December 12, 2016 /C15Available online 19 December 2016 http://dx.doi.org/10.1016/j.molmet.2016.12.005 Original Article 206MOLECULAR METABOLISM 6 (2017) 206 e218/C2112016 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1134/S1990750814030093 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1097/ALN.0b013e3181799d45 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1172/jci117936 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
Antioxidants & Redox Signaling 9(3):319 e 329. http://dx.doi.org/10.1089/ars.2007.9.ft-17 .,OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/ 10.1016/j.freeradbiomed.2014.05.016 .,OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.4161/viru.27794 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1242/jcs.01166 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1152/phys- rev.00014.2008 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/ 10.1042/cs20090433 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1016/j.free- radbiomed.2010.12.005 .,OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1038/nm1001-1138 .,OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1016/ j.cell.2010.02.034 .,OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1016/ j.mrfmmm.2004.06.056 .,OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
Nature Reviews Molecular Cell Biology 8(7):519 e 529. http://dx.doi.org/10.1038/nrm2199 .,OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1126/sci- ence.1103160 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
Science 313(5790):1137 e 1140. http://dx.doi.org/10.1126/science.1128294 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/ 10.1007/s00281-013-0370-z .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1016/ j.cellsig.2010.07.006 .,OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/ 10.1126/science.aaa0079 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.2337/db08-0506 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1038/oby.2009.194 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1016/j.taap.2010.04.005 .,OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
Journal of Clinical Investigation 90(5):1839 e 1849. http://dx.doi.org/10.1172/jci116060 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
Endocrinology 145(1):281 e 293. http://dx.doi.org/10.1210/en.2003-0575 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1371/journal.pone.0011621 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1007/ s00125-013-2976-z .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1172/jci116803 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1371/journal.pone.0054247 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1016/j.cmet.2009.11.003 .,OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1007/s00421- 010-1783-1 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1002/oby.20410 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1172/jci77812 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1038/nm.3735 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1126/science.aaf5549 aaf5549.,OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
Oxidative Medicine and Cellular Longevity 2015:181643. http://dx.doi.org/10.1155/2015/181643 .,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
http://dx.doi.org/10.1016/ j.jcjd.2014.02.023 .,OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ca/main.PMC5279911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/9b/main.PMC5279912.pdf
"Received October 7, 2016 /C15Revision received December 6, 2016 /C15Accepted December 12, 2016 /C15Available online 18 December 2016 http://dx.doi.org/10.1016/j.molmet.2016.12.004 Original Article 194MOLECULAR METABOLISM 6 (2017) 194 e205/C2112016 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/f4/9b/main.PMC5279912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/9b/main.PMC5279912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/9b/main.PMC5279912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/9b/main.PMC5279912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/9b/main.PMC5279912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/9b/main.PMC5279912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/9b/main.PMC5279912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/9b/main.PMC5279912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/9b/main.PMC5279912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/9b/main.PMC5279912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/9b/main.PMC5279912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/9b/main.PMC5279912.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f4/9b/main.PMC5279912.pdf
http://www.gtexportal.org .,Non-OADS,/arxiv_data1/oa_pdf/f4/9b/main.PMC5279912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/9b/main.PMC5279912.pdf
"Luiz Menna-Barreto Escola de Artes, Ciências e Humanidades, Universidade de São Paulo, Rua Arlindo Betio, 1000, 03828-000, Brazil E-mail address: menna@usp.br http://dx.doi.org/10.1016/j.slsci.2016.12.003Peer review under responsibility of Brazilian Association of Sleep.Sleep Science 9 (2016) 261 Available online 11 December 2016 1984-0063/ © 2016 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/79/cf/main.PMC5279926.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/cf/main.PMC5279926.pdf
http://dx.doi.org/10.1016/j.slsci.2016.12.001 Received 19 August 2016; Received in revised form 7 December 2016; Accepted 7 December 2016Peer review under responsibility of Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/75/7b/main.PMC5279927.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/75/7b/main.PMC5279927.pdf
Disponível em: http://www.pilotos.org.br/safety/2287-pesquisa-de- fadiga-veja-o-relatorio- ﬁnal.M.L.,Non-OADS,/arxiv_data1/oa_pdf/75/7b/main.PMC5279927.pdf
Associação Brasileira de Pilotos da Aviação Civil – ABRAPAC; 2014Disponível em: 〈http://www.pilotos.org.br/safety/2287-pesquisa- de-fadiga-veja-o-relatorio- ﬁnal〉.,Non-OADS,/arxiv_data1/oa_pdf/75/7b/main.PMC5279927.pdf
BMC Medical Res Methodol 2008;8:9. http://dx.doi.org/10.1186/1471- 2288-8-9.,Non-OADS,/arxiv_data1/oa_pdf/75/7b/main.PMC5279927.pdf
Disponível em: 〈http://www.scielo.br 〉 [acesso em 20.11.15].,Non-OADS,/arxiv_data1/oa_pdf/75/7b/main.PMC5279927.pdf
Disponível em: 〈http://www.scielo.br/scielo.php 〉[Acesso 20.11.15].,Non-OADS,/arxiv_data1/oa_pdf/75/7b/main.PMC5279927.pdf
40(4);2006. p. 684– 691Disponível em: 〈http://www.scielosp.org 〉[acesso em 20.11.,Non-OADS,/arxiv_data1/oa_pdf/75/7b/main.PMC5279927.pdf
Disponível em: 〈http://www.scielosp.org 〉[acesso em 20.11.15].,Non-OADS,/arxiv_data1/oa_pdf/75/7b/main.PMC5279927.pdf
Disponível em 〈http://www.abeso.org.br〉 [acesso em 28.12.15].,Non-OADS,/arxiv_data1/oa_pdf/75/7b/main.PMC5279927.pdf
Disponível em: 〈http://www.biblioteca.sebrae.com.br 〉 [acesso em: 07.12.15].,Non-OADS,/arxiv_data1/oa_pdf/75/7b/main.PMC5279927.pdf
"Psic., Saúde & Doenças, v.12, n. 2, Lisboa; 2011Disponível em:〈http://www.scielo.gpeari.mctes.pt/scielo.php 〉.",OADS,/arxiv_data1/oa_pdf/75/7b/main.PMC5279927.pdf
Disponível em: 〈http://www.sinpojud.org.br/destaques 〉.,Non-OADS,/arxiv_data1/oa_pdf/75/7b/main.PMC5279927.pdf
Sleep Med Clin 2015;10(4):455– 68.http://dx.doi.org/10.1016/ j.jsmc.2015.07.005 .M.L.,OADS,/arxiv_data1/oa_pdf/75/7b/main.PMC5279927.pdf
"These changes in the work sphere have led to shifts http://dx.doi.org/10.1016/j.slsci.2016.10.001 Received 1 July 2016; Received in revised form 5 October 2016; Accepted 7 October 2016☆Peer review under responsibility of Brazilian Association of Sleep ⁎Corresponding author at: Department of Environmental Health, School of Public Health, University of São Paulo, Av.",Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
J Psychosom Res 2010;51(6):745– 55.http://dx.doi.org/10.1016/ S0022-3999(01)00285-9 .,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
BMC Public Health 2010;10(1):531. http://dx.doi.org/10.1186/1471-2458-10- 531.,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
J Sleep Res 2002;11(4):339– 46.http://dx.doi.org/10.1046/j.1365- 2869.2002.00317.x.,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
http://dx.doi.org/10.1053/ smrv.2002.0186.,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Sleep Med 2010;11(6):520– 4.http://dx.doi.org/10.1016/ j.sleep.2009.12.011 .,OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Ann Neurol2013;74(4):537 –46.http://dx.doi.org/10.1002/ana.23945 .,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Int J Hypertens2013(43):6502. http://dx.doi.org/10.1155/2013/436502 .,OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
BMC Public Health 2013;13:84. http://dx.doi.org/10.1186/ 1471-2458-13-84.,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Sleep Med Rev 2013;17(4):241 –54.http://dx.doi.org/10.1016/j.smrv.2012.09.005 .,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Sleep Med2010;11(9):934 –40.http://dx.doi.org/10.1016/j.sleep.2010.04.014 .,OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Sleep Med 2008;9(5):488 –93.http://dx.doi.org/10.1016/j.sleep.2007.06.009 .,OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
〈http://www.ac.gov.br/ wps/wcm/connect/7625130047d6567c9c6bdd9c939a56dd/acre%2Bem%2Bnumeros%2B2011+Editado.pdf?MOD=AJPERES & CONVERT_TO=url & CACHEID=7625130047d6567c9c6bdd9c939a56dd〉; 2010 [accessed 10.03.16].,OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
〈http://www.mtps.gov.br/seguranca-e-saude-no-trabalho/normatizacao/ normas-regulamentadoras/norma-regulamentadora-n-15-atividades-e-operacoes-insalubres 〉; 1978 [acessed 10.04.16].,OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Appl Ergon 1987;18(3):233– 7.http://dx.doi.org/10.1016/0003- 6870(87)90010-X .,OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
〈http://bvsms.saude.,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Chronobiol Int 2016. http://dx.doi.org/10.3109/07420528.2016.1167730 .,OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
http://dx.doi.org/10.1016/j.sleep.2012.05.009 .,OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
http://dx.doi.org/10.1053/smrv.2000.0110 .,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
http://dx.doi.org/10.1590/S0303-A.J.,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Arch Women'S Ment Health 2012;15(4):237 –47.http://dx.doi.org/10.1007/s00737- 012-0281-3 .,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Prev Med 2009;49(4):280 –2.http://dx.doi.org/10.1016/ j.ypmed.2009.05.002 .,OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
http://dx.doi.org/10.1590/S1413-81232011001000007 .,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Act Paul Enferm 2014;27(4):333– 9. http://dx.doi.org/10.1590/1982-0194201400056 .,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Arq De Neuro-Psiquiatr 2010;68(3):372– 6.http://dx.doi.org/10.1590/ S0004-282X2010000300008 .,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Sci Rep 2015;5:14074. http://dx.doi.org/10.1038/ srep14074 .,OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Soc Nat 2010;22(2):373– 90. http://dx.doi.org/10.1590/S1982-45132010000200011 .,OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
http://dx.doi.org/10.1177/0748730415590702.,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Sleep Med 2009;10(9):1025 –30.http://dx.doi.org/ 10.1016/j.sleep.2008.12.008 .,OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Rev Bras Epidemiol 2015;18(1):42 –53.http://dx.doi.org/10.1590/1980-5497201500010004 .,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
Qual Health Res 2012;22:466 –75.http://dx.doi.org/10.1177/1049732311422050.,Non-OADS,/arxiv_data1/oa_pdf/fd/65/main.PMC5279928.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/26/main.PMC5279931.pdf
Data reported here indicate that melatonin levels are modi ﬁed before delirium onset and that the loss of melatonin rhythms can be used as a strategy to predict risk to developContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.08.001 1984-0063/ &2016 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/e3/26/main.PMC5279931.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/26/main.PMC5279931.pdf
Moreover the PER3 VNTR is a special characteristic of primate molecular clock since this genomic http://dx.doi.org/10.1016/j.slsci.2016.12.002 Received 5 July 2016; Received in revised form 20 October 2016; Accepted 7 December 2016Peer review under responsibility of Brazilian Association of Sleep.,OADS,/arxiv_data1/oa_pdf/87/83/main.PMC5279932.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/87/83/main.PMC5279932.pdf
"During the time of this case report, tuco tucos were caught year- http://dx.doi.org/10.1016/j.slsci.2016.06.001 Received 28 January 2016; Received in revised form 12 May 2016; Accepted 20 June 2016Peer review under responsibility of Brazilian Association of Sleep.",OADS,/arxiv_data1/oa_pdf/e7/38/main.PMC5279933.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e7/38/main.PMC5279933.pdf
"2016, PeerJ 4:e2559; http://dx.doi.org/10.7717/peerj.2559 [45] Bloch G, Robinson GE.",OADS,/arxiv_data1/oa_pdf/e7/38/main.PMC5279933.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
"Received November 10, 2016 /C15Revision received December 10, 2016 /C15Accepted December 26, 2016 /C15Available online 3 January 2017 http://dx.doi.org/10.1016/j.molmet.2016.12.008 Brief Communication MOLECULAR METABOLISM 6 (2017) 219 e225/C2112016 The Authors.",OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1146/ annurev-immunol-031210-101322 .,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/ 10.1016/j.cmet.2014.03.029 .,OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1038/39335 .,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1172/JCI29881 .,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1084/jem.20151570 .,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1038/ni.2956 .,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1016/j.cmet.2016.06.004 .,OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1016/j.immuni.2015.02.005 .,OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
Cell Metabolism 4:13 e24.http://dx.doi.org/10.1016/ j.cmet.2006.05.011 .,OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1007/s10545-010-9061-2 .,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1038/ni1008-1091 .,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/ 10.1194/jlr.M043448 .,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/ 10.1074/jbc.M109.032888 .,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1016/j.cmet.2012.04.005 .,OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
Nature Medicine 21:263 e 269. http://dx.doi.org/10.1038/nm.3804 .,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1007/978-1-62703-523-1_15 .,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1038/nm.2279 .,OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1074/ jbc.M114.634568 .,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1016/ j.immuni.2013.04.001 .,OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1016/j.cmet.2013.11.001 .,OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1172/JCI42845 .,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1016/ j.cell.2016.07.026 .,OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
http://dx.doi.org/10.1016/ j.celrep.2015.12.030 .,OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/8c/main.PMC5279934.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/43/main.PMC5279935.pdf
"Received December 5, 2016 /C15Revision received December 24, 2016 /C15Accepted December 28, 2016 /C15Available online 31 December 2016 http://dx.doi.org/10.1016/j.molmet.2016.12.009 Brief Communication 226MOLECULAR METABOLISM 6 (2017) 226 e231/C2112016 The Authors.",OADS,/arxiv_data1/oa_pdf/6b/43/main.PMC5279935.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/43/main.PMC5279935.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/43/main.PMC5279935.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/43/main.PMC5279935.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/43/main.PMC5279935.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6b/43/main.PMC5279935.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/43/main.PMC5279935.pdf
http://dx.doi.org/10.1016/ j.cmet.2016.10.007 .,OADS,/arxiv_data1/oa_pdf/6b/43/main.PMC5279935.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/43/main.PMC5279935.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/9e/main.PMC5279936.pdf
"Received November 22, 2016 /C15Revision received December 5, 2016 /C15Accepted December 15, 2016 /C15Available online 21 December 2016 http://dx.doi.org/10.1016/j.molmet.2016.12.006 Review MOLECULAR METABOLISM 6 (2017) 185 e193/C2112016 The Authors.",OADS,/arxiv_data1/oa_pdf/c8/9e/main.PMC5279936.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/9e/main.PMC5279936.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/9e/main.PMC5279936.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/9e/main.PMC5279936.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/9e/main.PMC5279936.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/9e/main.PMC5279936.pdf
"The rs34702397 SNP in Ocn is unevenly distributed in the world population, with 4.65% of people with African, 0.26% of Latino, <0.01% of European, and 0% of Asian descent having the mutant allele (http://exac.broadinstitute.org/variant/6-117150008-G-A ).",Non-OADS,/arxiv_data1/oa_pdf/c8/9e/main.PMC5279936.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/9e/main.PMC5279936.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/9e/main.PMC5279936.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/9e/main.PMC5279936.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/9e/main.PMC5279936.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/3f/main.PMC5279937.pdf
"Actigraphy is based on the monitoring of movements during sleep or activity for long periods of time and, thanks to the use of speci ﬁc computer algorithms, small devices canContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.05.004 1984-0063/ &2016 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/6c/3f/main.PMC5279937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/3f/main.PMC5279937.pdf
http://dx.doi.org/10.1016/j.slsci.2016.10.004 Received 16 February 2016; Received in revised form 12 October 2016; Accepted 17 October 2016Peer review under responsibility of Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/0a/bf/main.PMC5279954.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0a/bf/main.PMC5279954.pdf
"from: 〈http://www.el-temps.com 〉, 1999.",Non-OADS,/arxiv_data1/oa_pdf/0a/bf/main.PMC5279954.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0c/4f/copd-12-427.PMC5279955.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 427–434International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  427OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12615 8 Patterns and characterization of COPD  exacerbations using real-time data collection stanley I ejiofor1,2 Jan stolk3 Pablo Fernandez4 robert a stockley1,2 1Centre for Translational Inflammation  research, University of Birmingham,   2aDaPT Project, University hospital  Birmingham, Birmingham, UK;   3leiden University Medical Centre,   leiden, the netherlands; 4Independent  consultant, Penn, UKIntroduction:  Patients with chronic obstructive pulmonary disease often experience  exacerbations.",Non-OADS,/arxiv_data1/oa_pdf/0c/4f/copd-12-427.PMC5279955.pdf
"With  this overall clinical definition, subsequent studies assessed exacerbation severity by  the degree of therapeutic intervention required and health care resources used.11–13 Correspondence: robert a stockley University hospital Birmingham,  aDaPT Project, respiratory  Department, Mindelsohn Way,  Birmingham, B15 2gW, UK email rob.stockley@uhb.nhs.u k Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Ejiofor et al Running head recto: Patterns and characterization of exacerbations DOI: http://dx.doi.org/10.2147/COPD.S126158",Non-OADS,/arxiv_data1/oa_pdf/0c/4f/copd-12-427.PMC5279955.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/0c/4f/copd-12-427.PMC5279955.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/4f/copd-12-427.PMC5279955.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/43/bc/copd-12-417.PMC5279956.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 417–426International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  417OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12448 2 Clinical audit of COPD in outpatient respiratory  clinics in spain: the ePOCOnsUl study Myriam Calle rubio1–3 Bernardino alcázar  navarrete4 Joan B soriano5 Juan J soler-Cataluña6 José Miguel rodríguez  gonzález-Moro7 Manuel e Fuentes Ferrer2,3,8 José luis lópez-Campos9 On behalf of the  ePOCOnsUl study 1Pulmonary Department, hospital  Clínico san Carlos, 2Department  of Medicine, Faculty of Medicine,   University Complutense of Madrid,   3research Institute of hospital  Clínico san Carlos (IdIssC),   Madrid, 4Pulmonary Department,   hospital de alta resolución de  noja, granada, 5research Institute  of hospital University la Princesa  (IIsP), University autónoma of  Madrid, 6Pulmonary Department,   hospital de arnau de Villanova,   Valencia, 7Pulmonary Department,   hospital Universitario Principe de  asturias, alcalá de henares, Madrid,   8UgC of Preventive Medicine and  research Institute of hospital Clínico  san Carlos, Madrid, 9Pulmonary  Department, hospital University  Virgen del rocio, Institute of  Biomedicine of sevilla (IBis),   sevilla, spainBackground:  Chronic obstructive pulmonary disease (COPD) outpatients account for a large  burden of usual care by respirologists.",Non-OADS,/arxiv_data1/oa_pdf/43/bc/copd-12-417.PMC5279956.pdf
"The recent, landmark European Clinical COPD Audit12 carried out in Correspondence: Myriam Calle rubio Pneumology Department, hospital  Clínico san Carlos, C/Martin lagos s/n,  Madrid 28040, spain Tel/fax +34 91 330 3477 email mcallerubio@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Calle Rubio et al Running head recto: Clinical audit of COPD in outpatient respiratory clinics in Spain DOI: http://dx.doi.org/10.2147/COPD.S124482",Non-OADS,/arxiv_data1/oa_pdf/43/bc/copd-12-417.PMC5279956.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/43/bc/copd-12-417.PMC5279956.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/bc/copd-12-417.PMC5279956.pdf
"Available from: http://www.nice.org.uk/guidance/ CG101/chapter/1-Guidanc e. Accessed September 29, 2016.",Non-OADS,/arxiv_data1/oa_pdf/43/bc/copd-12-417.PMC5279956.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysici an.ir December2016, Volume: 8, Issue:12, Pages:3309-3312,DOI:http://dx.doi.org/10.19082/3309 Corresponding author: Associate Professor Dr. Abdeljalil Khelassi, Abou Bekr Belkaid University of Tlemcen, Algeria .",Non-OADS,/arxiv_data1/oa_pdf/e7/8d/epj-08-3309.PMC5279959.pdf
http://www.ephysician.ir Page3310 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/e7/8d/epj-08-3309.PMC5279959.pdf
"http://www.ephysician.ir Page3312Table 2.Contributions by the stage of the cancer* Cancer stages Contributions Prevention (11) Diagnosis (2), (8), (10), (12), (13), (14), (15) Follow-up and Therapy (1), (3), (4), (5) , (6), (7), (9), (12), (16), (17), (18) *Citation policy: The citations to mentioned articles in this editorial are removed to prevent the self -citations to our journal.The in-text citations to the number of mentioned articles (and tables) are not includ ed in reference section.",Non-OADS,/arxiv_data1/oa_pdf/e7/8d/epj-08-3309.PMC5279959.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3313-3317,DOI:http://dx.doi.org/10.19082/3313 Corresponding author: Assistant Professor Dr. Hassan Al -Shehri, Department of Pediatrics, College of Medicine, Al -Imam Muhammad Ibn Saud Islamic University, P.O Box: 7544, Riyadh 13317 -4233, Kingdom of Saudi Arabia.",Non-OADS,/arxiv_data1/oa_pdf/28/98/epj-08-3313.PMC5279960.pdf
http://www.ephysician.ir Page3314This evidence helps physicians to implement strategies according to the maternal knowledge to reduce the psychological distress in mothers in this situation.,Non-OADS,/arxiv_data1/oa_pdf/28/98/epj-08-3313.PMC5279960.pdf
"http://www.ephysician.ir Page3316identified by remaining mothers were milk allergy, gastroesophageal reflux, and decreased emotional bonding between mother and baby.",Non-OADS,/arxiv_data1/oa_pdf/28/98/epj-08-3313.PMC5279960.pdf
Available from: http://www.biomedcen tral.com/imedia/1437048273213814_manuscript.pdf.,Non-OADS,/arxiv_data1/oa_pdf/28/98/epj-08-3313.PMC5279960.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3318-3324,DOI:http://dx.doi.org/10.19082/ 3318 Corresponding author: Assistant Professor Dr. Abdelrahim Abdrabou Sadek, Pediatric Department, Faculty of Medicine, Sohag Univer sity, Sohag, Egypt.",Non-OADS,/arxiv_data1/oa_pdf/1b/69/epj-08-3318.PMC5279961.pdf
http://www.ephysician.ir Page3320examination.,Non-OADS,/arxiv_data1/oa_pdf/1b/69/epj-08-3318.PMC5279961.pdf
http://www.ephysician.ir Page3322Table 6.Outcome after 6 months Variables n (%) Good outcome Full recovery 33 (66) 0 6 (12)Minor deficit upper limb Minor deficit lower limb Moderate (Moderate and independent) outcome 8 (16) Poor outcome Chair bound 3 (6) Bed ridden 0 Hughes motor scale (HMS)(0)Asymptomatic (1)Mild signs or symptoms but able to run (2)Able to walk unaided for 5 meters (3)Able to walk 5 meters with support (4)Bed ridden or chair bound (5)Requiring ventilatory assistance (6)Death29 (58) 9 (18) 6 (12) 3 (6) 3 (6) 0 (0.0 ) 0 (0.0) Medical Research Council (MRC) sum - scoreScore Initial At 3 months At 6 months p-value 51-60 41-50 31-40 ≥300 (0%) 7 (14%) 41 (82%) 2 (14%)1 (2%) 9 (18%) 39 (78%) 1 (2%)37 (74%) 9 (18%) 4 (8%) 0 (0%)< 0.0001 4.Discussion Infants and children presenting with acute flaccid paralysis represent a relatively common emergency in outpatients and inpatients divisions of the Pediatric department.,Non-OADS,/arxiv_data1/oa_pdf/1b/69/epj-08-3318.PMC5279961.pdf
"http://www.ephysician.ir Page33249)Overell JR, Hsieh ST, Odaka M, Yuki N, Willison HJ .",Non-OADS,/arxiv_data1/oa_pdf/1b/69/epj-08-3318.PMC5279961.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3325-3332,DOI:http://dx.doi.org/10.19082/ 3325 Corresponding author: Assistant Professor Dr. Shima Sheybani, Department of Anesthesiology, Ghaem Hospital, Mashhad University of Medical Sciences, Iran.",Non-OADS,/arxiv_data1/oa_pdf/68/a8/epj-08-3325.PMC5279962.pdf
http://www.ephysician.ir Page33261.,Non-OADS,/arxiv_data1/oa_pdf/68/a8/epj-08-3325.PMC5279962.pdf
"http://www.ephysician.ir Page3328related complications, interventions were stopped and were recorded in the checklist, and then when the complication disappeared, the mask was again used, if it was needed .",Non-OADS,/arxiv_data1/oa_pdf/68/a8/epj-08-3325.PMC5279962.pdf
http://www.ephysician.ir Page3330discontinuous for the patients.,Non-OADS,/arxiv_data1/oa_pdf/68/a8/epj-08-3325.PMC5279962.pdf
"http://www.ephysician.ir Page333221)Talebi H, Nourozi A, Jamilian M, Baharfar N, Eghtesadi -Araghi P. Entonox for labor pain: a ran domized placebo controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/68/a8/epj-08-3325.PMC5279962.pdf
"Electronic Physician (ISSN: 2008-5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3333-3342,DOI:http://dx.doi.org/10.19082/ 3333 Corresponding author: Assistant Professor Dr. Heshmatolah Heydari, Department of community Health Nursing, School of Nursing and Midwifery, Lorestan University of Medical Sciences, Khorramabad, Iran.",Non-OADS,/arxiv_data1/oa_pdf/28/7d/epj-08-3333.PMC5279963.pdf
http://www.ephysician.ir Page3334cooking and  more than 13% used butter and animal oil which was signific antly higher than the percentage reported for the urban population (10).,Non-OADS,/arxiv_data1/oa_pdf/28/7d/epj-08-3333.PMC5279963.pdf
"http://www.ephysician.ir Page3336Also, no significant difference was seen between the two groups in dietary cholesterol intake before intervention, although 2 and 6 months after the intervention, a significant di fference was found in the mean changes of fat intake among the two groups.",Non-OADS,/arxiv_data1/oa_pdf/28/7d/epj-08-3333.PMC5279963.pdf
http://www.ephysician.ir Page3338study conducted on patients with hypertension and serum cholesterol levels compared with those with normotensive people (3 8).,Non-OADS,/arxiv_data1/oa_pdf/28/7d/epj-08-3333.PMC5279963.pdf
Available from: http://nsft.sbmu.ac.ir/article -1-690-en.html.,Non-OADS,/arxiv_data1/oa_pdf/28/7d/epj-08-3333.PMC5279963.pdf
"http://www.ephysician.ir Page334021)Wingo BC, Desmond RA, Brantley P, Appel L, Svetkey L, Stevens VJ, et al.",OADS,/arxiv_data1/oa_pdf/28/7d/epj-08-3333.PMC5279963.pdf
"http://www.ephysician.ir Page334257)Shahar DR, Froom P, Harari G, Yerushalmi N, Lubin F, Kristal -Boneh E. Changes in dietary intake account for seasonal changes i n cardiovascular disease risk factors.",Non-OADS,/arxiv_data1/oa_pdf/28/7d/epj-08-3333.PMC5279963.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3343-3347,DOI:http://dx.doi.org/10.19082/3343 Corresponding author: Assistant Professor Dr. Hassan Al -Shehri, Department of Pediatrics, College of Medicine, Al -Imam Muhammad Ibn Saud Islamic University, Ri yadh, Saudi Arabia , E -mail: dr.h.alshehri@hotmail.com Received: August 08, 2016 , Accepted: October 10, 2016 , Published: December2016 iThenticate screening: October 10, 2016 , English editing: November 26, 2016 , Quality control: December 06, 2016 © 2016The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b4/34/epj-08-3343.PMC5279964.pdf
http://www.ephysician.ir Page3344(15).,Non-OADS,/arxiv_data1/oa_pdf/b4/34/epj-08-3343.PMC5279964.pdf
http://www.ephysician.ir Page3346(52.5%) being in the age group of 25 –29 years.,Non-OADS,/arxiv_data1/oa_pdf/b4/34/epj-08-3343.PMC5279964.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3348-3356,DOI:http://dx.doi.org/10.19082/3348 Corresponding author: Associate Professor Dr. Mohammad Reza Amiresmaili, Medical Informatics Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.",Non-OADS,/arxiv_data1/oa_pdf/cf/e8/epj-08-3348.PMC5279965.pdf
http://www.ephysician.ir Page3350hospitals.,Non-OADS,/arxiv_data1/oa_pdf/cf/e8/epj-08-3348.PMC5279965.pdf
http://www.ephysician.ir Page33523.3.,Non-OADS,/arxiv_data1/oa_pdf/cf/e8/epj-08-3348.PMC5279965.pdf
http://www.ephysician.ir Page3354Shivam et al.,OADS,/arxiv_data1/oa_pdf/cf/e8/epj-08-3348.PMC5279965.pdf
"http://www.ephysician.ir Page335628)Reiter KL, Harless DW, Pink GH, Mark BA.",Non-OADS,/arxiv_data1/oa_pdf/cf/e8/epj-08-3348.PMC5279965.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3357-3362,DOI:http://dx.doi.org/10.19082/ 3357 Corresponding author: Amir Akhavan Rezayat, Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.",Non-OADS,/arxiv_data1/oa_pdf/8f/d6/epj-08-3357.PMC5279966.pdf
http://www.ephysician.ir Page3358has been designed to assess empathy in the medical profession (HP version) and related students (S -version) (22 ).,Non-OADS,/arxiv_data1/oa_pdf/8f/d6/epj-08-3357.PMC5279966.pdf
http://www.ephysician.ir Page3360Table 2.Empathy score among different specialties Dependent Variable (I) Specialty (J) Specialty Mean Difference (I -J)Std.,OADS,/arxiv_data1/oa_pdf/8f/d6/epj-08-3357.PMC5279966.pdf
"http://www.ephysician.ir Page336219)Beckman HB, Frankel RM.",Non-OADS,/arxiv_data1/oa_pdf/8f/d6/epj-08-3357.PMC5279966.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3363-3368,DOI:http://dx.doi.org/10.19082/ 3363 Corresponding author: Dr. Effat Khodadadi, Department of P ediatrics, Faculty of Dentistry, Babol University of Medical Sciences, Babol, Iran.Tel: +98.9111116180, Email: Dr_ekhodadadi@yahoo.com Received: May 09, 2016 , Accepted: July 13, 2016 , Published: December 2016 iThenticate screening: July 10, 2016, English editing: September 26, 2016, Quality control: October 08, 2016 © 2016The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d6/38/epj-08-3363.PMC5279967.pdf
"http://www.ephysician.ir Page3364the teeth, sore s, sloughing ,and dry mouth.",Non-OADS,/arxiv_data1/oa_pdf/d6/38/epj-08-3363.PMC5279967.pdf
"http://www.ephysician.ir Page3366Table 3.MIC values ofamoxicillin, aqueous and ethanolic extracts of A.citriodora Bacteria Antibacterial agents Amoxicillin Aqueous extract Ethanolic extract Standardized strains S.mutans(n=1) 16 0 0 S.sobrinus(n=1)14 0 0 Clinical isolates S.mutans(n=8) 12.13 ± 1.52 *0 0 S.sobrinus(n=1)32 0 0 0 means no growth inhibition zones, Amoxicilline concentrations 1–32µg/ml,aqueousand ethanolicextracts concentration 62 5–20,000µg/ml, * Mean±SD 4.Discussion A.citrodora leaves have many medicinal properties ,which may make their extract a suitable replacement for chemical substances in mouthwash.",Non-OADS,/arxiv_data1/oa_pdf/d6/38/epj-08-3363.PMC5279967.pdf
"http://www.ephysician.ir Page336824)DuarteS, Gregoire S, Singh AP, Vorsa N, Schaich K, Bowen WH, et al.",OADS,/arxiv_data1/oa_pdf/d6/38/epj-08-3363.PMC5279967.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3369-3377,DOI:http://dx.doi.org/10.19082/ 3369 Corresponding author: Assistant Professor Dr. Mahrokh Dolatian.",Non-OADS,/arxiv_data1/oa_pdf/71/c3/epj-08-3369.PMC5279968.pdf
http://www.ephysician.ir Page3370viewed as a psychological state of regulated mechanisms that monitor the benefits and costs of marriage to a particular person (3).,Non-OADS,/arxiv_data1/oa_pdf/71/c3/epj-08-3369.PMC5279968.pdf
http://www.ephysician.ir Page33723.3.,Non-OADS,/arxiv_data1/oa_pdf/71/c3/epj-08-3369.PMC5279968.pdf
"http://www.ephysician.ir Page3374all aspects have been investigated in Iran; however, the researcher could not get access to them through searching keywords or in some cases, access to articles was not completely possible; t herefore, the abstracts of the articles were used.",Non-OADS,/arxiv_data1/oa_pdf/71/c3/epj-08-3369.PMC5279968.pdf
Available from: http://hdl.handle.net/123456789/540.,Non-OADS,/arxiv_data1/oa_pdf/71/c3/epj-08-3369.PMC5279968.pdf
"http://www.ephysician.ir Page337637)Askarian Omran S, Shaikhaleslami F, Tabari R, Kazemnejad lili E, Pariad E. Role of career factors on marital satisfaction of nurses.",Non-OADS,/arxiv_data1/oa_pdf/71/c3/epj-08-3369.PMC5279968.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3378-3384,DOI:http://dx.doi.org/10.19082/ 3378 Corresponding author: SaraKiani.",Non-OADS,/arxiv_data1/oa_pdf/90/58/epj-08-3378.PMC5279969.pdf
http://www.ephysician.ir Page33802.3.,Non-OADS,/arxiv_data1/oa_pdf/90/58/epj-08-3378.PMC5279969.pdf
"http://www.ephysician.ir Page3382Some single drugs are beneficial to reduce complications and are helpful in order to trigger protective mechanisms and to delay catabolic and tissue degrading pathways, which may be due to antioxidant, immuno -modulatory, neuroprotectiv e, hepatoprotective, anti -inflammatory, and vitalizing (iksir -e-badan/rasayana/elixir of life) effects (46, 47).",Non-OADS,/arxiv_data1/oa_pdf/90/58/epj-08-3378.PMC5279969.pdf
"http://www.ephysician.ir Page338440)Taghizade Mortezaee F, Tabatabaiefar MA, Hashemzadeh Chaleshtori M, Miraj S. Lack of Association between ESR1 and CYP1A1 Gene Polymorphisms and Susceptibility to Uterine Leiomyoma in Female Patients of Iranian Descent.",Non-OADS,/arxiv_data1/oa_pdf/90/58/epj-08-3378.PMC5279969.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3385-3394,DOI:http://dx.doi .org/10.19082/ 3385 Corresponding author: Assistant Professor Dr. Hashem Mohamadian, Research Centre for Health -Related Social Determinates, Faculty of Health, Department of HealthEducation and Promotion, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.",Non-OADS,/arxiv_data1/oa_pdf/ff/c0/epj-08-3385.PMC5279970.pdf
"http://www.ephysician.ir Page3386an opportunity to reduce human error, increase speed and accuracy of processes efficiency, and ease of access to timely information for health cycles, significant economic savings as well as inter -sectoral coordination and cooperation (2).",Non-OADS,/arxiv_data1/oa_pdf/ff/c0/epj-08-3385.PMC5279970.pdf
"http://www.ephysician.ir Page3388and the path analysis are used in testing the research hypotheses applying LISREL software, version 8.5 (20).",Non-OADS,/arxiv_data1/oa_pdf/ff/c0/epj-08-3385.PMC5279970.pdf
"http://www.ephysician.ir Page3390All the remaining items were loaded on this factor, as the factor loading ranged from a low of 0.71 to a high of 0.90.",OADS,/arxiv_data1/oa_pdf/ff/c0/epj-08-3385.PMC5279970.pdf
http://www.ephysician.ir Page3392another individual or a group .,Non-OADS,/arxiv_data1/oa_pdf/ff/c0/epj-08-3385.PMC5279970.pdf
"http://www.ephysician.ir Page339411)Deutsch M, Gerard HB.",Non-OADS,/arxiv_data1/oa_pdf/ff/c0/epj-08-3385.PMC5279970.pdf
Accessed April 3 2013. http://www.psych - it.com.au/Psychlopedia/article.asp?,Non-OADS,/arxiv_data1/oa_pdf/ff/c0/epj-08-3385.PMC5279970.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3395-3397,DOI:http://dx.doi.org/10.19082/ 3395 Corresponding author: Assistant professor Dr. Hassan Al -Shehri, Department of Pediatrics, College of Medicine, Al -Imam Muhammad Ibn Saud Islamic University, P.O Box: 7544, Riyadh 13317 -4233, Riyadh, Kingdom of Saudi Arabia, E -mail: dr.h.alshehri@hotmail .com Received: August 09, 2016 , Accepted: October 10, 2016 , Published: December2016 iThenticate screening: October 10, 2016 , English editing: November 14, 2016 , Quality control: December 02, 2016 © 2016The Authors.",Non-OADS,/arxiv_data1/oa_pdf/cf/6d/epj-08-3395.PMC5279971.pdf
http://www.ephysician.ir Page33962.Case presentation A 14-month-old Saudi boy was admitt ed to the Security Forces Hospital in 2015.,Non-OADS,/arxiv_data1/oa_pdf/cf/6d/epj-08-3395.PMC5279971.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3398-3402,DOI:http://dx.doi.org/10.19082/ 3398 Corresponding author: Associate Professor Dr. Maryam Javadi, Department of Nutrition, Faculty of Health, Qazvin University of Medical Sciences, Qazvin, Iran.",Non-OADS,/arxiv_data1/oa_pdf/be/5d/epj-08-3398.PMC5279972.pdf
http://www.ephysician.ir Page3400statistical analysis showed no significant relationship between gender and food security (p=0.372).,OADS,/arxiv_data1/oa_pdf/be/5d/epj-08-3398.PMC5279972.pdf
"http://www.ephysician.ir Page34027)Armour BS, Pitts MM, Lee CW.",Non-OADS,/arxiv_data1/oa_pdf/be/5d/epj-08-3398.PMC5279972.pdf
Available from: http://www.epinex.com/#!corporate -information -series-1/j5zhi.,Non-OADS,/arxiv_data1/oa_pdf/be/5d/epj-08-3398.PMC5279972.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3403-3408,DOI:http://dx.doi.org/10.19082/ 3403 Corresponding author: Professor Hassan Eftekhar Ardebili, Department of Health Education and Promotion, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/6b/a0/epj-08-3403.PMC5279973.pdf
"http://www.ephysician.ir Page3404increase in popularity of hookah smoking is due to various reasons, such as the social context of its usage (among friends and in public places), the appeal of fruity flavors and a misconception that it is less harmful than cigarettes (3, 5).",Non-OADS,/arxiv_data1/oa_pdf/6b/a0/epj-08-3403.PMC5279973.pdf
http://www.ephysician.ir Page3406positive social appearance.,Non-OADS,/arxiv_data1/oa_pdf/6b/a0/epj-08-3403.PMC5279973.pdf
"http://www.ephysician.ir Page340824)Jawaid A, Zafar AM, Rehman TU, Nazir MR, Ghafoor ZA, Afzal O, et al.",Non-OADS,/arxiv_data1/oa_pdf/6b/a0/epj-08-3403.PMC5279973.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3409-3411,DOI:http://dx.doi.org/10.19082/ 3409 Corresponding author: Hamid Reza Ahmadkhaniha, Department of Psychiatr y, IranUniversity of Medical Science, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/c0/0b/epj-08-3409.PMC5279974.pdf
"http://www.ephysician.ir Page34102.Case presentation The patient was a 29 year old male, with no personal or family rec ord of psychotic illness.",Non-OADS,/arxiv_data1/oa_pdf/c0/0b/epj-08-3409.PMC5279974.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3412-3420,DOI:http://dx.doi.org/10.19082/3412 Correspondi ng author: Assistant Professor Dr. Zohre Keshavarz, Department of Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/6f/e2/epj-08-3412.PMC5279975.pdf
http://www.ephysician.ir Page3414abstracted and labeled with codes.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/epj-08-3412.PMC5279975.pdf
http://www.ephysician.ir Page34163.2.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/epj-08-3412.PMC5279975.pdf
http://www.ephysician.ir Page3418health care provider did not show sympathy and mental support.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/epj-08-3412.PMC5279975.pdf
"http://www.ephysician.ir Page342022)Momeni Javid F, Simbar  M, Dolatian M, Alavi Majd H. Comparison of Pregnancy Sel f-Care, Perceived Social Support and Perceived Stress of Women with Gestational Diabetes and Healthy Pregnant Women.",Non-OADS,/arxiv_data1/oa_pdf/6f/e2/epj-08-3412.PMC5279975.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3421-3425,DOI:http://dx.doi.org/10.19082/ 3421 Corresponding author: Assistant Professor Dr. Mohammad Mehdi Naghibi Sistani, Oral Health Research Center, Department of Community Oral Health, Faculty of Dentistry, Babol University of Medical Sciences, Babol, Iran.",Non-OADS,/arxiv_data1/oa_pdf/6a/16/epj-08-3421.PMC5279976.pdf
http://www.ephysician.ir Page3422health (5).,Non-OADS,/arxiv_data1/oa_pdf/6a/16/epj-08-3421.PMC5279976.pdf
http://www.ephysician.ir Page34244.Discussion The present study results revealed that inadequate parents’ OHL was associated with high children’s dental caries and less dental fillings.,Non-OADS,/arxiv_data1/oa_pdf/6a/16/epj-08-3421.PMC5279976.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3426-3428,DOI:http://dx.doi.org/10.19082/ 3426 Corresponding author: Dr. Amir Anushiravani, Department of Internal Medicine, Faculty of Medicine, Allergy Research Center, Shiraz University of Medical Sciences, Sh iraz, Iran.",Non-OADS,/arxiv_data1/oa_pdf/88/11/epj-08-3426.PMC5279977.pdf
http://www.ephysician.ir Page34289)N franklin adinson jr bruces Bochner.,Non-OADS,/arxiv_data1/oa_pdf/88/11/epj-08-3426.PMC5279977.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3429-3433,DOI:http://dx.doi.org/10.19082/ 3429 Corresponding author: Tamer Adel Refa i, Refractive Unit, Ophthalmology Department, Research Institute of Ophthalmology, Giza, Egypt.",Non-OADS,/arxiv_data1/oa_pdf/0f/c1/epj-08-3429.PMC5279978.pdf
http://www.ephysician.ir Page3430considered as the gold standard for clinical IOP measurement (2).,Non-OADS,/arxiv_data1/oa_pdf/0f/c1/epj-08-3429.PMC5279978.pdf
http://www.ephysician.ir Page3432p>0.05) existed between post -Lasik reduction of IOPcc and CH among patients under study.,Non-OADS,/arxiv_data1/oa_pdf/0f/c1/epj-08-3429.PMC5279978.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3434-3440,DOI:http://dx.doi.org/10.19082/3434 Corresponding author: Professor Dr.Ali Akbari Sari, Department of Health Management and Economics, School of Public Health, Tehran University of Me dical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/27/8d/epj-08-3434.PMC5279979.pdf
http://www.ephysician.ir Page34362.2.3.A 6-hour hospitali zation is needed for injection of Zoledronic acid.,Non-OADS,/arxiv_data1/oa_pdf/27/8d/epj-08-3434.PMC5279979.pdf
http://www.ephysician.ir Page3438health insurance companies of the country.,Non-OADS,/arxiv_data1/oa_pdf/27/8d/epj-08-3434.PMC5279979.pdf
"http://www.ephysician.ir Page34402)Meybodi HA, Heshmat R, Maasoumi Z, Soltani A, Hossein -Nezhad A, Keshtkar AA, et al.",Non-OADS,/arxiv_data1/oa_pdf/27/8d/epj-08-3434.PMC5279979.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3441-3444,DOI:http://dx.doi.org/10.19082/ 3441 Corresponding author: Associate Professor Dr. Sherif Emerah, Ophthalmology Department, Research Institute o f Ophthalmology, Giza, Egypt.",Non-OADS,/arxiv_data1/oa_pdf/94/1f/epj-08-3441.PMC5279980.pdf
http://www.ephysician.ir Page3442thinnest point.,Non-OADS,/arxiv_data1/oa_pdf/94/1f/epj-08-3441.PMC5279980.pdf
"http://www.ephysician.ir Page34448)Ciolino JB, Khachikian SS, Belin MW.",Non-OADS,/arxiv_data1/oa_pdf/94/1f/epj-08-3441.PMC5279980.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3445-3449,DOI:http://dx.doi.org/10.19082/3445 Corresponding author: Dr. Manuchehr Babaei, Department of Neurology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.",Non-OADS,/arxiv_data1/oa_pdf/91/28/epj-08-3445.PMC5279981.pdf
"http://www.ephysician.ir Page3446as headache, tinnitus, sleep disorders and other neurological complaints when exposed to these fields.",Non-OADS,/arxiv_data1/oa_pdf/91/28/epj-08-3445.PMC5279981.pdf
"http://www.ephysician.ir Page3448mobile phone use was concordance with increasing rate of migraine headaches, tinnitus, and fatigue (10).",Non-OADS,/arxiv_data1/oa_pdf/91/28/epj-08-3445.PMC5279981.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3450-3455,DOI:http://dx.doi.org/10.19082/3450 Corresponding author: Sedigheh Amir Ali Akbari, Department of Midwifery, Faculty of Midwifery and Nursing School, Shahid Beheshti University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/5a/0a/epj-08-3450.PMC5279982.pdf
"http://www.ephysician.ir Page3452The American College of Obstetricians and Gynecologists (b2013) proposed new criteria for the diagnosis of preeclampsia in 2013, including proteinuria (a dipstick reading of 1+ or ≥300 mg in 24 hours) or evidence of maternal multi -organ involvement, including thrombocytopenia, renal dysfunction (increased serum creatinine), liver dysfunction (increased liver transaminase), central nervous system disorders (headache, dizziness, blurred vision) or pulmonary edema.",Non-OADS,/arxiv_data1/oa_pdf/5a/0a/epj-08-3450.PMC5279982.pdf
"http://www.ephysician.ir Page3454References: 1)Feng Y, Xu J, Zhou Q, Wang R, Liu N, Wu Y, et al.",OADS,/arxiv_data1/oa_pdf/5a/0a/epj-08-3450.PMC5279982.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3456-3461,DOI:http://dx.doi.org/10.19082/ 3456 Corresponding author: Associate Professor Dr. Mahyar Mohammadifard, Department of Radiology, Imam Reza Hospital, Bi rjand University of Medical Sciences, Birjand, Iran.",Non-OADS,/arxiv_data1/oa_pdf/84/cc/epj-08-3456.PMC5279983.pdf
"http://www.ephysician.ir Page3458the initial quality (in terms of damage), were checked, and if the sample size was not adequate or the sample was fragmented, another biopsy was performed a round the site of the previous biopsy, following the same procedure.",Non-OADS,/arxiv_data1/oa_pdf/84/cc/epj-08-3456.PMC5279983.pdf
http://www.ephysician.ir Page3460(p=0.090).,Non-OADS,/arxiv_data1/oa_pdf/84/cc/epj-08-3456.PMC5279983.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir December2016, Volume: 8, Issue:12, Pages:3462-3467,DOI:http://dx.doi.org/10.19082/ 3462 Corresponding author: Dr. Hamed Gouklani, Molecular Medicine Research C enter, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.",Non-OADS,/arxiv_data1/oa_pdf/bc/37/epj-08-3462.PMC5279984.pdf
"http://www.ephysician.ir Page3464The PCR products were incubated with restriction enzymes Ava II and MboI (New England Biolabs, Inc., USA) for 16 h at 37°C in a 15 μL reaction sample according to the manufacturer’s recommendations.",Non-OADS,/arxiv_data1/oa_pdf/bc/37/epj-08-3462.PMC5279984.pdf
"http://www.ephysician.ir Page34662)Huang Y, Deng H, Peng Z, Huang Y, Long Q, Huang A. Mutations of Basal core promoter and precore regions in hepatitis B virus genotypes B and C. Hepat Mon.",Non-OADS,/arxiv_data1/oa_pdf/bc/37/epj-08-3462.PMC5279984.pdf
"This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Sugiyamaella xylanicola, genome sequence D-xylose-fermenting yeast Xylan-degrading species Speci ﬁcations Organism/cell line/tissue Sugiyamaella xylanicola UFMG-CM-Y1884T Sex N/A Sequencer or array type Illumina MiSeq and Illumina HiSeq 2500Data format AnalyzedExperimental factors Microbial strainExperimental features Whole genome sequencing and gene annotationConsent N/A Sample source location Belo Horizonte, Minas Gerais, Brazil 1.",Non-OADS,/arxiv_data1/oa_pdf/5b/d9/main.PMC5279996.pdf
http://dx.doi.org/10.1016/j.gdata.2017.01.006 2213-5960/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/d9/main.PMC5279996.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/d9/main.PMC5279996.pdf
"6 (2013) 339–355, http://dx.doi.org/10.1016/j.funeco.2013.06.005 .",OADS,/arxiv_data1/oa_pdf/5b/d9/main.PMC5279996.pdf
"Antonie Van Leeuwenhoek 110 (2016) 53 –67,http://dx.doi.org/10.1007/s10482-016-0775-5 .",Non-OADS,/arxiv_data1/oa_pdf/5b/d9/main.PMC5279996.pdf
"63 (2013) 2356 –2360, http://dx.doi.org/10.1099/ijs.0.050856-0 .",Non-OADS,/arxiv_data1/oa_pdf/5b/d9/main.PMC5279996.pdf
"Bioinformatics 29 (2013) 2669 –2677, http://dx.doi.org/10.1093/ bioinformatics/btt476 .",Non-OADS,/arxiv_data1/oa_pdf/5b/d9/main.PMC5279996.pdf
"19 (2012) 455 –477, http://dx.doi.org/10.1089/cmb.2012.0021 .",Non-OADS,/arxiv_data1/oa_pdf/5b/d9/main.PMC5279996.pdf
"Bioinformatics 23 (2007) 1061 –1067, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5b/d9/main.PMC5279996.pdf
"Bioinformatics 31 (2015) 3210 –3212, http://dx.doi.org/10.1093/ bioinformatics/btv351 .",Non-OADS,/arxiv_data1/oa_pdf/5b/d9/main.PMC5279996.pdf
"Bioinformatics 29 (2013) 1072 –1075, http://dx.doi.org/10.1093/ bioinformatics/btt086 .",Non-OADS,/arxiv_data1/oa_pdf/5b/d9/main.PMC5279996.pdf
"12 (2011) 491, http://dx.doi.org/10.1186/1471-2105-12-491 .",Non-OADS,/arxiv_data1/oa_pdf/5b/d9/main.PMC5279996.pdf
"10 (2009) 421, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5b/d9/main.PMC5279996.pdf
"25 (2007) 425 –441, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/5b/d9/main.PMC5279996.pdf
"43 (2015) D250 –D256, http://dx.doi.org/10.1093/nar/gku1220 .",Non-OADS,/arxiv_data1/oa_pdf/5b/d9/main.PMC5279996.pdf
"Bioinformatics 30 (2014) 1236 –1240, http://dx.doi.org/10.1093/ bioinformatics/btu031 .Table 1 CEGMA assessment returned 248 core orthologous proteins.",OADS,/arxiv_data1/oa_pdf/5b/d9/main.PMC5279996.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: CortisolTrier social stress test 1H–MRS Repeated scans 1.,Non-OADS,/arxiv_data1/oa_pdf/a0/d2/main.PMC5280001.pdf
http://dx.doi.org/10.1016/j.nicl.2017.01.001 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/d2/main.PMC5280001.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a0/d2/main.PMC5280001.pdf
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3103086&tool= pmcentrez&rendertype=abstract .,OADS,/arxiv_data1/oa_pdf/a0/d2/main.PMC5280001.pdf
29: 275–279 ( http://www.ncbi.nlm.nih.gov/pubmed/3362921 ).,Non-OADS,/arxiv_data1/oa_pdf/a0/d2/main.PMC5280001.pdf
5:131 ( http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/a0/d2/main.PMC5280001.pdf
"10, 459–466 (http://www.ncbi.nlm.nih.gov/pubmed/19339973\\nhttp://www.pubmed central.nih.gov/articlerender.fcgi?artid=PMC2844123).",Non-OADS,/arxiv_data1/oa_pdf/a0/d2/main.PMC5280001.pdf
http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3412149&tool=pmcentrez&rendertype=abstract .,OADS,/arxiv_data1/oa_pdf/a0/d2/main.PMC5280001.pdf
http://www.nature.com/doi ﬁnder/10.1038/nrn3339 .,Non-OADS,/arxiv_data1/oa_pdf/a0/d2/main.PMC5280001.pdf
s-provencher.com/ pages/lcm-manual.shtml .http://s-provencher.com/pub/LCModel/manual/manual.,Non-OADS,/arxiv_data1/oa_pdf/a0/d2/main.PMC5280001.pdf
http://www.r-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/a0/d2/main.PMC5280001.pdf
:n/a http://dx.doi.org/10.1002/hbm.23244 .,Non-OADS,/arxiv_data1/oa_pdf/a0/d2/main.PMC5280001.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).Keywords: Antisocial behaviorCallous-unemotional traitsDiffusion tensor imagingNeuroimagingPsychopathy Systematic review Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/94/c5/main.PMC5280002.pdf
http://dx.doi.org/10.1016/j.nicl.2017.01.014 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/94/c5/main.PMC5280002.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/c5/main.PMC5280002.pdf
"&E. Mihailov evelin.mihailov@ut.ee; http://www.geenivaramu.ee/en 1Estonian Genome Center, University of Tartu, 23b Riia Street, 51010 Tartu, Estonia 2Surgery Clinic, Tartu University Hospital, 8 Puusepa Street, 51014 Tartu, Estonia 3Institute of Molecular and Cell Biology, University of Tartu, 23 Riia Street, 51010 Tartu, Estonia 123Hernia (2017) 21:95–100 DOI 10.1007/s10029-016-1491-9",Non-OADS,/arxiv_data1/oa_pdf/5a/9c/10029_2016_Article_1491.PMC5281683.pdf
"Single-nucleotide substitutions (SNVs) and small indel variants were calledwith SAMtools (version 0.1.18), Picard tools (version 1.60; http://picard.sourceforge.net/ ), and a Genome Analysis Toolkit (GATK, version 1.5.21) and annotated with in-house scripts [ 19,20].",OADS,/arxiv_data1/oa_pdf/5a/9c/10029_2016_Article_1491.PMC5281683.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/5a/9c/10029_2016_Article_1491.PMC5281683.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/5e/dc/10029_2016_Article_1554.PMC5281684.pdf
"Food and Drug Administration Center for Evaluation Research (2009) Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims,p 43. http://www.fda.gov .",Non-OADS,/arxiv_data1/oa_pdf/5e/dc/10029_2016_Article_1554.PMC5281684.pdf
http://herniasurge.com/contact/ .,Non-OADS,/arxiv_data1/oa_pdf/5e/dc/10029_2016_Article_1554.PMC5281684.pdf
©2017 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/86/a8/jvms-79-052.PMC5282410.pdf
"79© 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Prognosis of Hepatocellular Carcinoma after Liver Transplantation:   Comparative Analysis with Partial Hepatectomy Kyuho Lee · Kyoung-Bun Lee   Nam-Joon Yi1 · Kyung-Suk Suh1  Ja-June Jang Departments of Pathology and 1Surgery,   Seoul National University College of Medicine,  Seoul, KoreaBackground:  Liver transplantation (LT) is the treatment of choice for hepatocellular carcinoma  (HCC).",Non-OADS,/arxiv_data1/oa_pdf/5e/a3/jptm-2016-10-13.PMC5282549.pdf
"Key Words:  Liver transplantation; Hepatocellular carcinoma; Recurrence; PrognosisReceived:  September 19, 2016 Revised:  October 4, 2016 Accepted:  October 13, 2016 Corresponding Author Kyoung-Bun Lee, MD Department of Pathology, Seoul National University  Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080,  Korea  Tel: +82-2-2072-2968 Fax: +82-2-743-5530 E-mail: kblee@snuh.orgJournal of Pathology and Translational Medicine 2017; 51: 79-86 https://doi.org/10.4132/jptm.2016.10.13▒ ORIGINAL ARTICLE ▒ Hepatocellular carcinoma (HCC) is the fifth most common  malignant tumor in the world.1 The treatments for HCC vary  depending on the stage of the primary tumors and the patient’s  hepatic function.",Non-OADS,/arxiv_data1/oa_pdf/5e/a3/jptm-2016-10-13.PMC5282549.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.10.13 80     •  Lee K, et al.",OADS,/arxiv_data1/oa_pdf/5e/a3/jptm-2016-10-13.PMC5282549.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.10.13Liver Transplantation for HCC   •     81 calculated using Kaplan-Meier analysis and compared by log- rank testing.,Non-OADS,/arxiv_data1/oa_pdf/5e/a3/jptm-2016-10-13.PMC5282549.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.10.13 82     •  Lee K, et al.",OADS,/arxiv_data1/oa_pdf/5e/a3/jptm-2016-10-13.PMC5282549.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.10.13Liver Transplantation for HCC   •     83 expression and gross type were not independent prognostic fac - tors.,OADS,/arxiv_data1/oa_pdf/5e/a3/jptm-2016-10-13.PMC5282549.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.10.13 84     •  Lee K, et al.",OADS,/arxiv_data1/oa_pdf/5e/a3/jptm-2016-10-13.PMC5282549.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.10.13Liver Transplantation for HCC   •     85 organ donations, but maintaining a balance between the benefit  to the recipient and the risk to the living donor is another  emerging issue in this field.",Non-OADS,/arxiv_data1/oa_pdf/5e/a3/jptm-2016-10-13.PMC5282549.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.10.13 86     •  Lee K, et al.",OADS,/arxiv_data1/oa_pdf/5e/a3/jptm-2016-10-13.PMC5282549.pdf
"Also, over 96% of par - ticipants had at least high school diploma,  which may somewhat limit the generaliz - ability for populations with lower educa -For more informa - tion on the job stress  among Iranian prison  employees see http://www.theijoem.",Non-OADS,/arxiv_data1/oa_pdf/1c/ed/ijoem-6-79.PMC5282587.pdf
(https://genomevolution.org/wiki/index.php/  Sequenced_plant_genomes).,OADS,/arxiv_data1/oa_pdf/a3/d7/CG-17-460.PMC5282599.pdf
Roche 454 GSFLX.http:// www.454.com/;  SOLiD.http://www3.appliedbiosystems.com/AB_Home/applica tionstechnologies/ SOLiDSystemSequencing/index.htm.,OADS,/arxiv_data1/oa_pdf/a3/d7/CG-17-460.PMC5282599.pdf
"http://www.helicos bio.com/, leading to sequence errors and difficulty for sequence assemblies [33].",Non-OADS,/arxiv_data1/oa_pdf/a3/d7/CG-17-460.PMC5282599.pdf
The newly web-based system for  integrated plant genome annotation MEGANTE  (https://megante.dna.affrc.go.jp/.),OADS,/arxiv_data1/oa_pdf/a3/d7/CG-17-460.PMC5282599.pdf
"PlantSEED (http://plantseed.theseed.org/) appeared as a  new resource to support functional identification, annotation,  comparative analysis, and modeling of plant genomes allow-ing downstream data analyses [91].",OADS,/arxiv_data1/oa_pdf/a3/d7/CG-17-460.PMC5282599.pdf
doi:http://dx.doi.org/10.1016/j.molp.2015.02.011.,OADS,/arxiv_data1/oa_pdf/a3/d7/CG-17-460.PMC5282599.pdf
"http://www.genome.arizona.edu/crispr/ (accessed  June 29, 2015).",OADS,/arxiv_data1/oa_pdf/4f/24/CG-17-499.PMC5282601.pdf
"http://cbi.hzau.edu.cn/crispr/ (accessed  June 29, 2015).",Non-OADS,/arxiv_data1/oa_pdf/4f/24/CG-17-499.PMC5282601.pdf
"http://www-urgv.versailles.inra.fr/  tilling/index.htm ( accessed June 24, 2015).",Non-OADS,/arxiv_data1/oa_pdf/4f/24/CG-17-499.PMC5282601.pdf
"http://limstill.niob.knaw.nl/ ( accessed July 1, 2015).",Non-OADS,/arxiv_data1/oa_pdf/4f/24/CG-17-499.PMC5282601.pdf
"http://www.arcadiabio.com/about  (accessed June 30, 2015).",Non-OADS,/arxiv_data1/oa_pdf/4f/24/CG-17-499.PMC5282601.pdf
"[88] Barley-TILLING http://www.scri.ac.uk/research/genetics/platform  technologies/barley tilling ( accessed June 24, 2015).",Non-OADS,/arxiv_data1/oa_pdf/4f/24/CG-17-499.PMC5282601.pdf
"[90] B-rapa https://www.jic.ac.uk/ staff/Lars-Osterg aard/tilling.htm  (accessed June 24, 2015).",Non-OADS,/arxiv_data1/oa_pdf/4f/24/CG-17-499.PMC5282601.pdf
"[92] RevGen http://revgenuk.jic.ac.uk/TILLING.htm ( accessed June 24,  2015).",Non-OADS,/arxiv_data1/oa_pdf/4f/24/CG-17-499.PMC5282601.pdf
"[93] Wheat-TILLING http://dubcovskylab.ucdavis.edu/wheat- tilling  (accessed June 24, 2015).",Non-OADS,/arxiv_data1/oa_pdf/4f/24/CG-17-499.PMC5282601.pdf
"http://flaxomics.univ-lille1.fr/Flaxomics/PTFLAX.html (a ccessed  June 24, 2015).",Non-OADS,/arxiv_data1/oa_pdf/4f/24/CG-17-499.PMC5282601.pdf
"[95] Lotus-TILLING http://www.genetik.bio.lmu.de/research/parniske/  models/lotustilling/index.html ( accessed June 24, 2015).",Non-OADS,/arxiv_data1/oa_pdf/4f/24/CG-17-499.PMC5282601.pdf
"[97] GABI-TILL http://plantbreeding.wzw.tum.de/index.php?id=28&  L=1 (accessed June 24, 2015).",Non-OADS,/arxiv_data1/oa_pdf/4f/24/CG-17-499.PMC5282601.pdf
"[98] TOMATOMA Micro-Tom TILLING http://tomatoma.nbrp.jp/  (accessed June 24, 2015).",Non-OADS,/arxiv_data1/oa_pdf/4f/24/CG-17-499.PMC5282601.pdf
"[99] Tef-TILLING http://www.tef-research.org/ (accessed June 24,  2015).",Non-OADS,/arxiv_data1/oa_pdf/4f/24/CG-17-499.PMC5282601.pdf
"ZFIN Data Contents  http://zfin.org/zf_info/zfin_stats.html (A ccessed Dic 05, 2014).",OADS,/arxiv_data1/oa_pdf/e3/35/CG-17-515.PMC5282603.pdf
Available from: http://water.epa.,OADS,/arxiv_data1/oa_pdf/e3/35/CG-17-515.PMC5282603.pdf
The comparison of various meta-analysis programs is available on the web through http://meta-analysis.com/pages/compari  sons.html.,OADS,/arxiv_data1/oa_pdf/d5/16/CG-17-528.PMC5282604.pdf
"[12]  Then, differentially expressed genes were researched by  Funnet and Uniprot database (http://www.uniprot.org).",OADS,/arxiv_data1/oa_pdf/e5/b4/CMJ-130-179.PMC5282675.pdf
"The UniProt knowledge base (Swiss‑Prot/ TrEMBL, http://www.uniprot.org/) and GO database were  applied to further classify these differentially expressed  proteins.",OADS,/arxiv_data1/oa_pdf/e5/b4/CMJ-130-179.PMC5282675.pdf
Available from: http://uroweb.org/guideline/urinary‑ incontinence/#4.,Non-OADS,/arxiv_data1/oa_pdf/83/39/CMJ-130-231.PMC5282682.pdf
"Data were analyzed with standard analysis of variance  procedures in GenStat 14 program for windows (VSN inter - national, http://www.vsni.co.uk/software/genstat).",OADS,/arxiv_data1/oa_pdf/76/20/66_15158.PMC5282747.pdf
Chromosomal positions of the remaining DArT markers were determined based on the Triticarte wheat map alignment version 1.2 (http://www.triticarte.com.au).,OADS,/arxiv_data1/oa_pdf/76/20/66_15158.PMC5282747.pdf
"For element analy ­ sis, 266 landraces along with all reference lines, which yield­ed good grain shape, were chosen (Supplemental Table 1; http://shigen.nig.ac.jp/wheat/komugi/).",OADS,/arxiv_data1/oa_pdf/a0/ea/66_16041.PMC5282750.pdf
"1), A–D which have relatively drier weather were reported as a rain-fed pre-dominant region (USDA; http://www.pecad.fas.usda.gov/highlights/2009/06/afghanistan/).",Non-OADS,/arxiv_data1/oa_pdf/e4/ff/66_16043.PMC5282751.pdf
Literature Cited Afghanistan Statistical Yearbook (2010–11) http://cso.gov.af/Content/ files/Agricalture.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e4/ff/66_16043.PMC5282751.pdf
Sequences are available at the DDBJ Sequence Read Archive (http://trace.ddbj.nig.ac.jp/dra/index_e.shtml; Accession no.,OADS,/arxiv_data1/oa_pdf/a7/a4/66_16059.PMC5282754.pdf
"2014) and draft sequences are available  in a public database, such as Pytozome (http://phytozome.jgi.doe.gov/pz/portal.html) and the Citrus Genome Data-base (https://www.citrusgenomedb.org/).",OADS,/arxiv_data1/oa_pdf/a4/92/66_16060.PMC5282755.pdf
Japan (Shizuoka) O a Discription by NIAS Genebank (http://www.gene.affrc.go.jp/databases-plant_search.php).,OADS,/arxiv_data1/oa_pdf/a4/92/66_16060.PMC5282755.pdf
"In 2013, the global melon pro-duction was more than 29 million tons (http://faostat.fao.org).",Non-OADS,/arxiv_data1/oa_pdf/d8/e2/66_16066.PMC5282756.pdf
"As is well known, MR-1 was selected from PI 124111 (Thomas 1986); the 100-seed weight of PI 124111 exceeds 2.5 g. Thus, it is a large-seed type melon (https://npgsweb.ars-grin.gov).",Non-OADS,/arxiv_data1/oa_pdf/d8/e2/66_16066.PMC5282756.pdf
"According to Oryzabase (http://www.shigen.nig.ac.jp/rice/oryzabase/, Yamazaki et al.",OADS,/arxiv_data1/oa_pdf/5e/4d/66_16071.PMC5282758.pdf
"Candidate chromosomal region of HWC2, location of AB002266, Os04g0623066, Os04g0623300 and Os04g0624500 in Os-  Nipponbare-Reference-IRGSP-1.0, based on RAP-DB (http://rapdb.dna.affrc.go.jp/).",OADS,/arxiv_data1/oa_pdf/5e/4d/66_16071.PMC5282758.pdf
"Then WRC54 was  removed from it (for details, NIAS Genebank database page: https://www.gene.affrc.go.jp/databases-core_collections_wr.php#note02_a).",OADS,/arxiv_data1/oa_pdf/5e/4d/66_16071.PMC5282758.pdf
"For more SNP informa - tion for both cultivated and wild rice accessions around  HWC2 locus, we downloaded a SNP file of 1,083 cultivated rice accessions and 446 wild rice (O. rufipogon) accessions for chromosome 4 ‘Cul_Wild_1529lines.chr4’ from the Rice Haplotype Map Project database (http://www.ncgr.ac.cn/RiceHap3), which has contributed to revealing the origin of cultivated rice (Huang et al.",OADS,/arxiv_data1/oa_pdf/5e/4d/66_16071.PMC5282758.pdf
"Because this file is too  large (2.14 Gb) and difficult to handle, we used software (Div 1.10a; http://www.vector.co.jp/soft/win95/util/se088352.html) to divide it into subfiles (ca.",Non-OADS,/arxiv_data1/oa_pdf/5e/4d/66_16071.PMC5282758.pdf
RAP-DB: http://rapdb.dna.affrc.go.jp/index.html).,OADS,/arxiv_data1/oa_pdf/5e/4d/66_16071.PMC5282758.pdf
The reference genome of rice (IRGSP 1.0) was downloaded from “The Rice Annota-tion Project Data Base” website (http://rapdb.dna.affrc.go.jp) and used for the analysis.,OADS,/arxiv_data1/oa_pdf/68/40/66_16083.PMC5282759.pdf
"Linkage and QTL analysis A linkage map was constructed using JoinMap version  4.1 (van Ooijen 2011, http://www.kyazma.nl/), with a LOD threshold of 3.0.",OADS,/arxiv_data1/oa_pdf/9d/cf/66_16108.PMC5282762.pdf
The Acp1 locus is located at 67 cM on the classi- cal genetic map (http://www.shigen.nig.ac.jp/rice/oryzabase/genes/symbolDetailAction.do?mutantGeneld=966).,OADS,/arxiv_data1/oa_pdf/9d/cf/66_16108.PMC5282762.pdf
Tomato is considered as  a vegetable model and has thus been subjected to molecular investigation resulting in abundant genomic information (http://solgenomics.net/).,Non-OADS,/arxiv_data1/oa_pdf/02/10/66_16112.PMC5282763.pdf
"Twenty-five micro-satellite markers were selected based on their previous use and their wide distribution through the tomato genome (https://solgenomics.net/search/markers, Villalta et al.",OADS,/arxiv_data1/oa_pdf/02/10/66_16112.PMC5282763.pdf
http://www.powermarker.net.,Non-OADS,/arxiv_data1/oa_pdf/02/10/66_16112.PMC5282763.pdf
Linkedin discussion forum ( http://sciex.com/com - munity/blogs/blogs/top-five-misconceptions-about- mass-spectrometry?utm source=linkedin&utm medium=social&utm campaign=2016+blogs+communit y&utm_content=newsletter ).,Non-OADS,/arxiv_data1/oa_pdf/b5/2e/ejifcc-27-264.PMC5282912.pdf
Available from:  http://www.ncbi.nlm.nih.gov/books/NBK138654 .,Non-OADS,/arxiv_data1/oa_pdf/2a/be/ejifcc-27-288.PMC5282914.pdf
Available from:  http://www.prosolia.com/liquid-microjunction-surface-   sampling .62.,Non-OADS,/arxiv_data1/oa_pdf/2a/be/ejifcc-27-288.PMC5282914.pdf
"One of the greatest advantages of GC-MS is  that the ionization mode used in this technique  is highly standardized and reproducible across  GC-MS systems from different vendors world - wide (based on 70 eV ionization) which allows  for the establishment of comprehensive GC-MS  mass spectral libraries such as the NIST ( http:// www.nist.gov/srd/nist1a.htm ), Agilent’s FienLab  (http://fiehnlab.ucdavis.edu/db ) [42], or pub - lically available [Golm Metabolome Database  (GMD, http://gmd.mpimp-golm.mpg.de ) [41],  which contain TMS (tri-methylsilylated)-deriva - tized metabolites.",OADS,/arxiv_data1/oa_pdf/c8/c0/ejifcc-27-331.PMC5282916.pdf
"An online database  containing 2651 confirmed human urine me - tabolite species, 3079 in total, concentrations,  related literature references and links to their  known disease associations are freely available  at http://www.urinemetabolome.ca  [45].",OADS,/arxiv_data1/oa_pdf/c8/c0/ejifcc-27-331.PMC5282916.pdf
"For food com - pounds, FoodDB ( http://foodb.ca/ ), however its  mass spectral information is also duplicated in  the HMDB.",OADS,/arxiv_data1/oa_pdf/c8/c0/ejifcc-27-331.PMC5282916.pdf
METLIN is a metabolite repository is  a web and freely accessible electronic database  (http://metlin.scripps.edu/ ) to facilitate metab - olite annotation through MS analysis.,OADS,/arxiv_data1/oa_pdf/c8/c0/ejifcc-27-331.PMC5282916.pdf
"In  2012, MetaboLights ( http://www.ebi.ac.uk/me - tabolights ) was the first general purpose database  in metabolomics, developed and maintained by  the European Bioinformatics Institute (EMBL-EBI)  which combines small molecule ‘reference’ layer  with information about individual metabolites,  chemistries, spectrometry and biological roles  with a study archive, where primary data and  metadata from metabolomics studies are onto - logically tagged and stored [73].",OADS,/arxiv_data1/oa_pdf/c8/c0/ejifcc-27-331.PMC5282916.pdf
http://enao-eth.org/enao+documents.php?page=7 .,Non-OADS,/arxiv_data1/oa_pdf/ab/26/ejifcc-27-351.PMC5282918.pdf
http://enao-eth.org/enao+documents.php?page= 9   Accessed 05 January 2016.,Non-OADS,/arxiv_data1/oa_pdf/ab/26/ejifcc-27-351.PMC5282918.pdf
http://ilac.org/publication-and-resources/pub - lication-list .,Non-OADS,/arxiv_data1/oa_pdf/ab/26/ejifcc-27-351.PMC5282918.pdf
http://ilac.org/publication-and-resources/publication-list    Accessed 05 January 2016.,Non-OADS,/arxiv_data1/oa_pdf/ab/26/ejifcc-27-351.PMC5282918.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/3f/traumamon-21-04-37585.PMC5282930.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/f3/traumamon-21-03-20927.PMC5282931.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/73/traumamon-21-04-21866.PMC5282932.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/a2/traumamon-21-04-23682.PMC5282933.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/a3/traumamon-21-03-22131.PMC5282934.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/6a/traumamon-21-03-19299.PMC5282935.pdf
Available from: http://www.ladieseuropeantour.com/health_n_ﬁtness_article.,Non-OADS,/arxiv_data1/oa_pdf/6e/6a/traumamon-21-03-19299.PMC5282935.pdf
Available from: http://www.besthealthmag.ca/get-healthy/ﬁtness/the-beneﬁts- of-stand-up-paddleboarding?slide=2 .,Non-OADS,/arxiv_data1/oa_pdf/6e/6a/traumamon-21-03-19299.PMC5282935.pdf
Available from: http://www.islesurfboards.com/paddle-board-size-and-weight- chart.aspx .,Non-OADS,/arxiv_data1/oa_pdf/6e/6a/traumamon-21-03-19299.PMC5282935.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/b4/traumamon-21-04-23749.PMC5282936.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/10/traumamon-21-04-23063.PMC5282937.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/ee/traumamon-21-04-23260.PMC5282938.pdf
Supplements Supplementary material(s) is available at below link: http://traumamon.com/?page=download&ﬁle_id=57595 Acknowledgments We wish to thank the ED staﬀ of the hospital for partic- ipating in the study .,Non-OADS,/arxiv_data1/oa_pdf/5a/ee/traumamon-21-04-23260.PMC5282938.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/9e/traumamon-21-04-25053.PMC5282939.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/84/traumamon-21-04-23869.PMC5282941.pdf
Available from: http://chpd.sbu.ac.ir/Portals/33/Constitution% 20of%20the%20Islamic%20Republic%20of%20Iran.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6b/84/traumamon-21-04-23869.PMC5282941.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/60/traumamon-21-04-23531.PMC5282942.pdf
"DOI: http://dx.doi.org/10.3727/096504016X14586627440192 Copyright Ó 2016 Cognizant, LLC.",Non-OADS,/arxiv_data1/oa_pdf/25/e5/OR-24-55.PMC5282972.pdf
"4, 297~304, December , 201 6  <Original research paper >  https://doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8c/e1/dr-20-4-297.PMC5282973.pdf
"Sequence analysis   The cDNA and amino acid sequences of OfLTLs  were  analyzed using the Basic Local Alignment Search Tool  (BLAST) at the  National Center for Biotechnology In - formation website ( http://blast.ncbi.nlm.nih.gov/Blast .cgi)  and the Expert Protein Analysis System (www.expasy.org),  as reported previously  (Wilkins et al., 1999) .",OADS,/arxiv_data1/oa_pdf/8c/e1/dr-20-4-297.PMC5282973.pdf
Sequence  alignment was performed using the ClustalX algorithm   (http://www.clustal.org/).,OADS,/arxiv_data1/oa_pdf/8c/e1/dr-20-4-297.PMC5282973.pdf
7(1): 1 -11  ISSN: 2226 -4485 (Print)  Original Article   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v7i1.1     ________________________________________________________________________________________________________   *Corresponding Author:  Ibrahim Eldaghayes .,Non-OADS,/arxiv_data1/oa_pdf/a4/35/OpenVetJ-7-1.PMC5283054.pdf
http://www.openveterinaryjournal.com   I. Eldaghayes et al.,Non-OADS,/arxiv_data1/oa_pdf/a4/35/OpenVetJ-7-1.PMC5283054.pdf
http://www.openveterinaryjournal.com   I. Eldaghayes et al.,Non-OADS,/arxiv_data1/oa_pdf/a4/35/OpenVetJ-7-1.PMC5283054.pdf
http://www.openveterinaryjournal.com   I. Eldaghayes et al.,Non-OADS,/arxiv_data1/oa_pdf/a4/35/OpenVetJ-7-1.PMC5283054.pdf
http://www.openveterinaryjournal.com   I. Eldaghayes et al.,Non-OADS,/arxiv_data1/oa_pdf/a4/35/OpenVetJ-7-1.PMC5283054.pdf
http://www.openveterinaryjournal.com   I. Eldaghayes et al.,Non-OADS,/arxiv_data1/oa_pdf/a4/35/OpenVetJ-7-1.PMC5283054.pdf
http://www.openveterinaryjournal.com   I. Eldaghayes et al.,Non-OADS,/arxiv_data1/oa_pdf/a4/35/OpenVetJ-7-1.PMC5283054.pdf
http://www.openveterinaryjournal.com   I. Eldaghayes et al.,Non-OADS,/arxiv_data1/oa_pdf/a4/35/OpenVetJ-7-1.PMC5283054.pdf
http://www.openveterinaryjournal.com   I. Eldaghayes et al.,Non-OADS,/arxiv_data1/oa_pdf/a4/35/OpenVetJ-7-1.PMC5283054.pdf
http://www.openveterinaryjournal.com   I. Eldaghayes et al.,Non-OADS,/arxiv_data1/oa_pdf/a4/35/OpenVetJ-7-1.PMC5283054.pdf
2012.  http://www.fao.org/fileadmin/user_upload/eufmd/d ocs/PCP/PCP_Guidelines_Eng_2012web.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a4/35/OpenVetJ-7-1.PMC5283054.pdf
"“OIE Manual of Diagnostics for Foot and  Mouth Disease: chapter 2.1.5,”  http://www.oie.int/fileadmin/Home/eng/Health_sta ndards/tahm/2.01.05_FMD.pdf .",Non-OADS,/arxiv_data1/oa_pdf/a4/35/OpenVetJ-7-1.PMC5283054.pdf
http://www.openveterinaryjournal.com   I. Eldaghayes et al.,Non-OADS,/arxiv_data1/oa_pdf/a4/35/OpenVetJ-7-1.PMC5283054.pdf
"FAO  World Reference Library  for Foot -and-Mouth Disease (WRLFMD), the  Pirbright    Institute,     Surrey,     United     Kingdom:                                                                                    http://www.wrlfmd.org/fmd_genotyping/2014/WR LFMD -2014 - 00029%20O%20Tunisia%202014.pdf .",Non-OADS,/arxiv_data1/oa_pdf/a4/35/OpenVetJ-7-1.PMC5283054.pdf
"FAO  World Reference Library  for Foot -and-Mouth Disease (WRLFMD), the  Pirbright Institute, Surrey, United Kingdom:  http://www.wrlfmd.org/fmd_genotyping/2014/WR LFMD -2014 - 00028%20O%20Algeria%202014.pdf .",Non-OADS,/arxiv_data1/oa_pdf/a4/35/OpenVetJ-7-1.PMC5283054.pdf
7(1): 1 2-15  ISSN: 2226 -4485 (Print)  Short Communication   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v7i1.2     ________________________________________________________________________________________________________   *Corresponding Author:  Stephan Neumann .,Non-OADS,/arxiv_data1/oa_pdf/9e/1b/OpenVetJ-7-12.PMC5283055.pdf
http://www.openveterinaryjournal.com   S. Neumann  et al.,OADS,/arxiv_data1/oa_pdf/9e/1b/OpenVetJ-7-12.PMC5283055.pdf
http://www.openveterinaryjournal.com   S. Neumann  et al.,OADS,/arxiv_data1/oa_pdf/9e/1b/OpenVetJ-7-12.PMC5283055.pdf
http://www.openveterinaryjournal.com   S. Neumann  et al.,OADS,/arxiv_data1/oa_pdf/9e/1b/OpenVetJ-7-12.PMC5283055.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6e/84/jmdh-10-049.PMC5283068.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6e/84/jmdh-10-049.PMC5283068.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2017:10 49–58submit your manuscript | www.dovepress.com Dovepress Journal of Multidisciplinary Healthcare Dovepress PERSPECTIVES open access to scientific and medical research Open Access Full T ext Article 49 http: //dx.doi.org/10.2147/JMDH.S121626Chronic disease self-management support for  persons with dementia, in a clinical setting Joseph Elias Ibrahim1  Laura J Anderson1  Aleece MacPhail2  Janaka Jonathan Lovell2  Marie-Claire Davis1  Margaret Winbolt3 1Department of Forensic Medicine,   Monash University, Southbank,   2Ballarat Health Services, Ballarat,   3Australian Centre for Evidence Based  Aged Care, College of Science, Health  and Engineering, La Trobe University,  Melbourne, VIC, AustraliaAbstract: The burden of chronic disease is greater in individuals with dementia, a patient group  that is growing as the population is aging.",Non-OADS,/arxiv_data1/oa_pdf/6e/84/jmdh-10-049.PMC5283068.pdf
Or use: http://youtu.be/mt9crO9jBRw Journal name: Journal of Multidisciplinary Healthcare Article Designation: PERSPECTIVESY ear: 2017V olume: 10Running head verso: Ibrahim et alRunning head recto: Chronic disease self-management support of cliniciansDOI: http://dx.doi.org/10.2147/JMDH.S121626,Non-OADS,/arxiv_data1/oa_pdf/6e/84/jmdh-10-049.PMC5283068.pdf
"Journal of Multidisciplinary Healthcare 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/6e/84/jmdh-10-049.PMC5283068.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 58 Ibrahim et al  10.,Non-OADS,/arxiv_data1/oa_pdf/6e/84/jmdh-10-049.PMC5283068.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 197–205Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  197RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12302 9 How do demographic transitions and public  health policies affect patients with Parkinson’s  disease in Brazil?",Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
"The period up to 2013 was characterized by Correspondence: Andre C Felicio Avenida Albert einstein 627/701,  Morumbi, CeP: 05651-901,  São Paulo, Brazil Tel +55 11 2151 9205 email cf.andre@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Bovolenta and Felicio Running head recto: Demographic transitions in Brazil and Parkinson’s disease DOI: http://dx.doi.org/10.2147/CIA.S123029",Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
"Available  from: http://biblioteca.ibge.gov.br/visualizacao/livros/liv95012.pd f. Accessed March 21, 2016.",Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
"Available from: http://biblioteca.ibge.gov.br/visualizacao/livros/ liv34956.pd f. Accessed February 8, 2016.",Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
Available from: http://www.ibge.gov.br/english/estatistica/populacao/ indic_sociosaude/2009/indicsaude.pdf.,Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
"Available from:  http://biblioteca.ibge.gov.br/visualizacao/livros/liv95011.pd f. Accessed  February 10, 2016.",Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
Available from: http://www.ibge.gov.br/apps/populacao/ projecao /.,Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
Available from: https://esa.un.org/unpd/wpp/ Graphs/DemographicProfiles /.,Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
Available  from: http://seriesestatisticas.ibge.gov.br/series.aspx?vcodigo=CD95.,Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
"Available  from: https://esa.un.org/unpd/wpp/publications/files/key_findings_ wpp_2015.pd f. Accessed July 20, 2016.",Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
Available from: http://tabnet.datasus.gov.br/cgi/tab - cgi.exe?cnes/cnv/atencbr.,OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
Available  from: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?cnes/cnv/atencbr.def/.,OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
Available from: http://tabnet.datasus.,OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
"Available from: http://www.planalto.gov.br/ccivil_03/leis/L8842.ht m.  Accessed March 1, 2016.",OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
"Available from: http://biblioteca.ibge.gov.br/visualizacao/livros/liv95012.pd f.  Accessed March 21, 2016.",Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
"Available from: http://www.planalto.gov.br/ccivil_03/ leis/2003/l10.741.ht m. Accessed March 1, 2016.",OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
"Available from: http://www.mds.gov.br/webarquivos/publicacao/ assistencia_social/Normativas/politica_idoso.pd f. Accessed March 3,  2016.",Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
"Available from: http://bvsms.saude.gov.br/bvs/saudelegis/sas/2010/ prt0228_10_05_2010.htm l. Accessed March 3, 2016.",OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
"Available from: http://bvsms.saude.gov.br/bvs/saudele - gis/gm/2013/prt1554_30_07_2013.htm l. Accessed March 1, 2016.",OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
Available from: http://www.planalto.gov.br/ccivil_03/leis/L8213cons.,Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
Available from: http://www.planalto.,Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
"Available from: http://www.planalto.gov.br/ccivil_03/decreto/ d3691.ht m. Accessed March 11, 2016.",OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
Available from:  http://www.who.int/gho/health_financing/out_pocket_expenditure/en/.,Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
"Available from: http://biblioteca.ibge.gov.br/visualizacao/livros/ liv95012.pd f. Accessed March 21, 2016.",Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
Available from: http://www.fns.saude.gov.br/ visao/consulta/grafico/comparativo/filtro.jsf.,Non-OADS,/arxiv_data1/oa_pdf/73/17/cia-12-197.PMC5283069.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/12/20/cia-12-207.PMC5283070.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 207–212Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  207OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12986 8 Which is preferable for orthostatic hypotension  diagnosis in older adults: active standing test  or head-up tilt table test?",Non-OADS,/arxiv_data1/oa_pdf/12/20/cia-12-207.PMC5283070.pdf
"Keywords:  active standing test, head-up tilt table, orthostatic hypotension, diagnosis Introduction Orthostatic hypotension (OH) is a common clinical problem among older adults,  which affects nearly 25%–30% of this population.1,2 Common comorbidities, such  as diabetes mellitus (DM), dehydration, and malnutrition, and frequent use of diuret - ics, antihypertensive drugs, levodopa, and benzodiazepines might lead to OH3 that  may cause dizziness, blackouts, blurred vision, balance impairment, recurrent falls,  dyspnea, angina pectoris, paracervical and lumbar pain, weakness, and nausea.4,5  However, one-third of elderly adults with OH are asymptomatic.6 The correct diag - nosis of OH in the elderly is of great importance; previous studies demonstrated  association of OH with mortality, ischemic stroke, falls, cognitive failure, impaired  sleep quality, depression, renal failure, and cognitive impairment in older adults.2,7–12  Therefore, evaluation of orthostatic blood pressure (BP) changes should be a part of  the comprehensive geriatric assessment (CGA).13Correspondence: Ahmet Turan Isik Yaşlanan Beyin ve Demans  Unitesi, Geriatri Bilim Dalı, Dokuz  Eylul Universitesi, Tıp Fakultesi,  35340 Balcova, Izmir, Turkey Tel +90 232 412 4341 Fax +90 232 412 4349 email atisik@yahoo.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Aydin et al Running head recto: Active standing test or head-up tilt table in older adults DOI: http://dx.doi.org/10.2147/CIA.S129868",Non-OADS,/arxiv_data1/oa_pdf/12/20/cia-12-207.PMC5283070.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/12/20/cia-12-207.PMC5283070.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/12/20/cia-12-207.PMC5283070.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5d/f0/cia-12-213.PMC5283071.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 213–222Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  213OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12336 2 An investigation of quality improvement initiatives  in decreasing the rate of avoidable 30-day,  skilled nursing facility-to-hospital readmissions:  a systematic review Michael Mileski Joseph Baar T opinka Kimberly lee Matthew Brooks Christopher Mcn eil Jenna Jackson school of health Administration, Texas  state University, san Marcos, TX, UsAObjectives:  The main objective was to investigate the applicability and effectiveness of quality  improvement initiatives in decreasing the rate of avoidable 30-day, skilled nursing facility  (SNF)-to-hospital readmissions.",Non-OADS,/arxiv_data1/oa_pdf/5d/f0/cia-12-213.PMC5283071.pdf
"Rehospitalization is not Correspondence: Michael Mileski Texas state University, 601 University  Drive, san Marcos, TX 78666, UsA Tel +1 832 752 4419 email mileski@txstate.ed u Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Mileski et al Running head recto: An investigation of quality improvement initiatives DOI: http://dx.doi.org/10.2147/CIA.S123362",Non-OADS,/arxiv_data1/oa_pdf/5d/f0/cia-12-213.PMC5283071.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/5d/f0/cia-12-213.PMC5283071.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/5d/f0/cia-12-213.PMC5283071.pdf
"Available from: http://www.cdc.gov/nchs/data/ad/ad359.pd f. Accessed  September 12, 2016.",OADS,/arxiv_data1/oa_pdf/5d/f0/cia-12-213.PMC5283071.pdf
Available from: http://tinyurl.com/j838zb 4.,Non-OADS,/arxiv_data1/oa_pdf/5d/f0/cia-12-213.PMC5283071.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/54/73/clep-9-053.PMC5283072.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/54/73/clep-9-053.PMC5283072.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2017:9 53–62Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 53 Original rEsEarCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S122916 Incidence, type of atrial fibrillation and risk factors  for stroke: a population-based cohort study Cecilia Johansson Erik Dahlqvist Jonas andersson Jan-Håkan Jansson Lars Johansson Department of Public Health and  Clinical Medicine, Skellefteå Research Unit, Umeå University, Umeå,  Västerbotten, SwedenPurpose: The aims of this study were to estimate the incidence of atrial fibrillation and atrial  flutter (AF), to assess the presence of provoking factors and risk factors for stroke and systemic  embolism, and to determine the type of AF in patients with first-diagnosed AF .",Non-OADS,/arxiv_data1/oa_pdf/54/73/clep-9-053.PMC5283072.pdf
"The proportion of patients with previous stroke, coronary artery disease,  hypertension, Correspondence: Cecilia Johansson Department of Public Health and Clinical Medicine, Skellefteå Research Unit, Skellefteå County Hospital, SE-931 86 Skellefteå, SwedenTel +46 9 1077 1000Fax +46 9 1077 1657Email cecjoh@gmail.comJournal name: Clinical Epidemiology Article Designation: Original ResearchY ear: 2017V olume: 9Running head verso: Johansson et alRunning head recto: Patients with first-diagnosed atrial fibrillationDOI: http://dx.doi.org/10.2147/CLEP .S122916 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/54/73/clep-9-053.PMC5283072.pdf
Or use: http://youtu.be/jU_NvQ0TqfM,Non-OADS,/arxiv_data1/oa_pdf/54/73/clep-9-053.PMC5283072.pdf
Available from http://www.socialstyrelsen.se/register/halsodataregister/patien-tregistret/inenglish.,Non-OADS,/arxiv_data1/oa_pdf/54/73/clep-9-053.PMC5283072.pdf
"Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/54/73/clep-9-053.PMC5283072.pdf
"Comprehensive lists of ECM proteins for human and mouse have been compiled (http://matrisomeproject.mit.edu,in the public domain), and the lists of core and ECM-associated proteins for human were used to extract the corresponding protein sequence from UniProt.",OADS,/arxiv_data1/oa_pdf/34/58/i1552-5783-58-1-573.PMC5283081.pdf
"Anin-house Python program was used to run a local installation of BLAST (ftp://ftp.ncbi.nlm.nih.gov/blast/executables/blast+/ LATEST/, in the public domain) to determine the reciprocalbest matches between the identiﬁed proteins and the human ECM proteins.",OADS,/arxiv_data1/oa_pdf/34/58/i1552-5783-58-1-573.PMC5283081.pdf
The database is freely available to the public at http://live.ece.utexas.edu/research/ChallengeDB/index.html.,OADS,/arxiv_data1/oa_pdf/05/31/i1534-7362-17-1-32.PMC5283082.pdf
"Retrieved from http://www.irccyn.ec-nantes.fr/ivcdb/ Campbell, F. W., & Robson, J. G. (1968).",Non-OADS,/arxiv_data1/oa_pdf/05/31/i1534-7362-17-1-32.PMC5283082.pdf
55The data can be accessed at https://genome.uiowa.,OADS,/arxiv_data1/oa_pdf/28/dc/i1552-5783-58-1-492.PMC5283088.pdf
"Developmental  Cognitive  Neuroscience  18  (2016)  113–120 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience j  o  ur  nal  ho  me  pa  ge:  http://www.elsevier.com/locate/dcn Long-range  orbitofrontal and amygdala  axons  show  divergent patterns  of maturation in the  frontal  cortex  across  adolescence Carolyn  M.  Johnsona,b,c,  F.  Alexandra  Loucksa,  Hannah  Pecklerb,  A.  Wren  Thomasc, Patricia H.  Janakd,  Linda  Wilbrechtb,c,∗ aNeuroscience  Graduate  Program,  University  of  California,  San  Francisco,  CA  94158,  United  States bPsychology Department, University  of  California,  Berkeley,  CA  94720,  United  States cHelen  Wills  Neuroscience  Institute,  University  of  California,  Berkeley,  CA  94720,  United  States dDepartment  of  Psychological  and  Brain  Sciences,  Johns  Hopkins  University,  Baltimore,  MD  21218,  United  States a  r  t  i  c  l  e  i  n  f  o Article history: Received  4  August  2015 Received  in  revised  form  26  January  2016 Accepted  30  January  2016 Available  online  4  February  2016 Keywords:Axonal bouton Dendritic  spine DevelopmentTwo-photon microscopy Structural  plasticity Pruninga  b  s  t  r  a  c  t The  adolescent  transition  from  juvenile  to  adult  is  marked  by  anatomical  and  functional  remodeling  of brain networks.",Non-OADS,/arxiv_data1/oa_pdf/68/52/main.PMC5283395.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/52/main.PMC5283395.pdf
Critical  periods  are  developmental  windows  in  which  circuits are  more  plastic  and  may  be  sculpted  by  the  environment  or http://dx.doi.org/10.1016/j.dcn.2016.01.005 1878-9293/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/68/52/main.PMC5283395.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/68/52/main.PMC5283395.pdf
C57Bl/6 mice were  used  for  axonal  viral  labeling  experiments and  Thy1-YFP-H  mice  (strain  00378  H  line;  http://jaxmice.jax.org/ strain/003782.html )  for  imaging  of  dendritic  spines.,Non-OADS,/arxiv_data1/oa_pdf/68/52/main.PMC5283395.pdf
"7,  http://dx.doi.org/10.3389/fncom.2013.00110 .",Non-OADS,/arxiv_data1/oa_pdf/68/52/main.PMC5283395.pdf
"7, 10785,  http://dx.doi.org/10.1038/ncomms10785 .",Non-OADS,/arxiv_data1/oa_pdf/68/52/main.PMC5283395.pdf
"A 5.2 kgfetus would be 0.8 –1 kg heavier than more than 98% of the birth population accordingto WHO standards for male and femalenewborns, respectively (http://www.cdc.gov/growthcharts/).",Non-OADS,/arxiv_data1/oa_pdf/ec/e2/EMBR-17-1679.PMC5283592.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
"1, e1255395 (6 pages)http://dx.doi.org/10.1080/2162402X.2016.1255395",Non-OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
ORCID David W. Threadgill http://orcid.org/0000-0003-3538-1635 References 1.,Non-OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
Science 1991; 253:661-5; PMID:1651562; http://dx.doi.org/10.1126/science.1651562 2.,Non-OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
Cell 1991; 66:589-600; PMID:1651174; http://dx.doi.org/10.1016/0092-8674(81)90021-0 3.,OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
Clin Colon Rectal Surg 2009; 22:198-208; PMID:21037810; http://dx.doi.org/10.1055/s- 0029-1242459 4.,Non-OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
Eur J Cancer 1995; 31:1061-4; http://dx.doi.org/10.1016/0959- 8049(95)00181-H; PMID:7576992 5.,Non-OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
J Clin Invest 2009; 119:2702-13; PMID:19690388; http://dx.doi.org/10.1172/JCI36435 6.,Non-OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
Cancer Gene Ther 2008; 15:413-48;PMID:18404164; http://dx.doi.org/10.1038/cgt.2008.157.,Non-OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
Science 2002; 297:1330-3;PMID:12154198; http://dx.doi.org/10.1126/science.1074611 8.,OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
PLoS Genet 2008; 4:e1000177;PMID:18773073; http://dx.doi.org/10.1371/journal.pgen.1000177 9.,Non-OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
Clin Biochem1997; 30:455-63; PMID:9316739; http://dx.doi.org/10.1016/S0009-9120(97)00049-0 10.,OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
Proc Natl Acad Sci USA 2002; 99:1521-6; PMID:11818567; http://dx.doi.org/10.1073/ pnas.032678499 11.,OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
Vaccine 2003; 21:3374-6; PMID:12850343; http://dx.doi.org/10.1016/S0264-410X (03)00336-0 12.,Non-OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
Cell Stem Cell 2007; 1:113-26;PMID:18371340; http://dx.doi.org/10.1016/j.stem.2007.03.002 14.,OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
Nat Med 2010; 16:799-803; PMID:20512124; http://dx.doi.org/10.1038/nm.2161 15.,OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
"Aurisicchio L, Marra E, Roscilli G, Mancini R, Ciliberto G. The promise of anti-ErbB3 monoclonals as new cancer therapeutics.Oncotarget 2012; 3:744-58; PMID:22889873; http://dx.doi.org/ 10.18632/oncotarget.550 18.",Non-OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
Mol Cancer Ther 2016; 15:689-701;PMID:26880266; http://dx.doi.org/10.1158/1535-7163.MCT-15- 0555e1255395-6 D. J. BAUTZ ET AL.,Non-OADS,/arxiv_data1/oa_pdf/d6/b0/koni-06-01-1255395.PMC5283616.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
"1, e1261240 (11 pages)http://dx.doi.org/10.1080/2162402X.2016.1261240",Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Biology (Basel) 2013; 2:587-602; PMID:24832799; http://dx.doi.org/10.3390/biology2020587 2.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Oncotarget 2015; 6:44892-904; PMID:26539644; http://dx.doi.org/10.18632/oncotarget.6285 4.,OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Blood 2005; 106:2287-94; PMID:15961518; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Cancer Res 2010; 70:875-82; PMID:20103634; http://dx.doi.org/10.1158/0008-5472.CAN-09-2762 6.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Cancer Res 2015; 75:22-30; PMID:25398436; http://dx.doi.org/10.1158/0008-5472.CAN-14-2533 7.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Mayo Clin Proc 2014; 89:926-33; PMID:24835528; http://dx.doi.org/10.1016/j.mayocp.2014.04.003 8.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Nat Rev Cancer 2014; 14:559-67; PMID:24990523; http://dx.doi.org/10.1038/nrc3770 9.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Oncoimmunology 2016; 5; e1066961; PMID:26942085; http://dx.doi.org/10.1080/ 2162402X.2015.1066961 10.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Cancer Res 2008; 68:4882-92; PMID:18559536; http://dx.doi.org/10.1158/0008-5472.CAN-07-6265 11.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Gene Ther 2013; 20:7-15; PMID:22170342; http://dx.doi.org/10.1038/gt.2011.205 12.,OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Clin Cancer Res 2013; 19:1147-58; PMID:23339127; http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Front Immunol 2015; 6:129; PMID:25852695; http://dx.doi.org/10.3389/ ﬁmmu.2015.00129 14.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Blood 2010; 116:e74-80;PMID:20628149; http://dx.doi.org/10.1182/blood-2010-02-258558 15.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Trends Immunol 2014;35:38-46; PMID:24262387; http://dx.doi.org/10.1016/j.it.2013.10.007 16.,OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Nat Rev Cancer 2008; 8:782- 98; PMID:18813321; http://dx.doi.org/10.1038/nrc2465 18.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
J Virol 2000; 74:556-9; PMID:10590149; http://dx.doi.org/10.1128/JVI.74.1.556-559.2000 19.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Immunobiology 2001; 204:629-38; PMID:11846228; http://dx.doi.org/10.1078/0171-2985-00102 20.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
J Immunol 2006; 176:248-55; PMID:16365416; http://dx.doi.org/10.4049/jimmunol.176.1.248 21.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Blood 2009; 114:3854-63; PMID:19690337; http://dx.doi.org/10.1182/blood-2009-04-217927 22.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
J Immunol2012; 188:1583-91; PMID:22231699; http://dx.doi.org/10.4049/ jimmunol.1102437 23.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Blood 2012; 120:3936-44; PMID:22966165; http://dx.doi.org/10.1182/blood-2012-06-435941 24.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Cell 2006; 124:783-801; PMID:16497588; http://dx.doi.org/ 10.1016/j.cell.2006.02.015 25.,OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
J Virol 2010; 84:372-9; PMID:19846522; http://dx.doi.org/10.1128/JVI.01690-09 26.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
PLoS Pathog 2014; 10:e1004081; PMID:24743923; http://dx.doi.org/10.1371/journal.ppat.1004081 27.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Immunity 2013; 38:855-69; PMID:23706667; http://dx.doi.org/10.1016/j.immuni.2013.05.007 28.,OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Apoptosis 2003; 8:237-49; PMID:12766484; http://dx.doi.org/10.1023/A:1023668705040 29.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
J Exp Med 2005; 202:1131-9; PMID:16230478; http://dx.doi.org/10.1084/jem.20050914 30.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Biochem J 2011; 434:93-104; PMID:21138416; http://dx.doi.org/10.1042/BJ20101701e1261240-10 C. ACHARD ET AL.,OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Virus Res 2010; 152:115-25; PMID:20600391; http://dx.doi.org/10.1016/j.virusres.2010.06.013 32.,OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Science 2007; 315:1398-401; PMID:17272685; http://dx.doi.org/10.1126/science.1136880 33.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
J TranslMed 2009; 7:10; PMID:19173717; http://dx.doi.org/10.1186/1479-5876-7-10 34.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
PLoS Pathog 2011; 7:e1001284; PMID:21379343;http://dx.doi.org/10.1371/journal.ppat.1001284 35.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
J Virol 2012; 86:909-18;PMID:22090096; http://dx.doi.org/10.1128/JVI.06235-11 36.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Sci Signal 2015; 8:ra25;PMID:25737587; http://dx.doi.org/10.1126/scisignal.aaa1552 37.,OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Blood 2009; 114:1794-802; PMID:19553637; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Immunity 2005; 23:19-28; PMID:16039576; http://dx.doi.org/10.1016/j.immuni.2005.04.010 39.,OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
J Immunol 2006; 177:5785-9; PMID:17056502; http://dx.doi.org/10.4049/jimmunol.177.9.5785 40.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Immunity 2006; 24:633-42; PMID:16713980; http://dx.doi.org/10.1016/j.immuni.2006.04.004 41.,OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
J Immunol 2004; 173:5935-43; PMID:15528327; http://dx.doi.org/10.4049/jimmunol.173.10.5935 42.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Proc Natl Acad Sci U S A 2011; 108:17093-8; PMID:21949249; http://dx.doi.org/10.1073/ pnas.1114194108 43.,OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Nature 2006; 439:208-11; PMID:16306936; http://dx.doi.org/10.1038/nature04374 44.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Nature 2006; 439:204-7; PMID:16306937; http://dx.doi.org/10.1038/nature04369 45.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
J Leukoc Biol 2013; 93:599-609; PMID:23341538; http://dx.doi.org/10.1189/jlb.0912452 46.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
JImmunol 2006; 177:7959-67; PMID:17114468; http://dx.doi.org/ 10.4049/jimmunol.177.11.7959 47.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
J Exp Med 2002; 195:1507-12;PMID:12045249; http://dx.doi.org/10.1084/jem.20020207 48.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Eur J Immunol2001; 31:3388-93; PMID:11745357; http://dx.doi.org/10.1002/1521- 4141(200111)31:11%3c3388::AID-IMMU3388%3e3.0.CO;2-Q 49.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
J Exp Med 2001; 194:863-9; PMID:11561001; http://dx.doi.org/10.1084/ jem.194.6.863 50.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Genes Immun 2011; 12:399-414; PMID:21490621; http://dx.doi.org/10.1038/gene.2011.21 51.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
J Leukoc Biol 2003; 74:1125-38;PMID:12960254; http://dx.doi.org/10.1189/jlb.0603255 52.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
JClin Invest 2011; 121:1088-101; PMID:21339641; http://dx.doi.org/ 10.1172/JCI44960 53.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
J Exp Med 2007; 204:1441-51; PMID:17535975; http://dx.doi.org/10.1084/ jem.20070021 54.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Tissue Antigens 2012; 80:477-87; PMID:23137319; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Immunity 2014; 41:960-72; PMID:25526309; http://dx.doi.org/ 10.1016/j.immuni.2014.11.012 56.,OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Eur Respir J 2011; 38:1117-26; PMID:21540305; http://dx.doi.org/10.1183/09031936.00160210 57.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
J Immunol2004; 173:3051-61; PMID:15322165; http://dx.doi.org/10.4049/ jimmunol.173.5.3051 58.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Nat Rev Immunol 2015; 15:405-14; PMID:26027717; http://dx.doi.org/10.1038/nri3845 60.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
Cytotherapy 2012; 14:887-96; PMID:22687187; http://dx.doi.org/10.3109/14653249.2012.689129 61.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
J Virol 2003; 77:11546-54;PMID:14557640; http://dx.doi.org/10.1128/JVI.77.21.11546-11554.2003ONCOIMMUNOLOGY e1261240-11,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/koni-06-01-1261240.PMC5283625.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
"1, e1257452 (13 pages)http://dx.doi.org/10.1080/2162402X.2016.1257452",Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
ORCID Laurence Buisseret http://orcid.org/0000-0002-3751-0819 Cinzia Solinas http://orcid.org/0000-0001-6782-8708 Karen Willard-Gallo http://orcid.org/0000-0002-1150-1295 References 1.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Cancer 2015; 121:4108- 23; PMID:26308244; http://dx.doi.org/10.1002/cncr.29634 2.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
J Clin Invest 2015; 125:739-51; PMID:25562322;http://dx.doi.org/10.1172/JCI74894 3.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
J Clin Oncol 2016; 34:1223-30; PMID:26834066; http://dx.doi.org/10.1200/JCO.2015.63.0970 4.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Ann Oncol 2015; 26:259-71; PMID:25214542; http://dx.doi.org/10.1093/annonc/mdu450 5.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Nat Rev Clin Oncol 2016; 13:228-41; PMID:26667975; http://dx.doi.org/10.1038/nrclinonc.2015.215 6.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
J Clin Invest 2013; 123:2873-92; PMID:23778140; http://dx.doi.org/10.1172/ JCI67428 7.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Cell 2016; 164:1233-47; PMID:26967289; http://dx.doi.org/10.1016/j.cell.2016.01.049 8.,OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Ann Oncol 2014; 25:1536-43; PMID:24915873; http://dx.doi.org/10.1093/annonc/mdu191 9.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
J ClinOncol 2006; 24:5373-80; PMID:17135638; http://dx.doi.org/10.1200/ JCO.2006.05.9584 10.,OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Immunology 2013; 138:105- 15; PMID:23216602; http://dx.doi.org/10.1111/imm.12036ONCOIMMUNOLOGY e1257452-11,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Immunol Rev 2016; 271:260-75;PMID:27088920; http://dx.doi.org/10.1111/imr.12405 12.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Immu- nology 2016; 147:141-51; PMID:26551738; http://dx.doi.org/10.1111/ imm.12554 13.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
J Clin Oncol 2008; 26:4410-7;PMID:18802153; http://dx.doi.org/10.1200/JCO.2007.15.0284 15.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Immunol Letters 2006; 102:229-36; PMID:16246429; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Cell 2015; 163:1038-e1; PMID:26544946; http://dx.doi.org/10.1016/j.cell.2015.10.054 18.,OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Sci Transl Med 2012; 4:127ra37; PMID:22461641; http://dx.doi.org/ 10.1126/scitranslmed.3003689 19.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Cancer Res 2015; 75:2139-45; PMID:25977340; http://dx.doi.org/10.1158/0008-5472.CAN-15-0255 20.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Sci- ence 2015; 348:56-61; PMID:25838373; http://dx.doi.org/10.1126/science.aaa8172 21.,OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Nature 2014; 515:568-71; PMID:25428505; http://dx.doi.org/10.1038/nature13954 24.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Hum Pathol 2016; 47:52-63;PMID:26527522; http://dx.doi.org/10.1016/j.humpath.2015.09.003 25.,OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Ann Oncol 2015; 26:1488-93; PMID:25897014; http://dx.doi.org/10.1093/annonc/mdv518.22 26.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Cancer 2016; 122:3263-6; PMID:27533794; http://dx.doi.org/10.1002/cncr.30260 29.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Cancer 2016; 122:3344-53; PMID:27533448; http://dx.doi.org/ 10.1002/cncr.30258 30.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Cancer 2016; 122:3354- 62; PMID:27533633; http://dx.doi.org/10.1002/cncr.30259 31.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Cancer Res 2012; 72:3997-4007; PMID:22850419; http://dx.doi.org/10.1158/0008-5472.CAN-12-1377 3 2 .,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
J Clin Oncol 2015; 33:983-91; PMID:25534375; http://dx.doi.org/10.1200/JCO.2014.58.1967 33.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
J Clin Oncol 2014; 32(27):2959-66; PMID:25071121;http://dx.doi.org/10.1200/JCO.2013.55.0491 35.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Nat Rev Immunol 2016;PMID:27748397; http://dx.doi.org/10.1038/nri.2016.107 3 6 .,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
J Cli n Oncol 2010; 28:105-13; PMID:19917869; http://dx.doi.org/10.1200/JCO.2009.23.7370 37.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
J Clin Oncol 2012; 30:1996-2004; PMID:22508827; http://dx.doi.org/10.1200/JCO.2011.39.5624 38.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
JAMA Oncol 2016; 2:242-6; PMID:26719971; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Am J Respir Crit Care Med 2014; 189:832-44; PMID:24484236; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Breast Cancer Res 2014; 16:432; PMID:25193543; http://dx.doi.org/10.1186/s13058-014-0432-8 41.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Cancer Res 2013; 73:2127-38;PMID:23365136; http://dx.doi.org/10.1158/0008-5472.CAN-12-4184 42.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Science 2015; 348:69-74; PMID:25838375; http://dx.doi.org/10.1126/science.aaa4971 43.,OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Front Immunol 2016; 7:407; PMID:27752258; http://dx.doi.org/10.3389/ ﬁmmu.2016.00407 44.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Immunity 2015; 43:579-90; PMID:26341400; http://dx.doi.org/10.1016/j.immuni.2015.08.006 45.,OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
BMC Cancer 2015; 15:101; PMID:25884667; http://dx.doi.org/10.1186/s12885-015-1116-1 46.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
J Clin Pathol 2016; 69(5):422-30; PMID:26475777; http://dx.doi.org/10.1136/jclinpath-2015-203089 47.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Am J Clin Pathol 2015; 144:278-88; PMID: 26185313; http://dx.doi.org/10.1309/AJCPIXUYDVZ0RZ3G 48.,OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Cancer Immunol Immunother 2014; 63:643-62; PMID:24695950; http://dx.doi.org/10.1007/s00262-014-1544-9 49.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Nat Rev Clin Oncol 2016; 13:143-58; PMID:26598942; http://dx.doi.org/ 10.1038/nrclinonc.2015.209 50.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Immunity 2016; 44:1069-78; PMID:27192570; http://dx.doi.org/10.1016/j.immuni.2016.04.02351.,OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Breast Cancer Res Treat 2014; 146:15-24; PMID:24842267; http://dx.doi.org/10.1007/s10549-014- 2988-5 52.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Hum Pathol 2016; 47:78-84; PMID:26541326; http://dx.doi.org/10.1016/j.humpath.2015.09.006 53.,OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Cancer Immunol Res 2015;3:326-32; PMID:25527356; http://dx.doi.org/10.1158/2326-6066.CIR- 14-0133 54.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Clin Cancer Res 2014; 20:2773-82; PMID:24647569; http://dx.doi.org/10.1158/ 1078-0432.CCR-13-2702 55.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Sci Transl Med 2016; 8:328rv4; PMID:26936508;http://dx.doi.org/10.1126/scitranslmed.aad7118 57.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
J Vis Exp 2014; PMID:25548995; http://dx.doi.org/10.3791/52392 58.,OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
Appl Immunohistoc hem Mol Morphol 2009; 17:96- 101; PMID:18838917; http://dx.doi.org/10.1097/PAI.0b013e3 181845ef4 59.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
J Vis Exp 2013; PMID:23328703; http://dx.doi.org/10.3791/ 4059ONCOIMMUNOLOGY e1257452-13,Non-OADS,/arxiv_data1/oa_pdf/6e/61/koni-06-01-1257452.PMC5283629.pdf
"Published with license by Taylor & Francis Group, LLC © Elias J. Sayour, Gabriel De Leon, Christina Pham, Adam Grippin, Hanna Kemeny, Joshua Chua, Jian ping Huang, John H. Sampson, Luis San- chez-Perez, Catherine Flores, and Duane A. Mitchell.This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
"1, e1256527 (14 pages)http://dx.doi.org/10.1080/2162402X.2016.1256527",Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
ORCID Gabriel De Leon http://orcid.org/0000-0001-7489-6186 Jianping Huang http://orcid.org/0000-0001-7442-2669 References 1.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Nature 2015; 519:366-9; PMID:25762141; http://dx.doi.org/10.1038/nature14320 2.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Neurotherapeutics 2009; 6:527- 38; PMID:19560742; http://dx.doi.org/10.1016/j.nurt.2009.04.003 3.,OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Nat Nanotechnol 2007; 2:751-60; PMID:18654426; http://dx.doi.org/ 10.1038/nnano.2007.387 5.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Nat Rev Cancer 2005; 5:161-71; PMID:15738981; http://dx.doi.org/ 10.1038/nrc1566 6.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Nanomedicine 2011; 7:445-53; PMID:21220051; http://dx.doi.org/ 10.1016/j.nano.2010.12.010 8.,OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Vaccine 2003; 21:883-90; PMID:12547598; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Sci Translat Med 2012; 4:127ps8; PMID:22461638; http://dx.doi.org/10.1126/scitranslmed.3003634 10.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
PloS One 2012; 7:e34833; PMID:22558101; http://dx.doi.org/10.1371/journal.pone.0034833 11.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
110:4077-85; PMID:17690256; http://dx.doi.org/10.1182/blood-2007- 02-073841 12.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
J Immunol 2002;169:2407-13; PMID:12193708; http://dx.doi.org/10.4049/ jimmunol.169.5.2407 13.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
J Immunol 2007; 179:201-10; PMID:17579039; http://dx.doi.org/ 10.4049/jimmunol.179.1.201 14.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
J Control Release 2015; 203:1-15; PMID:25660205; http://dx.doi.org/10.1016/j.jconrel.2015.02.003 15.,OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Cell Mol Life Sci 2004; 61:2418-24; PMID:15378210; http://dx.doi.org/10.1007/s00018-004-4255-0 16.,OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Novel role of hematopoi- etic stem cells in immunologic rejection of malignant gliomas.Oncoimmunology 2015; 4:e994374; PMID:25949916; http://dx.doi.org/10.4161/2162402X.2014.994374 18.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Pharm Res 2011; 28:273-8; PMID:20814720; http://dx.doi.org/10.1007/s11095-010-0214-7 20.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
J Immunother 2008; 31:180-8; PMID:18481387; http://dx.doi.org/ 10.1097/CJI.0b013e31815ce501 21.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Nat Biotechnol 1997; 15:647-52;PMID:9219267; http://dx.doi.org/10.1038/nbt0797-647 22.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Cancer Immunol Immunother 2006; 55:672-83; PMID:16133108; http://dx.doi.org/10.1007/s00262-005-0064-z 23.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Mol Ther Nucleic Acids 2016; 5:e326; PMID:27327138;http://dx.doi.org/10.1038/mtna.2016.38 24.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.Nature 2016; 534:396-401; PMID:27281205; http://dx.doi.org/ 10.1038/nature18300 25.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009; 1:264-71;PMID:20049796; http://dx.doi.org/10.1002/wnan.6 26.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Gene Ther 1997; 4:210-8; PMID:9135734; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Head Neck 2013; 36:976-84;PMID:23733258; http://dx.doi.org/10.1002/hed.23397 28.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
"Fasol U, Frost A, Buchert M, Arends J, Fiedler U, Scharr D, Scheuenp ﬂug J, Mross K. Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis.Ann Oncol 2012; 23:1030-6; PMID:21693769; http://dx.doi.org/ 10.1093/annonc/mdr300 29.",OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
RNA Biol 2012; 9:1319-30; PMID:23064118;http://dx.doi.org/10.4161/rna.22269 30.,OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Clin Cancer Res 2013; 19:3165-75; PMID:23613317; http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
J Virol 2016; 90:4670-80; PMID:26912619; http://dx.doi.org/10.1128/JVI.02998-15 32.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
PloS One 2013; 8:e59082; PMID:23527092; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Cancer Res 2005; 65:2009-17; PMID:15753401;http://dx.doi.org/10.1158/0008-5472.CAN-04-3216 34.,Non-OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
Nat Biotechnol 2004; 22:1125-32; PMID:15300260; http://dx.doi.org/10.1038/nbt1007e1256527-14 E. J. SAYOUR ET AL.,OADS,/arxiv_data1/oa_pdf/08/9d/koni-06-01-1256527.PMC5283636.pdf
"1, e1259050 (13 pages)http://dx.doi.org/10.1080/2162402X.2016.1259050",Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
ORCID Sean G. Smith http://orcid.org/0000-0003-0457-2295 John L. Baltz http://orcid.org/0000-0001-5726-3205 Bhanu Prasanth Koppolu http://orcid.org/0000-0001-9570-3902 Sruthi Ravindranathan http://orcid.org/0000-0003-0451-7931 Khue Nguyen http://orcid.org/0000-0003-4954-1126 David A. Zaharoff http://orcid.org/0000-0001-6885-6727 References 1.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
Bladder Cancer 2016; 2:285-92;PMID:27500196; http://dx.doi.org/10.3233/BLC-160056 3.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
Lancet 2009; 374:239-49; PMID:19520422; http://dx.doi.org/10.1016/S0140-6736 (09)60491-8 4.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
Cancer 2013; 119:3219-3227; PMID:23737352; http://dx.doi.org/10.1002/cncr.28147 6.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
Bladder Cancer 2016; 2:15-25; PMID:27376121; http://dx.doi.org/10.3233/BLC-150026 7.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
Cancer Res 2009; 69:61926199; PMID:19638573; http://dx.doi.org/10.1158/0008-5472.CAN-09-1114 8.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
Biomaterials 2013; 34:3828-36; PMID:23453060; http://dx.doi.org/10.1016/j.biomaterials.2013.02.031 9.,OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
Cancer Immunol Immunother 2015; 64:689-96; http://dx.doi.org/10.1007/s00262-015-1672-x 10.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
JImmunother 2010; 33:697; PMID:20664357; http://dx.doi.org/ 10.1097/CJI.0b013e3181eb826d 11.,OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
OncoImmunol 2014; 3:e968001; PMID:25964864; http://dx.doi.org/10.4161/21624011.2014.968001 12.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
J Immunol Baltim Md 1950 2009; 182:4217-25; PMID:19299720; http://dx.doi.org/10.4049/jimmunol.0802793 13.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
J Exp Med 2013; 210:2803-11; http://dx.doi.org/10.1084/jem.20130678 15.,OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
Immunity2010; 32:104-115; PMID:20079666; http://dx.doi.org/10.1016/j.immuni.2009.10.011 16.,OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
Eur J Immunol 2014; 44:69-79; PMID:24114780; http://dx.doi.org/10.1002/eji.201343718 17.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
J Immunol Res 2016; 2016:1-14; PMID:27314056; http://dx.doi.org/10.1155/2016/8941260 18.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
J Immunol 2007; 178:2396-406; PMID:17277146; http://dx.doi.org/10.4049/jimmunol.178.4.2396 19.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
Cancer Immunol Res 2014; 2(2): 91-8; http://dx.doi.org/10.1158/2326-6066.CIR-13-021620.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
J Immunol 2015; 194(5):2049-56;http://dx.doi.org/10.4049/jimmunol.1402669 21.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
Cancer Res 2010; 70(21):8368-77; http://dx.doi.org/10.1158/ 0008-5472.CAN-10-1322 22.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
J Immunol 2008; 180(5):3122-31; http://dx.doi.org/10.4049/ jimmunol.180.5.3122 23.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
Blood 2007; 109(12):5346-54; http://dx.doi.org/10.1182/ blood-2006-10-051318 24.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
Nat Rev Urol 2015; 12(4):225-35; http://dx.doi.org/10.1038/nrurol.2015.58 25.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
Endocr Metab Immune Disord Drug Targets 2007; 7(4):266-70; http://dx.doi.org/10.2174/ 187153007782794335 26.,Non-OADS,/arxiv_data1/oa_pdf/5c/76/koni-06-01-1259050.PMC5283638.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, tran sformed, or built upon in any way.ONCOIMMUNOLOGY 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/c4/1f/koni-06-01-1257453.PMC5283641.pdf
"1, e1257453 (5 pages)http://dx.doi.org/10.1080/2162402X.2016.1257453",Non-OADS,/arxiv_data1/oa_pdf/c4/1f/koni-06-01-1257453.PMC5283641.pdf
Pharmacol Ther 2015; 147:22-31; PMID:25444759; http://dx.doi.org/ 10.1016/j.pharmthera.2014.11.001 2.,Non-OADS,/arxiv_data1/oa_pdf/c4/1f/koni-06-01-1257453.PMC5283641.pdf
Nat Rev Mol Cell Biol 2012; 13:616-30; PMID:22992590; http://dx.doi.org/10.1038/nrm3434 3.,OADS,/arxiv_data1/oa_pdf/c4/1f/koni-06-01-1257453.PMC5283641.pdf
Br J Clin Pharmacol 2014; 77:796-807; PMID:24843434; http://dx.doi.org/10.1111/bcp.12256 4.,Non-OADS,/arxiv_data1/oa_pdf/c4/1f/koni-06-01-1257453.PMC5283641.pdf
Mol Ther J Am Soc Gene Ther 2015; 23:1103-9; PMID:25917459; http://dx.doi.org/10.1038/mt.2015.43 9.,OADS,/arxiv_data1/oa_pdf/c4/1f/koni-06-01-1257453.PMC5283641.pdf
Invest New Drugs 2015; 33:357-70; PMID:25529192; http://dx.doi.org/10.1007/s10637-014-0192-4 12.,Non-OADS,/arxiv_data1/oa_pdf/c4/1f/koni-06-01-1257453.PMC5283641.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.ONCOIMMUNOLOGY 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
"1, e1249561 (13 pages)http://dx.doi.org/10.1080/2162402X.2016.1249561",Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
ORCID Ruea-Yea Huang http://orcid.org/0000-0002-2630-3806ONCOIMMUNOLOGY e1249561-11,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Nat Rev Cancer 2012; 12(4):252-64; PMID:22437870;http://dx.doi.org/10.1038/nrc3239 3.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Nat Immunol 2011; 12(6):492-9; PMID:21739672; http://dx.doi.org/10.1038/ni.2035 4.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
PLoS One 2012; 7(2):e30852; PMID:22347406; http://dx.doi.org/10.1371/journal.pone.0030852 5.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Cancer Cell 2014; 26(6):923-37; PMID:25465800; http://dx.doi.org/ 10.1016/j.ccell.2014.10.018 6.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
N Engl JMed 2012; 366(26):2455-65; PMID:22658128; http://dx.doi.org/ 10.1056/NEJMoa1200694 8.,OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
N Engl J Med 2012; 366(26):2443-54; PMID:22658127; http://dx.doi.org/ 10.1056/NEJMoa1200690 9.,OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Semin Oncol 2010; 37(5):473-84; PMID:21074063;http://dx.doi.org/10.1053/j.seminoncol.2010.09.001 10.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Nature 2006; 439(7077):682-7;PMID:16382236; http://dx.doi.org/10.1038/nature04444 11.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
J Immunother 2010; 33(3):225-35;PMID:20445343; http://dx.doi.org/10.1097/CJI.0b013e3181c01fcb 12.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
J Clin Oncol 2015; 33(17):1974-82;PMID:25605845; http://dx.doi.org/10.1200/JCO.2014.59.4358 13.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
J Immunol Res 2015; 2015:191832; PMID:26236750; http://dx.doi.org/10.1155/2015/191832 14.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Cell Res 2015; 25(2):208-24; PMID:25582080; http://dx.doi.org/10.1038/ cr.2015.3 1 5 .,OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
J Clin Oncol 2015; 33(34):4015-22; PMID:26351349; http://dx.doi.org/10.1200/JCO.2015.62.339716.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Proc NatlAcad Sci USA 2010; 107(9):4275-80; PMID:20160101; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Cancer Res 2012; 72(4):917-27;PMID:22186141; http://dx.doi.org/10.1158/0008-5472.CAN-11-1620 18.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Cancer Res 2013; 73(12):3591-603; PMID:23633484; http://dx.doi.org/10.1158/0008-5472.CAN-12-4100 19.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Oncotarget 2015; 6(29):27359-77; PMID:26318293; http://dx.doi.org/10.18632/oncotarget.4751 20.,OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
N Engl J Med 2013; 369 (2):122-33; PMID:23724867; http://dx.doi.org/10.1056/NEJMoa1302369 21.,OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
J Exp Med 2010; 207(10):2175-86; PMID:20819923; http://dx.doi.org/10.1084/ jem.20100637 22.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Blood 2010; 116(8):1291-8; PMID:20472828; http://dx.doi.org/10.1182/blood-2010-01-265975 24.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Proc Natl Acad Sci U S A 2010; 107(17):7875-80; PMID:20385810; http://dx.doi.org/10.1073/ pnas.1003345107 25.,OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Immunity 2007; 27(4):670-84; PMID:17950003; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
CancerImmunol Res 2013; 1(3):158-62; PMID:24777678; http://dx.doi.org/10.1158/2326-6066.CIR-13-0016 27.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Nat Rev Immunol 2009; 9(3):162-74;PMID:19197294; http://dx.doi.org/10.1038/nri2506 28.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
J Immunol 2008; 181(8):5791-802; PMID:18832739; http://dx.doi.org/10.4049/jimmunol.181.8.5791 29.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
J Clin Invest 2006; 116(10):2777-90; PMID:17016559; http://dx.doi.org/10.1172/JCI28828 30.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
37(4):764-82; PMID:25823918; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Cancer Res 2013; 73(23):6900-12; PMID:23975756; http://dx.doi.org/10.1158/0008-5472.CAN-13-1550 32.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
PLoS One 2013; 8(12):e84927; PMID:24367702; http://dx.doi.org/10.1371/journal.pone.0084927 33.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Eur J Immunol 1994; 24(12):3216-21; PMID:7805750; http://dx.doi.org/ 10.1002/eji.1830241246 34.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Int Immunol 1996; 8(5):765-72;PMID:8671665; http://dx.doi.org/10.1093/intimm/8.5.765 36.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Nat Immunol 2009; 10(1):29-37;PMID:19043418; http://dx.doi.org/10.1038/ni.1679 37.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
J Exp Med 2015; 212(7):1125-37; PMID:26034050; http://dx.doi.org/10.1084/jem.2014223738.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Nat Commun 2016; 7:10501; PMID:26883990; http://dx.doi.org/10.1038/ncomms10501 39.,OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Immunogenetics 1998; 48(2):116-24; PMID:9634475; http://dx.doi.org/10.1007/s002510050411 40.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Nat Rev Immunol 2011; 11(12):852- 63; PMID:22116087; http://dx.doi.org/10.1038/nri3108 41.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Science 2008; 322(5899):271-5; PMID:18845758; http://dx.doi.org/10.1126/science.1160062 42.,OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
J Exp Med 2009; 206(8):1717-25; PMID:19581407; http://dx.doi.org/ 10.1084/jem.20082492 43.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Immunity 2015; 42(2):265-78; PMID:25680272; http://dx.doi.org/10.1016/j.immuni.2015.01.006 44.,OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Carcinogenesis 2000; 21(4):585-91; PMID:10753190; http://dx.doi.org/10.1093/carcin/21.4.585 45.,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
Eur J Immunol 2010; 40 (6):1768-77; PMID:20391435; http://dx.doi.org/10.1002/eji.200939874ONCOIMMUNOLOGY e1249561-13,Non-OADS,/arxiv_data1/oa_pdf/23/86/koni-06-01-1249561.PMC5283642.pdf
"1, e1253655 (18 pages)http://dx.doi.org/10.1080/2162402X.2016.1253655",Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
"(A) Tabular overview of transcription factor activity showing (from left to right) motif name, activity s igniﬁcance (Z), functional data (source: http://www.ncbi.nlm.nih.gov/gene ) and a graphical representation of differential regulation: CD11bCDCs from (1) lungs of tumor-free hosts, (2) peritumoral lung tissue, and (3) lung tumor tissue.",OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
"Analysis of the microarray data was performed in the R programming environment, in conjunction with the packagesdeveloped within the Bioconductor project ( http://www.biocon ductor.org ).",OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Data have been deposited in Gene Expression Omnibus under accessionnumber GSE85044 and can be viewed at http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
The expression levels of the selected miRNAs forall patients were combined with clinical data available at TCGAData Portal [ https://tcga-data.nci.nih.gov/tcga/ ].,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
ORCID Celine Everaert http://orcid.org/0000-0001-7772-4259 Melissa Dullaers http://orcid.org/0000-0003-0223-230X Jo Vandesompele http://orcid.org/0000-0001-6274-0184References 1.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Nat Rev Immunol 2014; 14:705-11; PMID:25190285; http://dx.doi.org/10.1038/nri3727 2.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Nat Rev Cancer 2012; 12:265-77; PMID:22437871; http://dx.doi.org/ 10.1038/nrc3258 3.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Am JRespir Critical Care Med 2015; 191:377-90; PMID:25369536; http://dx.doi.org/10.1164/rccm.201409-1671PP 5.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Cancer Res 2014; 74:705-15; PMID:24366885; http://dx.doi.org/10.1158/0008-5472.CAN-13-1342 7.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Cancer Immunol Immunother 2016; 65:821-33; PMID:26984847; http://dx.doi.org/10.1007/s00262-016-1820-y 8.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
J Immunol 2007; 178:2763-9; PMID:17312119; http://dx.doi.org/10.4049/jimmunol.178.5.2763 9.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Cancer Res 2009; 69:3086-94; PMID:19293186; http://dx.doi.org/10.1158/0008-5472.CAN-08-2826 10.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Int J Cancer 2013; 132:967-77; PMID:22870862; http://dx.doi.org/10.1002/ijc.27710 11.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Nat Rev Immunol 2012; 12:253-68;PMID:22437938; http://dx.doi.org/10.1038/nri3175 12.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Immunity 2013; 38:322-35;PMID:23352232; http://dx.doi.org/10.1016/j.immuni.2012.10.016 13.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
NatBiotechnol 2006; 24:1151-61; PMID:16964229; http://dx.doi.org/ 10.1038/nbt1239 14.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
LabInvest 2014; 94:536-44; PMID:24614194; http://dx.doi.org/10.1038/labinvest.2014.41 15.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Prevent Res 2010; 3:424-37; PMID:20354164; http://dx.doi.org/ 10.1158/1940-6207.CAPR-10-0032 16.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Genome Res 2014; 24:869-84;PMID:24515121; http://dx.doi.org/10.1101/gr.169508.113 18.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
J Immunol2002; 168:5448-54; PMID:12023338; http://dx.doi.org/10.4049/ jimmunol.168.11.5448 1 9 .,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
J Immunol 2001; 166:4446-55; PMID:11254700; http://dx.do i.org/10.4049/jimmunol.166.7.4446 20.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Blood 2012; 119:115-26; PMID:22053106; http://dx.doi.org/10.1182/blood-2011-06-363093 21.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
J Immunol 2007; 179:7577-84; PMID:18025203; http://dx.doi.org/10.4049/jimmunol.179.11.7577 22.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Immunity 2015; 42:1197-211; PMID:26084029; http://dx.doi.org/10.1016/j.immuni.2015.05.018 23.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Cancer Disco 2012; 2:706-21; PMID:22609699; http://dx.doi.org/10.1158/2159-8290.CD-11-0239 24.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Science 2014; 344:921-5; PMID:24812208; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Cancer Cell 2014; 26:638-52;PMID:25446897; http://dx.doi.org/10.1016/j.ccell.2014.09.007 26.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
J Immu- nol 2009; 182:2777-85; PMID:19234172; http://dx.doi.org/10.4049/ jimmunol.0803172 29.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Immunity 2016; 44:924-38; PMID:27096321; http://dx.doi.org/10.1016/j.immuni.2016.03.012 30.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Lancet 2016; 387:1837-46;PMID:26970723; http://dx.doi.org/10.1016/S0140-6736(16)00587-0 31.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
"Liu Q, Zhang C, Sun A, Zheng Y, Wang L, Cao X. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I. J Immunol 2009; 182:6207-16; PMID:19414774;http://dx.doi.org/10.4049/jimmunol.0803926 32.",Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Nature Med 2010; 16:880-6;PMID:20622859; http://dx.doi.org/10.1038/nm.2172 33.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Immunobiology 2013; 218:76-89; PMID:22465745; http://dx.doi.org/ 10.1016/j.imbio.2012.02.002 34.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Blood 2011; 117:2625-39;PMID:21148811; http://dx.doi.org/10.1182/blood-2010-06-292136 35.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Eur J Immunol 2013; 43:949-66; PMID:23436478; http://dx.doi.org/10.1002/eji.201242709 36.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Clinical Immunol 2009; 132:371-84; PMID:19553159; http://dx.doi.org/10.1016/j.clim.2009.05.016 37.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Cancer Cell 2002; 2:289-300; PMID:12398893; http://dx.doi.org/10.1016/S1535-6108(02)00153-8 38.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
J Clin Invest 2002; 110:993-1002; PMID:12370277; http://dx.doi.org/10.1172/JCI0215337 39.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Immunology 2013; 138:402-10; PMID:23278551; http://dx.doi.org/ 10.1111/imm.12053 40.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Nat Med 2003; 9:562-7; PMID:12704383; http://dx.doi.org/10.1038/nm863 41.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
J Exp Med 2014; 211:781-90; PMID:24778419; http://dx.doi.org/10.1084/jem.20131916 42.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Nature2014; 508:103-7; PMID:24670641; http://dx.doi.org/10.1038/ nature13119 43.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Cell 2015; 161:1527-38; PMID:26073941; http://dx.doi.org/10.1016/j.cell.2015.05.025 44.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Int J Cancer 2014; 135:2868-77; PMID:24789737; http://dx.doi.org/10.1002/ijc.28945ONCOIMMUNOLOGY e1253655-17,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Tumour Biol 2014;35:11639-45; PMID:25139099; http://dx.doi.org/10.1007/s13277-014-2492-x 46.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Clin Cancer Res 2013; 19:5423-33; PMID:23946296; http://dx.doi.org/10.1158/1078-0432.CCR-13-0320 47.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Cancer Lett 2014; 343:249-57; PMID:24099915; http://dx.doi.org/10.1016/j.canlet.2013.09.034 48.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Tumour Biol 2013; 34:1959-65; PMID:23539435; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
miR-31 ablates expression of the HIF regulatory fac- tor FIH to activate the HIF pathway in head and neck carcinoma.Cancer Res 2010; 70:1635-44; PMID:20145132; http://dx.doi.org/10.1158/0008-5472.CAN-09-2291 51.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
GenesDev 2009; 23:2152-65; PMID:19759263; http://dx.doi.org/10.1101/ gad.1820109 52.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Nat Cell Biol 2006; 8:1369-75; PMID:17128264; http://dx.doi.org/10.1038/ncb1507 53.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Nat Commun 2013; 4:1853;PMID:23673638; http://dx.doi.org/10.1038/ncomms2856 54.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Oncol Rep 2015; 34:2889-900; PMID:26397389; http://dx.doi.org/ 10.3892/or.2015.4307 55.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
J Exp Med 2008; 205:2235-49;PMID:18809714; http://dx.doi.org/10.1084/jem.20080132 56.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Am J Respir Critical Care Med 2012; 186:1025-36; PMID:22955317; http://dx.doi.org/10.1164/rccm.201204-0636OC 57.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Immunotherapy 2016; 8:279-98; PMID:26860624;http://dx.doi.org/10.2217/imt.15.123 58.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
J Immu-nol Methods 1999; 223:77-92; PMID:10037236; http://dx.doi.org/ 10.1016/S0022-1759(98)00204-X 59.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Nat Genet 2003; 34:267-73; PMID:12808457; http://dx.doi.org/10.1038/ng1180 61.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Nucleic Acids Res 2008; 36:e143; PMID:18940866; http://dx.doi.org/10.1093/nar/gkn725 62.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Genome Biol 2009; 10:R64;PMID:19531210; http://dx.doi.org/10.1186/gb-2009-10-6-r64 63.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
Int J Dev Biol 2010;54:887-96; PMID:19757378; http://dx.doi.org/10.1387/ijdb.092948owe1253655-18 L. PYFFEROEN ET AL.,OADS,/arxiv_data1/oa_pdf/7b/9d/koni-06-01-1253655.PMC5283643.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/a7/pnw080.PMC5283700.pdf
Available at: http://nrlweb.ihelse.net/rapporter/rapport2013.pdf (accessed April 2016)Trajectories of Acute Pain After TKA 139,Non-OADS,/arxiv_data1/oa_pdf/35/a7/pnw080.PMC5283700.pdf
Substance Abuseand Mental Health Services Administration; 2012.Available at: http://www.samhsa.gov/data/NSDUH/2011SummNatFindDetTables/Index.aspx.,OADS,/arxiv_data1/oa_pdf/83/a3/pnw122.PMC5283701.pdf
US Department of Health and Human Services; US Food and Drug Administration; 2015.Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulator yInformation/Guidances/ UCM334743.pdf (accessed June 2015).,OADS,/arxiv_data1/oa_pdf/83/a3/pnw122.PMC5283701.pdf
Available at: http://www.cimalabs.com/technology/oraguard (accessed January 2015).,Non-OADS,/arxiv_data1/oa_pdf/83/a3/pnw122.PMC5283701.pdf
Available at: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf (accessed August2015).,Non-OADS,/arxiv_data1/oa_pdf/83/a3/pnw122.PMC5283701.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/d5/pnw129.PMC5283702.pdf
Available at: http://www.whitehouse.gov/sites/default/files/ondcp/ issues-content/prescription-drugs/rx_abuse_plan_0.pdf (accessed August 8 2015).,Non-OADS,/arxiv_data1/oa_pdf/b6/d5/pnw129.PMC5283702.pdf
Available at: http://www.fda.gov/down loads/Drugs/DrugSafety/InformationbyDrugClass/ucm277916.pdf (accessed 3 2015).,Non-OADS,/arxiv_data1/oa_pdf/b6/d5/pnw129.PMC5283702.pdf
"Washington, DC: Office of National Drug Control Policy.Available at: http://www.whitehouse.gov/ondcp/prescription-drug-abuse1 (accessed August 4 2015).",Non-OADS,/arxiv_data1/oa_pdf/b6/d5/pnw129.PMC5283702.pdf
Available at: http://www.ghc.org/all-sites/guidelines/chronicOpioid.pdf (accessed August19 2015).,Non-OADS,/arxiv_data1/oa_pdf/b6/d5/pnw129.PMC5283702.pdf
"KI Reports (2016) 1,94–104; http://dx.doi.org/10.1016/j.ekir.2016.05.001 KEYWORDS: ambulatory blood pressure monitoring; cardiovascular disease; chronic kidney disease; circadian rhythm; hypertensionª2016 International Society of Nephrology.",Non-OADS,/arxiv_data1/oa_pdf/ed/cc/main.PMC5283800.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/cc/main.PMC5283800.pdf
"2, 200 –212 http://dx.doi.org/10.1080/15384101.2016.1261766",Non-OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"ORCID Anna Maria Nuzzo http://orcid.org/0000-0001-9115-2007 Paolo Mele http://orcid.org/0000-0002-5685-6663 Ettore Piccoli http://orcid.org/0000-0002-6395-4122 Alessandro Rolfo http://orcid.org/0000-0001-6730-8067References [1] Clarke B, Chetty R. Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix.",Non-OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Gynecologic Oncol- ogy 2001; 82:238-46; PMID:11531273; http://dx.doi.org/10.1006/gyno.2001.6306 [2] Milde-Langosch K, Riethdorf S. Role of cell-cycle regulatory proteins in gynecological cancer.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
Journal of Cellular Physiology 2003; 196:224-44; PMID:12811815; http://dx.doi.org/10.1002/jcp.10286 [3] Funk JO.,Non-OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Molecular human reproduction 2014; 20:1026-40; PMID:25024139; http://dx.doi.org/10.1093/molehr/gau053 [5] Strickland S, Richards WG.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Cell 1992; 71:355-7; PMID:1423599; http://dx.doi.org/10.1016/0092- 8674(92)90503-5 [6] Ferretti C, Bruni L, Dangles-Marie V, Pecking AP, Bellet D. Molecu- lar circuits shared by placental and cancer cells, and their implica-tions in the proliferative, invasive and migratory capacities of trophoblasts.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Human Reproduction Update 2007; 13:121-41; PMID:17068222; http://dx.doi.org/10.1093/humupd/dml048 [7] Ray JE, Garcia J, Jurisicova A, Caniggia I. Mtd/Bok takes a swing: proapoptotic Mtd/Bok regulates trophoblast cell proliferation during human placental development and in preeclampsia.",Non-OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Cell Death Differ2010; 17:846-59; PMID:19942931; http://dx.doi.org/10.1038/cdd.2009.167 [8] Pijnenborg R, Vercruysse L, Verbist L, Van Assche FA.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Placenta 1998; 19:569-75; PMID:9859859; http://dx.doi.org/10.1016/S0143-4004(98)90016-9 [9] Rolfo A, Giuffrida D, Nuzzo AM, Pierobon D, Cardaropoli S, Piccoli E, Piccoli E, Giovarelli M, Todros T. Pro-in ﬂammatory pro ﬁle of pre- eclamptic placental mesenchymal stromal cells: new insights into theetiopathogenesis of preeclampsia.",Non-OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"PLoS One 2013; 8:e59403; PMID:23527185; http://dx.doi.org/10.1371/journal.pone.0059403 [10] Nuzzo AM, Giuffrida D, Zenerino C, Piazzese A, Olearo E, Todros T, et al.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Placenta 2014; 35:483-90; PMID:24780198; http://dx.doi.org/10.1016/j.placenta.2014.04.001 [11] Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Stem Cells 2004; 22:649-58; PMID:15342929; http://dx.doi.org/10.1634/stemcells.22-5-649 [12] Li C, Zhang W, Jiang X, Mao N. Human-placenta-derived mesen- chymal stem cells inhibit proliferation and function of allogeneic immune cells.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Cell and Tissue Research 2007; 330:437-46;PMID:17899199; http://dx.doi.org/10.1007/s00441-007-0504-5 [13] Demir R, Kaufmann P, Castellucci M, Erbengi T, Kotowski A. FETAL VASCULOGENESIS AND ANGIOGENESIS IN HUMANPLACENTAL VILLI.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Acta Anatomica 1989; 136:190-203;PMID:2481376; http://dx.doi.org/10.1159/000146886 [14] Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M. Cell cycle-depen- dent variations in c-Jun and JunB phosphorylation: a role in the con-trol of cyclin D1 expression.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"EMBO J 2000; 19:2056-68;PMID:10790372; http://dx.doi.org/10.1093/emboj/19.9.2056 [15] Passegue E, Wagner EF.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"EMBO J 2000;19:2969-79; PMID:10856241; http://dx.doi.org/10.1093/emboj/ 19.12.2969 [16] Andrecht S, Kolbus A, Hartenstein B, Angel P, Schorpp-Kistner M. Cell cycle promoting activity of JunB through cyclin A activation.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"JBiol Chem 2002; 277:35961-8; PMID:12121977; http://dx.doi.org/ 10.1074/jbc.M202847200 [17] Berthet C, Kaldis P. Cell-speci ﬁc responses to loss of cyclin-depen- dent kinases.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
Oncogene 2007; 26:4469-77; PMID:17297466; http://dx.doi.org/10.1038/sj.onc.1210243210 A. M. NUZZO ET AL.,OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Stem Cells and Development 2010; 19:143-54; PMID:19947828; http://dx.doi.org/10.1089/scd.2009.0404 [19] Ramasamy R, Lam EW, Soeiro I, Tisato V, Bonnet D, Dazzi F. Mes- enchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Leukemia 2007; 21:304-10; PMID:17170725; http://dx.doi.org/10.1038/sj.leu.2404489 [20] DeLoia JA, Burlingame JM, Krasnow JS.",Non-OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Placenta 1997; 18:9-16; PMID:9032805; http://dx.doi.org/10.1016/S0143-4004(97)90066-7 [21] Dai Y, Qiu Z, Diao Z, Shen L, Xue P, Sun H, et al.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
Pla- centa 2012; 33:824-9; PMID:22858023; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Stem Cells Transl Med 2016; 5:451-63; PMID:26956210; http://dx.doi.org/10.5966/sctm.2015-0155 [23] Chen CP, Huang JP, Chu TY, Aplin JD, Chen CY, Wu YH.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Placenta 2013; 34:913-23;PMID:23896030; http://dx.doi.org/10.1016/j.placenta.2013.06.311 [24] Hwang JH, Lee MJ, Seok OS, Paek YC, Cho GJ, Seol HJ, et al.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
Cytokine 2010;49:95-101; PMID:19819721; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Journal of Anatomy 2008; 213:30-44; PMID:18638068; http://dx.doi.org/10.1111/j.1469-7580.2008.00931.x [26] Sherr CJ, Roberts JM.",Non-OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Genes & Development 1995;9:1149-63; PMID:7758941; http://dx.doi.org/10.1101/gad.9.10.1149 [27] Schwaller J, Pabst T, Koef ﬂer HP, Niklaus G, Loetscher P, Fey MF, et al.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Leukemia 1997; 11:54- 63; PMID:9001419; http://dx.doi.org/10.1038/sj.leu.2400522 [28] Piechaczyk M, Farras R. Regulation and function of JunB in cell pro- liferation.",Non-OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Biochemical Society Transactions 2008; 36:864-7; PMID:18793152; http://dx.doi.org/10.1042/BST0360864 [29] Muller M. Cellular senescence: molecular mechanisms, in vivo signif- icance, and redox considerations.",Non-OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Antioxid Redox Signal 2009; 11:59-98; PMID:18976161; http://dx.doi.org/10.1089/ars.2008.2104 [30] Biron-Shental T, Sukenik-Halevy R, Sharon Y, Laish I, Fejgin MD, Amiel A. Telomere shortening in intra uterine growth restriction pla-centas.",Non-OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Early Hum Dev 2014; 90:465-9; PMID:25010904; http://dx.doi.org/10.1016/j.earlhumdev.2014.06.003 [31] D ’Ippolito S, Di Nicuolo F, Marana R, Castellani R, Stinson J, Ter- signi C, et al.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Fertility and Sterility 2012; 98:1028- C; PMID:22818289; http://dx.doi.org/10.1016/j.fertnstert.2012.06.042 [32] Smith SC, Price E, Hewitt MJ, Symonds EM, Baker PN.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"J Soc Gynecol Inves-tig 1998; 5:317-23; PMID:9824812; http://dx.doi.org/10.1016/S1071-5576(98)00035-5 [33] Hara E, Smith R, Parry D, Tahara H, Steven S, Peters G. Regulation of p16(CDKN2) expression and its implications for cell immortaliza-tion and senescence.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Molecular and Cellular Biology 1996; 16:859-67; PMID:8622687; http://dx.doi.org/10.1128/MCB.16.3.859 [34] Caplan AI, Dennis JE.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"J Cell Biochem 2006; 98:1076-84; PMID:16619257; http://dx.doi.org/10.1002/jcb.20886[35] Tetta C, Consiglio AL, Bruno S, Tetta E, Gatti E, Dobreva M, et al.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Cell Transplant 2010; 19:667-79; PMID:20525442; http://dx.doi.org/10.3727/096368910X508762 [37] Abumaree MH, Al Jumah MA, Kalionis B, Jawdat D, Al Khaldi A, Abomaray FM, et al.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Stem Cell Rev 2013; 9:620-41; PMID:23812784;http://dx.doi.org/10.1007/s12015-013-9455-2 [38] Pianta S, Magatti M, Vertua E, Bonassi Signoroni P, Muradore I, Nuzzo AM, et al.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Amniotic mesenchymal cells from pre-eclamptic placentae maintain immunomodulatory features as healthy controls.J Cell Mol Med 2016; 20(1):157-69; PMID:26515425; http://dx.doi.org/10.1111/jcmm.12715 [39] Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F. Bone marrow mes- enchymal stem cells induce division arrest anergy of activated T cells.Blood 2005; 105:2821-7; PMID:15591115; http://dx.doi.org/10.1182/ blood-2004-09-3696 [40] Rolfo A, Giuffrida D, Giuffrida MC, Todros T, Calogero AE.",Non-OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Aging Male 2014; 17:94-101; PMID:24597941; http://dx.doi.org/10.3109/13685538.2014.896894 [41] Qin S, Jiang H, Su S, Wang D, Liang Z, Zhang J, et al.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Cell 2013; 155:1104-18;PMID:24238962; http://dx.doi.org/10.1016/j.cell.2013.10.019 [43] Sheppard KE, McArthur GA.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Clin Cancer Res 2013; 19:5320-8; PMID:24089445; http://dx.doi.org/10.1158/1078-0432.CCR-13-0259 [44] Lee JH, Park CH, Chun KH, Hong SS.",Non-OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Neuroimmunomodulation 2015; 22:233-42; PMID:25341618; http://dx.doi.org/10.1159/000365483 [46] Chen J, Li Y, Hao H, Li C, Du Y, Hu Y, et al.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Cell Physiol Biochem 2015; 37:1830-46;PMID:26584283; http://dx.doi.org/10.1159/000438545 [47] Wu F, Tian FJ, Lin Y. Oxidative Stress in Placenta: Health and Dis- eases.",Non-OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"J Clin Invest 2000; 105:1663-8; PMID:10862779; http://dx.doi.org/10.1172/JCI10413 [49] Fukada S, Ma Y, Uezumi A.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Front Cell Dev Biol 2014; 2:10;PMID:25364718; http://dx.doi.org/10.3389/fcell.2014.00010 [50] Raffaghello L, Bianchi G, Bertolotto M, Montecucco F, Busca A, Dal- legri F, et al.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
Stem Cells 2008; 26:151-62; PMID:17932421; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Cell Mol Life Sci 2016; 73(2):365-76; PMID:26496726; http://dx.doi.org/10.1007/s00018-015-2069-x [52] Chuprin A, Gal H, Biron-Shental T, Biran A, Amiel A, Rozenblatt S, et al.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Genes Dev 2013; 27:2356-66; PMID:24186980; http://dx.doi.org/10.1101/gad.227512.113 [53] Goldman-Wohl D, Yagel S. United we stand not dividing: the syncy- tiotrophoblast and cell senescence.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Placenta 2014; 35:341-4; PMID:24709558; http://dx.doi.org/10.1016/j.placenta.2014.03.012 [54] Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Cell Tissue Res 2004; 317:187-94; PMID:15221443; http://dx.doi.org/10.1007/s00441-004-0880-z [56] Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Genes Dev 1993; 7:812-21; PMID:8491378; http://dx.doi.org/10.1101/gad.7.5.812 [57] Diehl JA, Cheng M, Roussel MF, Sherr CJ.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Glycogen synthase kinase- 3beta regulates cyclin D1 proteolysis and subcellular localization.Genes Dev 1998; 12:3499-511; PMID:9832503; http://dx.doi.org/ 10.1101/gad.12.22.3499[58] Alt JR, Cleveland JL, Hannink M, Diehl JA.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Genes Dev 2000; 14:3102-14; PMID:11124803; http://dx.doi.org/10.1101/gad.854900 [59] Bertino E, Di Battista E, Bossi A, Pagliano M, Fabris C, Aicardi G, et al.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Fetal growth velocity: kinetic, clinical, and biological aspects.Arch Dis Child Fetal Neonatal Ed 1996; 74:F10-5; PMID:8653429; http://dx.doi.org/10.1136/fn.74.1.F10 [60] Parazzini F, Cortinovis I, Bortolus R, Fedele L. [Standards of birth weight in Italy].",Non-OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"Ultrasound ObstetGynecol 48:224-31; PMID:26350023; http://dx.doi.org/10.1002/ uog.15741 [62] Livak KJ, Schmittgen TD.",OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/db/kccy-16-02-1261766.PMC5283823.pdf
"The paucity of original  investigations in the literature suggests that complement inhibition has been for the most part  This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public  License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial  use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/46/nihms844753.PMC5283843.pdf
http://linkinghub.elsevier.com/retrieve/pii/ S1043661816000414 .,Non-OADS,/arxiv_data1/oa_pdf/46/46/nihms844753.PMC5283843.pdf
Voxel-based lesion-symptom map - ping (VLSM) (http://www.neuroling.,Non-OADS,/arxiv_data1/oa_pdf/e4/6b/radiol.2016152685.PMC5283872.pdf
"Lacunar infarctions,  acute ischemic infarctions, chronic  subcortical ischemic lesions, and cor - tical infarctions were separately and  manually outlined (by D.M., a trained  investigator) on coregistered images  by using locally developed NeuRoi soft - ware (http://www.nottingham.ac.uk/   research/groups/clinicalneurology/ neuroi.aspx).",Non-OADS,/arxiv_data1/oa_pdf/e4/6b/radiol.2016152685.PMC5283872.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/dc/15/1349-7235-55-3551.PMC5283953.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/dc/15/1349-7235-55-3551.PMC5283953.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/e7/f3/1349-7235-55-3561.PMC5283954.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/e7/f3/1349-7235-55-3561.PMC5283954.pdf
"To view the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/bc/2e/1349-7235-55-3571.PMC5283955.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/bc/2e/1349-7235-55-3571.PMC5283955.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/90/a8/1349-7235-55-3579.PMC5283956.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/90/a8/1349-7235-55-3579.PMC5283956.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a6/8c/1349-7235-55-3585.PMC5283957.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/a6/8c/1349-7235-55-3585.PMC5283957.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/6f/f8/1349-7235-55-3591.PMC5283958.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/6f/f8/1349-7235-55-3591.PMC5283958.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/0a/1d/1349-7235-55-3595.PMC5283959.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/0a/1d/1349-7235-55-3595.PMC5283959.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/1f/f8/1349-7235-55-3603.PMC5283960.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/1f/f8/1349-7235-55-3603.PMC5283960.pdf
"To view the details of this license, please visi t (https://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/61/b1/1349-7235-55-3607.PMC5283961.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/61/b1/1349-7235-55-3607.PMC5283961.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/24/f3/1349-7235-55-3611.PMC5283962.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/24/f3/1349-7235-55-3611.PMC5283962.pdf
Available from: http://ncbi.nlm.nih.gov/books/NBK279047/ 2.Prostate Cancer Trialists’ Collaborative Group.,Non-OADS,/arxiv_data1/oa_pdf/3c/c4/1349-7235-55-3623.PMC5283963.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/3c/c4/1349-7235-55-3623.PMC5283963.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/3c/c4/1349-7235-55-3623.PMC5283963.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/25/7b/1349-7235-55-3627.PMC5283964.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/25/7b/1349-7235-55-3627.PMC5283964.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/74/41/1349-7235-55-3635.PMC5283965.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/74/41/1349-7235-55-3635.PMC5283965.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ca/3d/1349-7235-55-3641.PMC5283966.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/ca/3d/1349-7235-55-3641.PMC5283966.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/92/28/1349-7235-55-3645.PMC5283967.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/92/28/1349-7235-55-3645.PMC5283967.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/05/3a/1349-7235-55-3655.PMC5283968.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/05/3a/1349-7235-55-3655.PMC5283968.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/cf/83/1349-7235-55-3661.PMC5283969.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/cf/83/1349-7235-55-3661.PMC5283969.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/fa/4f/1349-7235-55-3665.PMC5283970.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/fa/4f/1349-7235-55-3665.PMC5283970.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/e2/6f/1349-7235-55-3671.PMC5283971.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/e2/6f/1349-7235-55-3671.PMC5283971.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/db/02/1349-7235-55-3675.PMC5283972.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/db/02/1349-7235-55-3675.PMC5283972.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/42/79/1349-7235-55-3679.PMC5283973.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/42/79/1349-7235-55-3679.PMC5283973.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/f2/33/1349-7235-55-3681.PMC5283974.pdf
"Department of Gastroenterology, Sendai Kousei Hospital, Japan Received for publication March 17, 2016; Accepted for publication April 26, 2016Correspondence to Dr. Rintaro Hash imoto, rinhashimoto@gmail.com ⡥2016 The Japanese Society of Internal Medicine Journal W ebsite: http://www.naika.or.jp/imonline/index.html",Non-OADS,/arxiv_data1/oa_pdf/f2/33/1349-7235-55-3681.PMC5283974.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/92/6b/1349-7235-55-3683.PMC5283975.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/92/6b/1349-7235-55-3683.PMC5283975.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/60/cf/1349-7235-55-3685.PMC5283976.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/60/cf/1349-7235-55-3685.PMC5283976.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/0b/8d/1349-7235-55-3687.PMC5283977.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/0b/8d/1349-7235-55-3687.PMC5283977.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/95/1a/1349-7235-55-3689.PMC5283978.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/95/1a/1349-7235-55-3689.PMC5283978.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2015-209087).,OADS,/arxiv_data1/oa_pdf/c6/8b/annrheumdis-2015-209087.PMC5284330.pdf
"Correspondence to Dr Michael Kreuter, Center forInterstitial and Rare Lung Diseases, Pneumology and Respiratory Critical CareMedicine, Thoraxklinik,Heidelberg University Hospital, Röntgenstrasse 1, Heidelberg 69120, Germany;kreuter@uni-heidelberg.de Received 22 April 2016 Revised 27 July 2016 Accepted 8 August 2016Published Online First5 October 2016 ▸http://dx.doi.org/10.1136/ thoraxjnl-2016-209293 To cite: Kreuter M, Bonella F, Maher TM, et al.",Non-OADS,/arxiv_data1/oa_pdf/09/e9/thoraxjnl-2016-208819.PMC5284334.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Meltzer EB, Noble PW.",Non-OADS,/arxiv_data1/oa_pdf/09/e9/thoraxjnl-2016-208819.PMC5284334.pdf
2012. http://www.qsrinternational.com).,Non-OADS,/arxiv_data1/oa_pdf/bc/23/tobaccocontrol-2015-052692.PMC5284335.pdf
Availablefrom http://www.qsrinternational.com) established Cohen ’sκ coefﬁcient among the three coders to be 0.74 –0.78.,Non-OADS,/arxiv_data1/oa_pdf/bc/23/tobaccocontrol-2015-052692.PMC5284335.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Brennan E, Momjian A, Jeong M, et al.",Non-OADS,/arxiv_data1/oa_pdf/bc/23/tobaccocontrol-2015-052692.PMC5284335.pdf
"2012. http://repository.upenn.edu/cgi/viewcontent.cgi?article=1384&context=asc_papers 2 Siegel M, Biener L. The impact of an antismoking media campaign on progression to established smoking: results of a longitudinal youth study.",Non-OADS,/arxiv_data1/oa_pdf/bc/23/tobaccocontrol-2015-052692.PMC5284335.pdf
2015. https://www.ecitizen.gov.sg/Topics/ Pages/Smoking-Rules-in-Singapore.aspx (accessed Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/bc/23/tobaccocontrol-2015-052692.PMC5284335.pdf
http://hpm.org/sg/a4/2.pdf (accessed Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/bc/23/tobaccocontrol-2015-052692.PMC5284335.pdf
2014. http://www.hpb.gov.sg/HOPPortal/programmes-article/2490 (accessed Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/bc/23/tobaccocontrol-2015-052692.PMC5284335.pdf
https://www.resourceportal.nyc.sg/nycp/ShowDoc/WLP+Repository/nyc/resources_fs/nys2013/statshandbook (accessed Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/bc/23/tobaccocontrol-2015-052692.PMC5284335.pdf
2015. http://www.hpb.gov.sg/HOPPortal/health-article/11946 (accessed Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/bc/23/tobaccocontrol-2015-052692.PMC5284335.pdf
2015. http://www.cdc.gov/tobacco/campaign/tips/resources/videos/ terrie-videos.html (accessed Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/bc/23/tobaccocontrol-2015-052692.PMC5284335.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2015-208786).,Non-OADS,/arxiv_data1/oa_pdf/0a/2a/annrheumdis-2015-208786.PMC5284338.pdf
"Correspondence to Professor Won Park, IN-HAUniversity, School of Medicine,Medicine/Rheumatology, 366, Seohae-Daero, Jung-Gu, Incheon 22332, Republic ofKorea; parkwon@inha.ac.krand Professor Dae Hyun Yoo, Division of Rheumatology, Hanyang University Hospital forRheumatic Diseases, 222-1Wangsimni-Ro, Seongdong-Gu, Seoul 04763, Republic of Korea; dhyoo@hanyang.ac.kr Received 17 October 2015 Revised 7 April 2016 Accepted 9 April 2016 Published Online First29 April 2016 ▸http://dx.doi.org/10.1136/ annrheumdis-2015-208783 To cite: Yoo DH, Prodanovic N, Jaworski J, et al.Ann Rheum Dis 2017; 76:355–363.ABSTRACT Objectives To assess the ef ﬁcacy and safety of switching from the in ﬂiximab reference product (RP; Remicade) to its biosimilar CT-P13 (Remsima,Inﬂectra) or continuing CT-P13 in patients with rheumatoid arthritis (RA) for an additional six infusions.Methods This open-label extension study recruited patients with RA who had completed the 54-week,randomised, parallel-group study comparing CT-P13 withRP (PLANETRA; NCT01217086).",Non-OADS,/arxiv_data1/oa_pdf/0a/2a/annrheumdis-2015-208786.PMC5284338.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Maini R, St Clair EW, Breedveld F, et al.I nﬂiximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial.",Non-OADS,/arxiv_data1/oa_pdf/0a/2a/annrheumdis-2015-208786.PMC5284338.pdf
2009. http://www.who.int/biologicals/areas/biological_therapeutics/BIOTHERAPEUTICS_FOR_WEB_22APRIL2010.pdf (accessed 4 Apr 2016).,OADS,/arxiv_data1/oa_pdf/0a/2a/annrheumdis-2015-208786.PMC5284338.pdf
April 2015. http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ UCM291128.pdf (accessed 4 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/0a/2a/annrheumdis-2015-208786.PMC5284338.pdf
2013. http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/0a/2a/annrheumdis-2015-208786.PMC5284338.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2016-209322).,Non-OADS,/arxiv_data1/oa_pdf/d1/bb/annrheumdis-2016-209322.PMC5284339.pdf
"AEs were sum-marised as events/100 patient-years (E/100 PY) ofadalimumab exposure, using preferred terms of theMedical Dictionary for Regulatory Activities(MedDRA) V .15.1 (http://www.meddra.org).",OADS,/arxiv_data1/oa_pdf/d1/bb/annrheumdis-2016-209322.PMC5284339.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 National Center for, Immunization Respiratory, Diseases.",Non-OADS,/arxiv_data1/oa_pdf/d1/bb/annrheumdis-2016-209322.PMC5284339.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2015-208783).,OADS,/arxiv_data1/oa_pdf/13/df/annrheumdis-2015-208783.PMC5284340.pdf
"45, Herne 44649,Germany; j.braun@ rheumazentrumruhrgebiet.de and Professor Dae Hyun Yoo,Division of Rheumatology,Hanyang University Hospital for Rheumatic Diseases, 222-1 Wangsimni-Ro, Seongdong-Gu,Seoul 04763, Republic ofKorea; dhyoo@hanyang.ac.kr Received 16 October 2015 Revised 22 March 2016 Accepted 23 March 2016Published Online First26 April 2016 ▸http://dx.doi.org/10.1136/ annrheumdis-2015-208786 To cite: Park W, Yoo DH, Miranda P, et al.Ann Rheum Dis 2017; 76:346 – 354.ABSTRACT Objectives To investigate the ef ﬁcacy and safety of switching from in ﬂiximab reference product (RP) to its biosimilar or maintaining biosimilar treatment in patientswith ankylosing spondylitis (AS).Methods This open-label extension study recruited patients with AS who completed a 54-week, randomisedcontrolled study comparing CT-P13 with RP (PLANETAS).CT-P13 (5 mg/kg) was administered intravenously every8 weeks from week 62 to week 102.",Non-OADS,/arxiv_data1/oa_pdf/13/df/annrheumdis-2015-208783.PMC5284340.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 WHO, World Health Organization.",Non-OADS,/arxiv_data1/oa_pdf/13/df/annrheumdis-2015-208783.PMC5284340.pdf
2009. http://www.who.int/biologicals/areas/biological_therapeutics/BIOTHERAPEUTICS_FOR_WEB_22APRIL2010.pdf (accessed 19 Feb 2015).,OADS,/arxiv_data1/oa_pdf/13/df/annrheumdis-2015-208783.PMC5284340.pdf
April 2015. http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ UCM291128.pdf (accessed 2 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/13/df/annrheumdis-2015-208783.PMC5284340.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1 Brennan TA, Leape LL, Laird NM, et al.",Non-OADS,/arxiv_data1/oa_pdf/71/10/bmjqs-2015-004828.PMC5284341.pdf
http://www.hiqa.ie/system/files/Patient-Safety-Investigation-UHG-Summary.pdf 6 Health Information and Quality Authority.,Non-OADS,/arxiv_data1/oa_pdf/71/10/bmjqs-2015-004828.PMC5284341.pdf
2009. http://apps.who.,Non-OADS,/arxiv_data1/oa_pdf/71/10/bmjqs-2015-004828.PMC5284341.pdf
http://www.hse.ie/eng/about/Who/clinical/.,Non-OADS,/arxiv_data1/oa_pdf/71/10/bmjqs-2015-004828.PMC5284341.pdf
17 January 2008. http://www.hse.ie/eng/ services/publications/Hospitals/An_Integrated_Health_Service_-_Briefing_Document.pdf 28 Health Service Executive.,Non-OADS,/arxiv_data1/oa_pdf/71/10/bmjqs-2015-004828.PMC5284341.pdf
2005. http://lenus.ie/hse/bitstream/ 10147/46288/1/1086.pdf 30 Health Service Executive.,Non-OADS,/arxiv_data1/oa_pdf/71/10/bmjqs-2015-004828.PMC5284341.pdf
http://www.hse.ie/eng/services/list/5/cancer/about/services/regservices.html 31 National Projects Office.,Non-OADS,/arxiv_data1/oa_pdf/71/10/bmjqs-2015-004828.PMC5284341.pdf
http://www.hse.ie/eng/ about/Who/is/areamanagermap.pdf 32 Economic and Social Research Institute.,Non-OADS,/arxiv_data1/oa_pdf/71/10/bmjqs-2015-004828.PMC5284341.pdf
http://www.hpo.ie/latest_hipe_nprs_reports/HIPE_2009/HIPE_Report_2009.pdf 33 W orld Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/71/10/bmjqs-2015-004828.PMC5284341.pdf
http://stateclaims.ie/contact-us/reporting-events-or-incidents/ 38 State Claims Agency .,OADS,/arxiv_data1/oa_pdf/71/10/bmjqs-2015-004828.PMC5284341.pdf
http://stateclaims.ie/2012/10/adverse-event-data-for-2011-published-by-the-hse-and-the-sca/ 39 Leape LL.,OADS,/arxiv_data1/oa_pdf/71/10/bmjqs-2015-004828.PMC5284341.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Enestvedt BK, Ahmad N. To cease or ‘de-cyst ’?",Non-OADS,/arxiv_data1/oa_pdf/07/f8/jim-2016-000167.PMC5284342.pdf
"http://dx.doi.org/10.1016/j.gie.2010.02.027 68 Kim YH, Saini S, Sahani D, et al.",OADS,/arxiv_data1/oa_pdf/07/f8/jim-2016-000167.PMC5284342.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Bird W .,Non-OADS,/arxiv_data1/oa_pdf/31/f9/bmjqs-2015-004735.PMC5284344.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 National Cancer Institute ’s (NCI) Team Science Toolkit Website.,Non-OADS,/arxiv_data1/oa_pdf/7e/13/jim-2016-000216.PMC5284346.pdf
"Arlington (VA): Institute of Medicine, 1972. http://eric.ed.gov/?id=ED110819 8 Baldwin DC.",Non-OADS,/arxiv_data1/oa_pdf/7e/13/jim-2016-000216.PMC5284346.pdf
"Washington (DC): Institute of Medicine, 2012. http://www.iom.edu/tbc 10 Timmermans S, Kolker ES.",Non-OADS,/arxiv_data1/oa_pdf/7e/13/jim-2016-000216.PMC5284346.pdf
"http://www.ctsaweb.org 27 Lut ﬁyya MN, Brandt BF, Cerra FB.",Non-OADS,/arxiv_data1/oa_pdf/7e/13/jim-2016-000216.PMC5284346.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al.",Non-OADS,/arxiv_data1/oa_pdf/48/b4/annrheumdis-2016-209285.PMC5284347.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2015-208953).,Non-OADS,/arxiv_data1/oa_pdf/2c/c7/annrheumdis-2015-208953.PMC5284350.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Loeser RF, Goldring SR, Scanzello CR, et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/c7/annrheumdis-2015-208953.PMC5284350.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2016-209247).,OADS,/arxiv_data1/oa_pdf/c7/bc/annrheumdis-2016-209247.PMC5284351.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Dougados M, Betteridge N, Burmester GR, et al.",Non-OADS,/arxiv_data1/oa_pdf/c7/bc/annrheumdis-2016-209247.PMC5284351.pdf
2007. http://www.cebm.,Non-OADS,/arxiv_data1/oa_pdf/c7/bc/annrheumdis-2016-209247.PMC5284351.pdf
"2005. https://www.niehs.nih.gov/research/resources/assets/docs/2005_ working_committee_meeting_summary_508.pdf 28 Brown VE, Pilkington CA, Feldman BM, et al.",OADS,/arxiv_data1/oa_pdf/c7/bc/annrheumdis-2016-209247.PMC5284351.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ archdischild-2016-310687).,Non-OADS,/arxiv_data1/oa_pdf/64/d6/archdischild-2016-310687.PMC5284464.pdf
"1Department of Public Health, Birmingham Children ’s Hospital, Birmingham, UK 2Institute of Applied Health Research, University of Birmingham, Birmingham, UK Correspondence to Dr Christopher Chiswell,Department of Public Health, Birmingham Children ’s Hospital, Steelhouse Lane,Birmingham B4 6NH, UK;Christopher.chiswell@bch.nhs.uk Received 11 February 2016 Revised 8 June 2016Accepted 20 June 2016Published Online First 14 July 2016 ▸http://dx.doi.org/10.1136/ archdischild-2016-311652 To cite: Chiswell C, Akram Y. Arch Dis Child 2017; 102:123 –130.ABSTRACT Background Tobacco smoke exposure in adults is linked to adverse anaesthetic and surgical outcomes.Environmental tobacco smoke (ETS) exposure, includingpassive smoking, causes a number of known harms inchildren, but there is no established evidence review onits impact on intraoperative and postoperative outcomes.Objectives To undertake a systematic review of the impact of ETS on the paediatric surgical pathway and toestablish if there is evidence of anaesthetic,intraoperative and postoperative harm.Eligibility criteria participants Children aged 0–18 years undergoing anaesthetic or surgical procedures, any country, English language papers.",Non-OADS,/arxiv_data1/oa_pdf/64/d6/archdischild-2016-310687.PMC5284464.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Jones LL, Hashim A, McKeever T, et al.",Non-OADS,/arxiv_data1/oa_pdf/64/d6/archdischild-2016-310687.PMC5284464.pdf
2006. http://www.ncbi.nlm.nih.gov/books/NBK44318/(accessed 6 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/64/d6/archdischild-2016-310687.PMC5284464.pdf
"London: RCP, 2010. https://cdn.shopify.com/s/ ﬁles/1/0924/4392/ ﬁles/passive-smoking-and-children.pdf (accessed 6 Jan 2016).",Non-OADS,/arxiv_data1/oa_pdf/64/d6/archdischild-2016-310687.PMC5284464.pdf
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N& PAGE=fulltext&D=med4&AN=9113178.,Non-OADS,/arxiv_data1/oa_pdf/64/d6/archdischild-2016-310687.PMC5284464.pdf
2005. http://www.lho.org.uk/viewResource.aspx?id=9078 (accessed 6 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/64/d6/archdischild-2016-310687.PMC5284464.pdf
2005. http://www.lho.org.uk/viewResource.aspx?id=9776 (accessed 6 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/64/d6/archdischild-2016-310687.PMC5284464.pdf
http://ovidsp.ovid.com/ ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med5&AN=15992470.,Non-OADS,/arxiv_data1/oa_pdf/64/d6/archdischild-2016-310687.PMC5284464.pdf
"See: http://creativecommons.org/licenses/ by-nc/4.0/ To cite Gagliardi AR, Kothari A, Graham ID.",Non-OADS,/arxiv_data1/oa_pdf/5a/cb/jech-2016-207743.PMC5284465.pdf
https://http://www.R-project.org/ 2016).,Non-OADS,/arxiv_data1/oa_pdf/77/48/jech-2016-208006.PMC5284466.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Hauser R, Skakkebaek NE, Hass U, et al.",Non-OADS,/arxiv_data1/oa_pdf/77/48/jech-2016-208006.PMC5284466.pdf
Chapter 1.14.1 in Health at a Glance: Europe 2010. http://ec.europa.eu/health/reports/docs/health_glance_en.pdf (accessed 31 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/77/48/jech-2016-208006.PMC5284466.pdf
"2014. http://w3.unece.org/pxweb/Dialog/varval.asp?ma=001_GEPOAGESEX_REG_r&ti=Population%2C+5-year+age+groups%2C+by+Age%2C+Sex%2C+Country+and+Year&path=../DATABASE/Stat/30-GE/01-Pop/&lang=1 (accessed 26 Aug 2014).Table 3 Attributable disease and cost estimates Risk factorBody mass indexEndocrine-disrupting chemical exposures European population, 70–75 years old18 045 093 Diabetes prevalence 6.5% Prevalent diabetes, Europe 1 172 931Preventable cases 469 172 152 481Cost/case €29 585 Preventable costs €13.9 billion €4.51 billion Trasande L, et al.J Epidemiol Community Health 2017; 71:111–114.",OADS,/arxiv_data1/oa_pdf/77/48/jech-2016-208006.PMC5284466.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Berkhemer OA, Fransen PSS, Beumer D, et al.",Non-OADS,/arxiv_data1/oa_pdf/bf/16/neurintsurg-2015-012131.PMC5284468.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/ejhpharm-2016-001003).,Non-OADS,/arxiv_data1/oa_pdf/78/8e/ejhpharm-2016-001003.PMC5284469.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 National Institute for Health and Care Excellence (NICE).,Non-OADS,/arxiv_data1/oa_pdf/78/8e/ejhpharm-2016-001003.PMC5284469.pdf
http://pathways.nice.org.uk/pathways/falls-in-older-people (accessed 26 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/78/8e/ejhpharm-2016-001003.PMC5284469.pdf
"London: The King ’s Fund, 2014. http://www.kingsfund.org.uk/ publications/making-health-care-systems- ﬁt-ageing-population (accessed 15 Jan 2016).",Non-OADS,/arxiv_data1/oa_pdf/78/8e/ejhpharm-2016-001003.PMC5284469.pdf
"London: The King ’s Fund, 2013. http://www.kingsfund.org.uk/ publications/polypharmacy-and-medicines-optimisation (accessed 15 Jan 2016).",Non-OADS,/arxiv_data1/oa_pdf/78/8e/ejhpharm-2016-001003.PMC5284469.pdf
Keeping people safe when they transfer between care providers —getting the medicine right: Good practice guidance for healthcare professionals July 2011. http://www.rpharms.com/medicines-safety/getting-the-medicines-right.asp 17 National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) http://clahrc-northwestlondon.nihr.ac.,Non-OADS,/arxiv_data1/oa_pdf/78/8e/ejhpharm-2016-001003.PMC5284469.pdf
"2015. http://www.sign.ac.uk/pdf/ polypharmacy_guidance.pdf 21 Söderberg KC, La ﬂamme L, Möller J.",Non-OADS,/arxiv_data1/oa_pdf/78/8e/ejhpharm-2016-001003.PMC5284469.pdf
"2016. https://www.medicinescomplete.com/mc/bnf/current/ 24 Darowski A, Dwight J, Reynolds J.",Non-OADS,/arxiv_data1/oa_pdf/78/8e/ejhpharm-2016-001003.PMC5284469.pdf
"(http://www.drugsandfalls.com) 25 Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults.",Non-OADS,/arxiv_data1/oa_pdf/78/8e/ejhpharm-2016-001003.PMC5284469.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/jech-2016-207296).,Non-OADS,/arxiv_data1/oa_pdf/6c/5b/jech-2016-207296.PMC5284470.pdf
This is the UK standard approach; see the Of ﬁce for National Statistics Quality and Methodology Information Paper http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/qmis/suicideratesintheukqmi.,Non-OADS,/arxiv_data1/oa_pdf/6c/5b/jech-2016-207296.PMC5284470.pdf
"Analyses used the pre-2011 coding for allyears of data with suicides post-2010 identi ﬁed according to dir- ection by NRS, see http://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-theme/vital-events/deaths/suicides/main-points and http://www .nrscotland.gov.uk/ ﬁles/statistics/vital-events/ changes-to-coding-of-causes-of-death-between-2010-2011.pdf Analyses by deprivation were based on Carstairs deprivation categories.",OADS,/arxiv_data1/oa_pdf/6c/5b/jech-2016-207296.PMC5284470.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 McCartney G, Walsh D, Whyte B, et al.",Non-OADS,/arxiv_data1/oa_pdf/6c/5b/jech-2016-207296.PMC5284470.pdf
2015. http://www.scotpho.org.uk/ health-wellbeing-and-disease/suicide/data/data-introduction (accessed 15 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/6c/5b/jech-2016-207296.PMC5284470.pdf
"http://acestudy.org/ (accessed Dec 2015).46 Furlong A, Cartmel F, Biggart A.",Non-OADS,/arxiv_data1/oa_pdf/6c/5b/jech-2016-207296.PMC5284470.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ References ADEMILUYI, A. O.",Non-OADS,/arxiv_data1/oa_pdf/46/24/vetrec-2016-103865.PMC5284471.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ gutjnl-2015-310814).,OADS,/arxiv_data1/oa_pdf/cc/40/gutjnl-2015-310814.PMC5284473.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Ferlay J, Soerjomataram I, Dikshit R, et al.",Non-OADS,/arxiv_data1/oa_pdf/cc/40/gutjnl-2015-310814.PMC5284473.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Kupperman HS, Epstein JA.",Non-OADS,/arxiv_data1/oa_pdf/6d/34/archdischild-2015-309538.PMC5284474.pdf
"58 Prometheon Pharma, 2016. http://www.prometheonpharma.com/blog/2016/8/8/ y4foi5eqp83tvfgnch3i8uai6khnn2 (accessed 24 Aug 2016).",Non-OADS,/arxiv_data1/oa_pdf/6d/34/archdischild-2015-309538.PMC5284474.pdf
2015. https://www.medicines.org.uk/emc/medicine/28304 (accessed 11 1).,Non-OADS,/arxiv_data1/oa_pdf/6d/34/archdischild-2015-309538.PMC5284474.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/heartjnl-2016-309509).,Non-OADS,/arxiv_data1/oa_pdf/ff/33/heartjnl-2016-309509.PMC5284475.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Mauri L, Kereiakes DJ, Yeh RW, et al.",Non-OADS,/arxiv_data1/oa_pdf/ff/33/heartjnl-2016-309509.PMC5284475.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/jech-2015-207015).,Non-OADS,/arxiv_data1/oa_pdf/8f/2c/jech-2015-207015.PMC5284477.pdf
All the analyses were carried out using the R software(http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/8f/2c/jech-2015-207015.PMC5284477.pdf
"It can be speculated that this incremental perceived vul-nerability corresponds to people ’s interpretation of the mass media description of distant events at the state and nationallevel (eg, http://www.economist.com/blogs/graphicdetail/2012/11/mexican-drug-war), their visual inspection of their surround-ings including the perception of corruption and impunity ofpublic institutions, 24and their own experience (home).",Non-OADS,/arxiv_data1/oa_pdf/8f/2c/jech-2015-207015.PMC5284477.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 United Nations Of ﬁce on Drugs and Crime (UNODC).,Non-OADS,/arxiv_data1/oa_pdf/8f/2c/jech-2015-207015.PMC5284477.pdf
http://www.inegi.org.mx/est/contenidos/proyectos/registros/vitales/mortalidad/default.aspx (accessed Jan 2015).,OADS,/arxiv_data1/oa_pdf/8f/2c/jech-2015-207015.PMC5284477.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Sung JJ, Lau JY, Goh KL, et al.",Non-OADS,/arxiv_data1/oa_pdf/96/47/gutjnl-2015-310256.PMC5284478.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Bernardo D, Peña AS.",Non-OADS,/arxiv_data1/oa_pdf/ae/2e/gutjnl-2015-310148.PMC5284479.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/gutjnl-2015-310230) For numbered af ﬁliations see end of article.,Non-OADS,/arxiv_data1/oa_pdf/3b/83/gutjnl-2015-310230.PMC5284480.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Blouet C, Schwartz GJ.",Non-OADS,/arxiv_data1/oa_pdf/3b/83/gutjnl-2015-310230.PMC5284480.pdf
"40, Göttingen D-37075, Germany;ingazerr@med.uni-goettingen.de Received 14 March 2016 Revised 15 June 2016 Accepted 21 June 2016Published Online First2 November 2016 ▸http://dx.doi.org/10.1136/ jnnp-2016-314578 To cite: Varges D, Manthey H, Heinemann U, et al.J Neurol Neurosurg Psychiatry 2017; 88:119 – 125.ABSTRACT Objectives The main objective of the present study is to study the therapeutic ef ﬁciency of doxycycline in a double-blinded randomised phase II study in a cohort ofpatients with sporadic Creutzfeldt-Jakob disease (sCJD).Methods From the National Reference Center of TSE Surveillance in Germany, patients with probable ordeﬁnite sCJD were recruited for a double-blinded randomised study with oral doxycycline (EudraCT2006-003934-14).",Non-OADS,/arxiv_data1/oa_pdf/c5/15/jnnp-2016-313541.PMC5284486.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Korth C, Peters PJ.",Non-OADS,/arxiv_data1/oa_pdf/c5/15/jnnp-2016-313541.PMC5284486.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/2b/main.PMC5284487.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2017.01.001 2213-2244/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/2b/main.PMC5284487.pdf
"Sequencing was performed by Synergene Biotech GmbH, Biotech Center Zurich, Switzerland ( http://www.synergene- biotech.com ).",OADS,/arxiv_data1/oa_pdf/5a/2b/main.PMC5284487.pdf
"83, 1e17.http://dx.doi.org/10.1080/11250003.2016.1249966 .",Non-OADS,/arxiv_data1/oa_pdf/5a/2b/main.PMC5284487.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
1936-5233/17 http://dx.doi.org/10.1016/j.tranon.2016.12.004,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1002/ijc.25516 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1038/nrurol.2010.46 .,OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1016/S0022-5347(05)65382-7 .,OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1016/j.cell.2011.02.013 .,OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1038/onc.2009.185 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1074/jbc.M801192200 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1074/jbc.272.39.24333 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
"Trends Cell Biol 13,1 3 –22.http://dx.doi.org/10.1016/S0962-8924(02)00004-1 .",OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1083/jcb.133.6.1403 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1126/science.279.5350.509 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1371/journal.pone.0111276 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1038/nrm1128 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
"Semin Cancer Biol 1,5 6–61.http://dx.doi.org/10.1016/j.semcancer.2012.06.005 .",OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1016/j.devcel.2011.02.010 .Translational Oncology Vol.,OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1002/bdra.23076 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1038/nrc725 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1016/S1535-6108(03)00162-4 .,OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-06-1878 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1016/j.cellsig.2009.05.012 .,OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1053/j.gastro.2005.06.066 .,OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1016/j.humpath.2007.11.016 .,OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1074/jbc.M109.007971 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1016/j.yexcr.2008.07.012 .,OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1038/35070009 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1074/jbc.M604298200 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1007/s00345-008-0259-y .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1002/cncr.22237 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1158/1078-0432.CCR-04-1776 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1002/cncr.11570 .,Non-OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1016/S0959-8049(01)00290-8 .,OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1016/j.eururo.2010.03.015 .,OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
"Oncol Lett 3,3 9–44.http://dx.doi.org/10.3892/ol.2011.441 .",OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
http://dx.doi.org/10.1093/ annonc/mdm007 .152 RT-PCR and Quantitative PCR Analyses Miyazaki et al.,OADS,/arxiv_data1/oa_pdf/e3/ed/main.PMC5284488.pdf
"http://dx.doi.org/10.1016/j.redox.2017.01.013 Received 25 November 2016; Received in revised form 5 January 2017; Accepted 13 January 2017⁎Correspondence to: FISABIO, University Hospital Doctor Peset, Avda Gaspar Aguilar 90, 46017 Valencia, Spain.",Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/ 10.1126/science.1082889 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
"[3] M. Brownlee, Biochemistry and molecular cell biology of diabetic complications, Nature 414 (6865) (2001) 813– 820. http://dx.doi.org/10.1038/414813a .",Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1038/sj.emboj.7601963 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1101/ cshperspect.a011072 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
393 (7) (2012) 547– 564. http://dx.doi.org/10.1515/hsz- 2012-0119 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/ 10.1016/j.redox.2014.06.004 eCollection 2014.,OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
12 (1) (2011) 9 –14.http://dx.doi.org/10.1038/nrm3028 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
"[10] K. Sharma, Mitochondrial hormesis and diabetic complications, Diabetes 64 (3) (2015) 663– 672. http://dx.doi.org/10.2337/db14-0874 .",Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
4 (2015) 6 –13.http://dx.doi.org/10.1016/j.re- dox.2014.11.006 .,OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
11 (12) (2010) 872– 884. http://dx.doi.org/10.1038/nrm3013 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1126/science.1219855 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
19 (4) (2013) 415– 430. http://dx.doi.org/10.1089/ars.2012.4779 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
176 (4) (2007) 405– 414. http://dx.doi.org/10.1083/jcb.200611080.,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
"de Brito, L. Scorrano, Mitofusin 2 tethers endoplasmic reticulum to mitochondria, Nature 456 (7222) (2008) 605– 610. http://dx.doi.org/10.1038/ nature07534 .",Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
149 (3) (2011) 241– 251. http://dx.doi.org/ 10.1093/jb/mvr002 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
14 (3) (2011) 439– 457. http://dx.doi.org/10.1089/ars.2010.3286 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
Cell 24 (5) (2013) 659– 667. http://dx.doi.org/10.1091/mbc.E12-10-0721 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
27 (2) (2016) 105– 117. http://dx.doi.org/10.1016/ j.tem.2015.12.001 .,OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1038/emboj.2012.70 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.2337/db15-1725 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1007/s00125-015-3704-7 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
"[26] N. Mizushima, M. Komatsu, Autophagy: renovation of cells and tissues, Cell 147 (4) (2011) 728– 741. http://dx.doi.org/10.1016/j.cell.2011.10.026 .",OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
116 (1) (2015) 167– 182. http://dx.doi.org/10.1161/ CIRCRESAHA.116.303554 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/ 10.1016/j.bbamcr.2014.12.041 .,OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
12 (2) (2010) 119– 131. http://dx.doi.org/10.1038/ ncb2012 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1161/ CIRCRESAHA.116.306374 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
189 (4) (2010) 671– 679. http://dx.doi.org/10.1083/ jcb.201001039 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
89 (3) (2009) 799– 845. http://dx.doi.org/10.1152/ physrev.00030.2008 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1007/s00125-006-0369-2 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
"Wollheim, Mitochondrial function in normal and diabetic beta- cells, Nature 414 (6865) (2001) 807– 812. http://dx.doi.org/10.1038/414807a .",Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
25 (2) (2016) 108– 115. http://dx.doi.org/10.1089/ars.2016.6707 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
"Shulman, Mitochondrial dysfunction and type 2 diabetes, Science 307 (5708) (2005) 384– 387. http://dx.doi.org/10.1126/science.1104343 .",Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1089/ars.2015.6447 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.2337/diabetes.51.10.2944 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
34 (3) (2003) 267– 273. http://dx.doi.org/10.1038/ng1180 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
22 (8) (2015)686– 729. http://dx.doi.org/10.1089/ars.2014.5952 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
10 (2016) 200– 205. http://dx.doi.org/10.1016/ j.redox.2016.10.017 .,OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
18 (6) (2004) 737– 739. http://dx.doi.org/10.1096/ fj.03-1104fje .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.2337/db07-0141 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
434 (2016) 36 –47.http://dx.doi.org/10.1016/j.mce.2016.06.008 .,OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1152/ajprenal.00574.2014.,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.3945/jn.115.210617 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
474 (4) (2016 10) 646– 651. http://dx.doi.org/10.1016/j.bbrc.2016.04.142 .,OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
283 (5) (2016) 822– 833. http://dx.doi.org/10.1111/febs.13632 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.2337/db07-1781 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
478 (1) (2016) 431– 438. http://dx.doi.org/10.1016/j.bbrc.2016.07.004 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
115 (1)(2009) 1 –12.http://dx.doi.org/10.1080/1381345080267633.,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
92 (2016) 163– 173. http://dx.doi.org/ 10.1016/j.yjmcc.2016.01.023 .,OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1038/nm.3735 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1089/ars.2014.6030 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1073/ pnas.0511154103 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
"Wouters, C. De Wolf-Peeters, Van, G. den Berghe, Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients, Lancet 365(9453) (2005) 53 –59.http://dx.doi.org/10.1016/S0140-6736(04)17665-4 .",Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
"Edme, P. Lefebvre, B. Staels, Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients, Circulation 130 (7) (2014) 554– 564. http://dx.doi.org/10.1161/CIRCULATIONAHA.113.008476 .",Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
1350 (2015) 82 –94.http://dx.doi.org/ 10.1111/nyas.12863.,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
14 (2) (2008) 193– 204. http://dx.doi.org/10.1016/j.devcel.2007.11.019 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1161/ CIRCULATIONAHA.109.906610 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.2337/ db16-0915 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
1 (2013) 542– 551. http://dx.doi.org/10.1016/j.redox.2013.10.011 .,OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1016/j.bbrc.2014.11.010 .,OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1371/journal.pone.0060967.,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
126 (Pt 3) (2013) 789– 802. http://dx.doi.org/10.1242/jcs.114439 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
461 (1) (2014) 137– 146. http://dx.doi.org/10.1042/BJ20131438 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1093/hmg/ddt301 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
Rep. 6 (2016) 32656. http://dx.doi.org/10.1038/ srep32656 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.18632/oncotarget.11339 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
63 (2013) 485– 494. http://dx.doi.org/10.1016/j.freeradbiomed.2013.05.038 .,OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
24 (4) (2014) 482– 496. http://dx.doi.org/ 10.1038/cr.2014.20 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1111/bph.12477 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1111/bph.12503 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1074/ jbc.M116.733410 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
http://dx.doi.org/10.1172/JCI39492 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
384 (4) (2009) 471– 475. http://dx.doi.org/10.1016/ j.bbrc.2009.04.136 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
27 (5) (2007) 495– 502. http://dx.doi.org/10.1159/000106782 .,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
Rep. 6 (2016) 29196. http://dx.doi.org/10.1038/ srep29196 .S.,Non-OADS,/arxiv_data1/oa_pdf/8e/dd/main.PMC5284490.pdf
The MALDI-TOF-MS spectrum of P. massiliensis is available online (http://www.mediterranee-infection.com/article.php?,Non-OADS,/arxiv_data1/oa_pdf/31/c2/main.PMC5284491.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.12.015,Non-OADS,/arxiv_data1/oa_pdf/31/c2/main.PMC5284491.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,3 7 –38 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/31/c2/main.PMC5284491.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/e1/main.PMC5284492.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.01.017 2049-0801/ ©2017 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.,Non-OADS,/arxiv_data1/oa_pdf/1b/e1/main.PMC5284492.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Annals of Medicine and Surgery 14 (2017) 36 e39,Non-OADS,/arxiv_data1/oa_pdf/1b/e1/main.PMC5284492.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2017.01.006 2352-5789/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/8b/main.PMC5284493.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/8b/main.PMC5284493.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/e9/main.PMC5284494.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.01.033 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/e9/main.PMC5284494.pdf
"With this approach, wegenerated a total of 774 primary phenotypes and sub- phenotypes for analysis, as listed in Supplemental Table 1 (Supplemental digital content 1, http://links.lww.",OADS,/arxiv_data1/oa_pdf/a5/67/fpc-27-101.PMC5285297.pdf
"A total of 2544 SNPs were included in the analysis (listed in Supplemental Table 2, Supplemental digital content 2, http://links.lww.com/FPC/B149 ).",OADS,/arxiv_data1/oa_pdf/a5/67/fpc-27-101.PMC5285297.pdf
"Definitions for each of the 774 phenotypes are provided in Supplemental Table 2 (Supplemental digital content 2, http://links.lww.com/FPC/B149 ).",Non-OADS,/arxiv_data1/oa_pdf/a5/67/fpc-27-101.PMC5285297.pdf
Available at: https://www.ebi.ac.uk/gwas/ .,Non-OADS,/arxiv_data1/oa_pdf/a5/67/fpc-27-101.PMC5285297.pdf
Available at: http://genome.ucsc.edu/cgi- bin/hgLiftOver .,OADS,/arxiv_data1/oa_pdf/a5/67/fpc-27-101.PMC5285297.pdf
Available at: https://www.hsph.harvard.edu/alkes- price/software/ .,Non-OADS,/arxiv_data1/oa_pdf/a5/67/fpc-27-101.PMC5285297.pdf
http://www.who.int/mediacentre/factsheets/fs343/en/index.,Non-OADS,/arxiv_data1/oa_pdf/ec/52/indhealth-55-003.PMC5285309.pdf
http://pestadistico.inteligenciadegestion.msssi.es .,Non-OADS,/arxiv_data1/oa_pdf/ec/52/indhealth-55-003.PMC5285309.pdf
Evolu - ción 2000 – 2008. http://www.mspsi.gob.es/estadEstudios/   estadisticas/estHospiInternado/inforAnual/homeESCRI.,Non-OADS,/arxiv_data1/oa_pdf/ec/52/indhealth-55-003.PMC5285309.pdf
Working time in the  twenty-first century 2011. http://www.ilo.org/wcmsp5/,Non-OADS,/arxiv_data1/oa_pdf/56/e2/indhealth-55-046.PMC5285313.pdf
Average usual weekly hours  worked — averages 2014. http://stats.oecd.org/viewhtml.,OADS,/arxiv_data1/oa_pdf/56/e2/indhealth-55-046.PMC5285313.pdf
Average annual hours actu - ally worked per worker 2014. http://stats.oecd.org/index.,OADS,/arxiv_data1/oa_pdf/56/e2/indhealth-55-046.PMC5285313.pdf
Labor Standard  Act 2014. http://www.moel.go.kr/policyinfo/labor/view.,Non-OADS,/arxiv_data1/oa_pdf/56/e2/indhealth-55-046.PMC5285313.pdf
Korean work condition  survey 2014. http://kostat.go.kr/portal/korea/kor_nw/2/3/3/ index.board?bmode = read&bSeq = &aSeq = 332139&page No= 1&rowNum= 10&navCount= 10&currPg= &sTarget= title&sTxt= .,Non-OADS,/arxiv_data1/oa_pdf/56/e2/indhealth-55-046.PMC5285313.pdf
"Country data (Source EUROSTAT: http://ec.europa.eu/ eurostat) CountryTotal RMC country millions of m3 2011 2012 2013 Austria  10,5  10,6  10,5 Belgium  11,6  12,5  12,5 Czech Republic   7,5   6,9   6,5 Denmark   2,1   2,0   2,3 Finland   3,0   2,7   2,7 France  41,3  38,9  38,6 Germany  48,0  46,0  45,6 Ireland   2,4   2,4   2,4 Israel  12,0  13,0  14,0 Italy  52,6  39,9  31,7 Japan  88,0  92,0  99,0 Netherlands   8,8   7,3   6,6 Norway   3,5   3,7   3,8 Poland  23,7  19,5  18,0 Portugal   6,1   3,7   2,7 Russia  40,0  42,0  44,0 Slovakia   2,3   1,9   1,7 Spain  30,8  21,6  16,3 Sweden   3,3   3,3 — Switzerland  12,5  13,0  12,0 Turkey  90,0  93,0 102,0 United Kingdom  19,2  17,6  19,6 USA 203,0 225,0 230,0 Fig.",Non-OADS,/arxiv_data1/oa_pdf/bf/ff/indhealth-55-054.PMC5285314.pdf
https://www.osha.gov/oshstats/commonstats.,Non-OADS,/arxiv_data1/oa_pdf/bf/ff/indhealth-55-054.PMC5285314.pdf
http://www.civileblog.com/ready- mix-concrete/#Advantages .,Non-OADS,/arxiv_data1/oa_pdf/bf/ff/indhealth-55-054.PMC5285314.pdf
http://www.thbb.org/en/industry/statistics/ .,OADS,/arxiv_data1/oa_pdf/bf/ff/indhealth-55-054.PMC5285314.pdf
http://www.thbb.org/en/activities/ blue-helmet/2nd-blue-helmet/ .,Non-OADS,/arxiv_data1/oa_pdf/bf/ff/indhealth-55-054.PMC5285314.pdf
http://www.ccohs.ca/   oshanswers/hsprograms/job-haz.html .,Non-OADS,/arxiv_data1/oa_pdf/bf/ff/indhealth-55-054.PMC5285314.pdf
International migrant stock  2015. http://www.un.org/en/development/desa/population/ migration/data/estimates2/estimates15.shtml .,OADS,/arxiv_data1/oa_pdf/7e/9d/indhealth-55-067.PMC5285315.pdf
"Journal of Statistics,  number of aliens who obtain legal permission to work in  Thailand 2014. http://www.doe.go.th/prd/assets/upload/ files/alien_th/5f790ebd8469fb89efbe60674b585459.pdf.",Non-OADS,/arxiv_data1/oa_pdf/7e/9d/indhealth-55-067.PMC5285315.pdf
http://www.who.int/tb/country/data/profiles/en/ .,OADS,/arxiv_data1/oa_pdf/7e/9d/indhealth-55-067.PMC5285315.pdf
http://www.boe.moph.go.th/ Annual/AESR2013/annual/Malaria.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7e/9d/indhealth-55-067.PMC5285315.pdf
Available at: http://www.labour.gov.,Non-OADS,/arxiv_data1/oa_pdf/3e/e2/indhealth-55-076.PMC5285316.pdf
http://www.mhlw.go.jp/bunya/ roudoukijun/anzeneisei42 .,Non-OADS,/arxiv_data1/oa_pdf/60/e0/indhealth-55-087.PMC5285317.pdf
The Primer-BLAST web-based software was used to design gene-speci ﬁc primers (http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/ce/87/mp2016182a.PMC5285465.pdf
"To test for social approachbehaviors towards a live unfamiliar mouse (that is, same age, sex and strain), a novel C57BL/6 mouse previously habituated to a grid enclosure (that is, inverted wire pencil cup, Galaxy, Kitchen Plus, http://www.kitchen-plus.com) was placed in one of the side chambers.",Non-OADS,/arxiv_data1/oa_pdf/ce/87/mp2016182a.PMC5285465.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Pglyrp2 modulates brain development and behavior T Arentsen et al 266 Molecular Psychiatry (2017), 257 –266",Non-OADS,/arxiv_data1/oa_pdf/ce/87/mp2016182a.PMC5285465.pdf
Graphs were produced in Graph-Pad prism 6.0 (http://www.graphpad.,OADS,/arxiv_data1/oa_pdf/32/ac/mp2016220a.PMC5285468.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Patient-speci ﬁc models of critical microglial functions CM Sellgren et al 177 Molecular Psychiatry (2017), 170 –177",Non-OADS,/arxiv_data1/oa_pdf/32/ac/mp2016220a.PMC5285468.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Pro- or antidepressant effects by MAGL inhibitors Y Wang et al 226 Molecular Psychiatry (2017), 215 –226",Non-OADS,/arxiv_data1/oa_pdf/b0/ae/mp201622a.PMC5285470.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-nd/4.0/ rThe Author(s) 2017 Supplementary Information accompanies the paper on Journal of Human Genetics website (http://www.nature.com/jhg)Genetic association between NSCL/P and DD BW a n g et al 268 Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/96/67/jhg2016121a.PMC5285488.pdf
"PCR duplicates, which were produced during library preparations, were removed using MarkDuplicates from Picard program (https://broadinstitute.github.io/picard/) as well as PickingBases, newlydeveloped by one of us (KK) (see Supplementary Perl Scripts S1).",Non-OADS,/arxiv_data1/oa_pdf/8a/6d/jhg2016110a.PMC5285490.pdf
"15,20 We deposit all short read sequences produced for this study to DDBJ Sequence Read Archive (http://trace.ddbj.nig.ac.jp/dra/).",Non-OADS,/arxiv_data1/oa_pdf/8a/6d/jhg2016110a.PMC5285490.pdf
26 Pairwise alignment of panTro2 and human (hg19) http://hgdownload.cse.ucsc.edu/ goldenPath/panTro2/vsHg19/.,OADS,/arxiv_data1/oa_pdf/8a/6d/jhg2016110a.PMC5285490.pdf
"Genetics 112, 1065 –1093 (2012) ADMIXTOOLS 1.1 http://genetics.med.harvard.edu/reich/Reich_Lab/Software.html.",Non-OADS,/arxiv_data1/oa_pdf/8a/6d/jhg2016110a.PMC5285490.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ rThe Author(s) 2017 Supplementary Information accompanies the paper on Journal of Human Genetics website (http://www.nature.com/jhg)Jomon nuclear genome H Kanzawa-Kiriyama et al 221 Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/8a/6d/jhg2016110a.PMC5285490.pdf
"Data evaluation was performed with the software GlycoWorkbench 2.0 (http://www.glycoworkbench.org, generated by EUROCarbDB).",OADS,/arxiv_data1/oa_pdf/96/9a/jhg2016133a.PMC5285491.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-nd/4.0/ rThe Author(s) 2017 Supplementary Information accompanies the paper on Journal of Human Genetics website (http://www.nature.com/jhg)Comparative study of idursulfase beta and idursulfase CK i m et al 174 Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/96/9a/jhg2016133a.PMC5285491.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1016/S0140-6736(09)60553-5 .,OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1056/NEJMoa011300 .,OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1056/ NEJMoa0810625 .,OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1056/NEJMoa1204942 .,OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1016/S0140-6736(09)60044-1 .,OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1056/NEJMoa1302564 .,OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1056/ NEJMoa1206044 .,OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1164/rccm.201002-0190OC .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1097/PCC.0b013e31826049b3 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1016/ S0022-3476(96)70425-0 .,OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1007/s00134-002-1601-2 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1542/peds.2006-0347 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/ 10.1177/1932296815577812 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1089/dia.2006.0031 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.2337/diab.26.11.1016 .,OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1097/PCC.0b013e31821926a5 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1056/NEJMoa070716 .,OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1097/CCM.0b013e31818f21aa .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1186/cc7017 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1097/PCC.,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1097/01.PCC.0000161287.61028.D4 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1164/rccm.,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
2002; 30:1772– 1777. http://dx.doi.org/10.1097/00003246-200208000-00016 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1097/PCC.,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1016/j.ajic.2008.03.002 .,OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1093/jpepsy/10.2.215 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1097/00005650-200108000-00006 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1001/jama.300.8.933 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1016/ S0166-4115(08)62387-0 .,OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1016/ S0166-4115(08)62386-9 .,OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1007/s001340050406 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
"Leeds,  United Kingdom: 2009. http://www.picanet.org.uk/Audit/Annual-Reporting/Annual-Report- Archive/PICANet_National_Report_2009.pdf 41.",Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1097/01.PCC.,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
2005; 146:30– 34. http://dx.doi.org/10.1016/j.jpeds.2004.08.076 .,OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1016/j.jpeds.2009.05.007 .,OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1111/pedi.12134 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/ 10.1097/CCM.0b013e3182653269 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.2337/dc09-9029 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1177/1062860613489339 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1542/peds.105.5.1141 .,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
http://dx.doi.org/10.1097/PCC.,Non-OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
2015; 174:193– 198. http://dx.doi.org/10.1016/j.jpeds.2016.03.048 .,OADS,/arxiv_data1/oa_pdf/80/5b/nihms841794.PMC5285511.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/44/ircmj-18-10-23272.PMC5285513.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/7c/ircmj-18-10-27056.PMC5285577.pdf
"The Golden Section in Greek [Online].Available  from: URL: art, http://milan.milanovic.org/math/english/golden/ golden4.html .",Non-OADS,/arxiv_data1/oa_pdf/0c/6d/JISPCD-6-182.PMC5285592.pdf
Available  from: http://www.cdc.gov/oralhealth/topics/healthy_people.,Non-OADS,/arxiv_data1/oa_pdf/d8/e7/JISPCD-6-232.PMC5285600.pdf
Available from  http://en.wikipedia.org/wiki/Intelligence_Quotient.,OADS,/arxiv_data1/oa_pdf/ed/bb/JISPCD-6-237.PMC5285601.pdf
Available from: http://www.who.int/medicines/publications/ essentialmedicines/en/.,Non-OADS,/arxiv_data1/oa_pdf/76/39/JISPCD-6-243.PMC5285602.pdf
Available from: http://cdsco.nic.in/html/drugsbanned.html [Last  accessed on 2016 April 24].,Non-OADS,/arxiv_data1/oa_pdf/76/39/JISPCD-6-243.PMC5285602.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/c4/ircmj-18-10-27241.PMC5285732.pdf
Available from: http://chenabindustries.blogspot.com .,Non-OADS,/arxiv_data1/oa_pdf/f0/c4/ircmj-18-10-27241.PMC5285732.pdf
Available from: http://www.bahramansaffron.,Non-OADS,/arxiv_data1/oa_pdf/f0/c4/ircmj-18-10-27241.PMC5285732.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/9e/ircmj-18-10-27734.PMC5285733.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/ed/ircmj-18-10-25292.PMC5286217.pdf
The script that was used for the centring and smoothing is available onhttps://github.com/plijnzaad/phto ols/blob/master/ngs/center+ smooth.pl.,OADS,/arxiv_data1/oa_pdf/d3/12/EMBJ-36-274.PMC5286361.pdf
"Akin to theDepartment of Energy’s (DOE) national labo-ratories hosting linear accelerators, theseNational Laboratories for Model Systemscan conduct consensus-driven experimentscritical to answering biomedical questions.The prototype for mouse studies may bethe Interventions Testing Program (ITP;http://www.nia.nih.gov/research/dab/interventions-testing-program-itp), in which drugsare tested for longevity effects [10].",Non-OADS,/arxiv_data1/oa_pdf/06/f3/EMBR-18-187.PMC5286389.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/9d/ircmj-18-10-25284.PMC5286443.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/40/ircmj-18-10-25390.PMC5286445.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/d2/ircmj-18-10-25158.PMC5286446.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/4e/ircmj-18-10-28920.PMC5286558.pdf
Available  at: https://www.alz.co.uk/research/world-report-2015.,Non-OADS,/arxiv_data1/oa_pdf/e5/f2/DialoguesClinNeurosci-18-437.PMC5286729.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/c0/ircmj-18-10-29279.PMC5286842.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.MOLECULAR & CELLULAR ONCOLOGY 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/67/22/kmco-04-01-1260672.PMC5286925.pdf
"1, e1260672 (3 pages)http://dx.doi.org/10.1080/23723556.2016.1260672",Non-OADS,/arxiv_data1/oa_pdf/67/22/kmco-04-01-1260672.PMC5286925.pdf
Cell 2009; 139:871-90;PMID:19945376; http://dx.doi.org/10.1016/j.cell.2009.11.007 2.,OADS,/arxiv_data1/oa_pdf/67/22/kmco-04-01-1260672.PMC5286925.pdf
Nature 2015; 527:472-6; PMID:26560033; http://dx.doi.org/10.1038/nature15748 3 .,Non-OADS,/arxiv_data1/oa_pdf/67/22/kmco-04-01-1260672.PMC5286925.pdf
Nature2015; 527:525-30; PMID:26560028; http://dx.doi.org/10.1038/nature16064 4.,Non-OADS,/arxiv_data1/oa_pdf/67/22/kmco-04-01-1260672.PMC5286925.pdf
J Clin Invest 2016; 126:4174-86; PMID:27721239; http://dx.doi.org/10.1172/ JCI86623 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/67/22/kmco-04-01-1260672.PMC5286925.pdf
Nat Rev Cancer2003; 3:411-21; PMID:12778131; http://dx.doi.org/10.1038/nrc1092 6 .,Non-OADS,/arxiv_data1/oa_pdf/67/22/kmco-04-01-1260672.PMC5286925.pdf
Cell 2013; 153:139-52;PMID:23540695; http://dx.do i.org/10.1016/j.cell.2013.02.021 7.,OADS,/arxiv_data1/oa_pdf/67/22/kmco-04-01-1260672.PMC5286925.pdf
J Mol Med (Berl) 2008; 86:135-44; PMID:17891366; http://dx.doi.org/10.1007/s00109-007-0258-28.,Non-OADS,/arxiv_data1/oa_pdf/67/22/kmco-04-01-1260672.PMC5286925.pdf
Nature 2016; 529:316-25; PMID:26791722; http://dx.doi.org/10.1038/nature17040 9.,OADS,/arxiv_data1/oa_pdf/67/22/kmco-04-01-1260672.PMC5286925.pdf
Br J Haematol 2014; 164:767-78; PMID:24405087; http://dx.doi.org/10.1111/bjh.12725 10.,Non-OADS,/arxiv_data1/oa_pdf/67/22/kmco-04-01-1260672.PMC5286925.pdf
Cancer Lett 2012; 326:183-90;PMID:22906417; http://dx.doi.org/10.1016/j.canlet.2012.08.013MOLECULAR & CELLULAR ONCOLOGY e1260672-3,Non-OADS,/arxiv_data1/oa_pdf/67/22/kmco-04-01-1260672.PMC5286925.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/6d/ircmj-18-10-23912.PMC5287050.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/d7/ircmj-18-10-29518.PMC5287051.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/e1/ircmj-18-10-29394.PMC5287052.pdf
"http://apallergy.org Asia Pacific allergy: 6 years old Yoon-Seok Chang* Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National Uni - versity College of Medicine, Seongnam 13620, Korea.",Non-OADS,/arxiv_data1/oa_pdf/fb/07/apa-7-1.PMC5287064.pdf
"org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is  properly cited.https://doi.org/10.5415/apallergy.2017.7.1.1 Asia Pac Allergy 2017;7:1-2",Non-OADS,/arxiv_data1/oa_pdf/fb/07/apa-7-1.PMC5287064.pdf
" Chang  YSAsia Pacific allergy2 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.1[9, 10].",Non-OADS,/arxiv_data1/oa_pdf/fb/07/apa-7-1.PMC5287064.pdf
https://doi.org/10.1016/j.jaci.2016.11.028.,OADS,/arxiv_data1/oa_pdf/fb/07/apa-7-1.PMC5287064.pdf
"http://apallergy.orgPranlukast reduces asthma exacerbations during  autumn especially in 1- to 5-year-old boys Yoshinori Morita1,2,*, Eduardo Campos Alberto1, Shuichi Suzuki1,3, Yoshinori Sato4, Akira Hoshioka5, Hiroki Abe6,   Kimiyuki Saito7, Toshikazu Tsubaki8, Mana Haraki9, Akiko Sawa10, Yoshio Nakayama11, Hiroyuki Kojima12,   Midori Shigeta13, Fumiya Yamaide1, Yoichi Kohno1,14, and Naoki Shimojo1 1Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba 263-8522, Japan 2Department of Pediatrics, Chiba Kaihin Municipal Hospital, Chiba 261-0012, Japan 3Department of Pediatrics, Shimoshizu National Hospital, Chiba 284-0003, Japan 4Satou Clinic, Arao 864-0041, Japan 5Department of Allergy and Rheumatology, Chiba Children’s Hospital, Chiba 266-0007, Japan 6Abe Hiroki Children’s Clinic, Chiba 264-0028, Japan 7Sunrise Children’s Clinic, Chiba 273-0035, Japan 8Tsubaki Children’s Clinic, Chiba 260-0001, Japan 9Mana Children’s Clinic, Chiba 266-0032, Japan 10Katsuyama Clinic, Chiba 299-2117, Japan 11Nakayama Clinic, Chiba 275-0021, Japan 12Higashi Koiwa Wanpaku Clinic, Tokyo 133-0052, Japan 13Department of Pediatrics, National Hospital Organization Chiba Medical Center, Chiba 260-8606, Japan 14Chiba Rosai Hospital, Ichihara 290-0003, Japan Background:  Leukotriene receptor antagonists have been used to prevent virus-induced asthma exacerbations in autumn.",Non-OADS,/arxiv_data1/oa_pdf/c2/3e/apa-7-10.PMC5287065.pdf
https://doi.org/10.5415/apallergy.2017.7.1.10 Asia Pac Allergy 2017;7:10-18Original Article,Non-OADS,/arxiv_data1/oa_pdf/c2/3e/apa-7-10.PMC5287065.pdf
"Pranlukast reduces exacerbations in boys aged 1 to 5 years11 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.10 INTRODUCTION Prevalence of asthma in developed countries is high,  asthma exacerbations are associated with an increased rate of  hospitalizations and account for a substantial burden of social  morbidity and economic costs [1].",Non-OADS,/arxiv_data1/oa_pdf/c2/3e/apa-7-10.PMC5287065.pdf
"Morita Y, et al.Asia Pacific allergy12 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.10symptoms were defined as those with either an orange or yellow  sticker.",Non-OADS,/arxiv_data1/oa_pdf/c2/3e/apa-7-10.PMC5287065.pdf
Pranlukast reduces exacerbations in boys aged 1 to 5 years13 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.10differences between groups according to medical history or  prescribed asthma treatments (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/c2/3e/apa-7-10.PMC5287065.pdf
"Morita Y, et al.Asia Pacific allergy14 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.10Univariate analysis Outcomes There were no differences in total asthma score on 8 weeks of  treatment between pranlukast and control groups ( p = 0.35), and  in the number of days with worse asthma symptoms ( p = 0.67)  (Fig.",OADS,/arxiv_data1/oa_pdf/c2/3e/apa-7-10.PMC5287065.pdf
Pranlukast reduces exacerbations in boys aged 1 to 5 years15 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.10observed when evaluated the effect of pranlukast on age and sex  (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/c2/3e/apa-7-10.PMC5287065.pdf
"Morita Y, et al.Asia Pacific allergy16 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.10Table 4.",Non-OADS,/arxiv_data1/oa_pdf/c2/3e/apa-7-10.PMC5287065.pdf
Pranlukast reduces exacerbations in boys aged 1 to 5 years17 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.10girls in the pranlukast group had asthma exacerbation during the  study period.,Non-OADS,/arxiv_data1/oa_pdf/c2/3e/apa-7-10.PMC5287065.pdf
"Morita Y, et al.Asia Pacific allergy18 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.102- to 5-year-old children with intermittent asthma.",Non-OADS,/arxiv_data1/oa_pdf/c2/3e/apa-7-10.PMC5287065.pdf
Pranlukast reduces exacerbations in boys aged 1 to 5 years apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.10Suppleme ntal material.,Non-OADS,/arxiv_data1/oa_pdf/c2/3e/apa-7-10.PMC5287065.pdf
"http://apallergy.org The transition of sputum inflammatory cell   profiles is variable in stable asthma patients Bomi Shin, Hyouk-Soo Kwon, So Young Park, Tae-Bum Kim, Hee-Bom Moon, and You Sook Cho * Division of Allergy and Clinical Immunology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine,  Seoul, Korea Background:  The sputum inflammatory cell profile is an important indicator for classifying asthma phenotypes.",Non-OADS,/arxiv_data1/oa_pdf/86/16/apa-7-19.PMC5287066.pdf
https://doi.org/10.5415/apallergy.2017.7.1.19 Asia Pac Allergy 2017;7:19-28Original Article,Non-OADS,/arxiv_data1/oa_pdf/86/16/apa-7-19.PMC5287066.pdf
Asia Pacific allergy20 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.19INTRODUCTION Asthma is a heterogeneous disease.,Non-OADS,/arxiv_data1/oa_pdf/86/16/apa-7-19.PMC5287066.pdf
"Transition of inflammation profile in asthmatics21 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.19records, overall clinical judgment of physician, and inhaler  technique assessment.",Non-OADS,/arxiv_data1/oa_pdf/86/16/apa-7-19.PMC5287066.pdf
Asia Pacific allergy22 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.1943.0% (n = 64) of the study population.,OADS,/arxiv_data1/oa_pdf/86/16/apa-7-19.PMC5287066.pdf
"Transition of inflammation profile in asthmatics23 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.19(n = 39) for groups 1, 2, 3, and 4, respectively.",Non-OADS,/arxiv_data1/oa_pdf/86/16/apa-7-19.PMC5287066.pdf
Asia Pacific allergy24 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.19or changes in certain types of airway inflammatory patterns.,Non-OADS,/arxiv_data1/oa_pdf/86/16/apa-7-19.PMC5287066.pdf
Transition of inflammation profile in asthmatics25 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.19effect on modulating airway inflammation may be excluded.,Non-OADS,/arxiv_data1/oa_pdf/86/16/apa-7-19.PMC5287066.pdf
Asia Pacific allergy26 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.19and 47% had persistent noneosinophilia [19].,Non-OADS,/arxiv_data1/oa_pdf/86/16/apa-7-19.PMC5287066.pdf
Transition of inflammation profile in asthmatics27 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.19REFERENCES   1.,Non-OADS,/arxiv_data1/oa_pdf/86/16/apa-7-19.PMC5287066.pdf
"Morita Y, et alAsia Pacific allergy apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.122.",Non-OADS,/arxiv_data1/oa_pdf/86/16/apa-7-19.PMC5287066.pdf
"http://apallergy.org Involvement of cross-reactive carbohydrate   determinants-specific IgE in pollen allergy testing Hidenori Yokoi1,*, Hiroshi Yoshitake2, Yuma Matsumoto1, Michitsugu Kawada1, Yoshiki Takato3, Kiyomi Shinagawa3,  Hiroyuki Sakurai4, and Koichiro Saito1 1Department of Otolaryngology-Head and Neck Surgery, Kyorin University School of Medicine, Tokyo 181-8611, Japan 2Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Inzai 270-1695, Japan  3SHIDAX Research Institute, Tokyo, Japan 4Department of Pharmacology, Kyorin University School of Medicine, Tokyo 181-8611, Japan Background:  Specific IgE antibodies against the low-molecular-weight carbohydrate antigen that does not bridge IgE molecules  on mast cells are not associated with clinical symptoms.",Non-OADS,/arxiv_data1/oa_pdf/e4/84/apa-7-29.PMC5287067.pdf
https://doi.org/10.5415/apallergy.2017.7.1.29 Asia Pac Allergy 2017;7:29-36Original Article,Non-OADS,/arxiv_data1/oa_pdf/e4/84/apa-7-29.PMC5287067.pdf
"Yokoi H, et al.Asia Pacific allergy30 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.29INTRODUCTION Identification of causative antigens is generally performed  using methods of allergen-specific IgE antibody tests, skin allergy  tests (e.g., intracutaneous and scratch tests), and allergen-induced  tests.",Non-OADS,/arxiv_data1/oa_pdf/e4/84/apa-7-29.PMC5287067.pdf
CCD-specific IgE in pollen allergy testing31 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.29Measurement of allergen-specific IgE antibody titers in  serum Serum samples were collected from the venous blood of  subjects and were preserved at -20°C.,Non-OADS,/arxiv_data1/oa_pdf/e4/84/apa-7-29.PMC5287067.pdf
"Yokoi H, et al.Asia Pacific allergy32 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.29pollen allergies, and the detection frequency of CCD.",OADS,/arxiv_data1/oa_pdf/e4/84/apa-7-29.PMC5287067.pdf
CCD-specific IgE in pollen allergy testing33 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.29antibodies may have limited cross-reactivity with HRP and ASOD.,Non-OADS,/arxiv_data1/oa_pdf/e4/84/apa-7-29.PMC5287067.pdf
"Yokoi H, et al.Asia Pacific allergy34 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.29 Table 4.",OADS,/arxiv_data1/oa_pdf/e4/84/apa-7-29.PMC5287067.pdf
"CCD-specific IgE in pollen allergy testing35 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.29CCD-related antigens, suggesting that the reactivity of Japanese  cedar-specific IgE antibodies to these allergens may significantly   depend on the peptide structure (amino-acid sequences and  conformation).",Non-OADS,/arxiv_data1/oa_pdf/e4/84/apa-7-29.PMC5287067.pdf
"Yokoi H, et al.Asia Pacific allergy36 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.29Conventionally, while the cross-reactivity of CCD-related- specific IgE antibodies to pollen allergens was considered as one  of the possible causes of false positives in pollen-specific IgE  antibody testing, cross-reactivity was not actually observed with  Japanese cedar pollen.",OADS,/arxiv_data1/oa_pdf/e4/84/apa-7-29.PMC5287067.pdf
"http://apallergy.org Eosinophilic esophagitis: current understanding  and evolving concepts Hamish Philpott1,*, Barry Kweh1, and Francis Thien2 Departments of 1Gastroenterology and 2Respiratory Medicine, Eastern Health Clinical School, Monash University, Melbourne, Victoria 3128,  Australia Eosinophilic esophagitis (EoE) is now considered to represent a form of food allergy and this is demonstrated by a response to  elimination diet in many patients.",Non-OADS,/arxiv_data1/oa_pdf/30/d4/apa-7-3.PMC5287068.pdf
https://doi.org/10.5415/apallergy.2017.7.1.3 Asia Pac Allergy 2017;7:3-9Current Review,Non-OADS,/arxiv_data1/oa_pdf/30/d4/apa-7-3.PMC5287068.pdf
"Philpott H, et al.Asia Pacific allergy4 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.3Gastroscopy and biopsy are mandatory both to diagnose EoE  and to determine treatment response [ 4].",Non-OADS,/arxiv_data1/oa_pdf/30/d4/apa-7-3.PMC5287068.pdf
"Eosinophilic esophagitis review5 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.3female ratio of approximately 3:1 in most series [ 4, 23].",Non-OADS,/arxiv_data1/oa_pdf/30/d4/apa-7-3.PMC5287068.pdf
"Philpott H, et al.Asia Pacific allergy6 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.3barostatic or planimetry (the assessment of esophageal  distensibility) have defined abnormalities in a significant  percentage of patients, with decreased distensibility and  pan-esophageal pressurisation characteristic [ 36, 37].",Non-OADS,/arxiv_data1/oa_pdf/30/d4/apa-7-3.PMC5287068.pdf
"Eosinophilic esophagitis review7 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.3remission in up to 90% of patients, and is well tolerated, resulting  in improvement in dysphagia scores and quality of life indices [ 46].",Non-OADS,/arxiv_data1/oa_pdf/30/d4/apa-7-3.PMC5287068.pdf
"Philpott H, et al.Asia Pacific allergy8 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.3elimination therapy is an effective option for adults with eosinophilic  esophagitis.",Non-OADS,/arxiv_data1/oa_pdf/30/d4/apa-7-3.PMC5287068.pdf
Eosinophilic esophagitis review9 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.3dosages for short-term treatment of eosinophilic oesophagitis.,Non-OADS,/arxiv_data1/oa_pdf/30/d4/apa-7-3.PMC5287068.pdf
"http://apallergy.org Administration of the adrenaline auto-injector at  the nursery/kindergarten/school in Western   Japan  Seigo Korematsu1,2,*, Michiko Fujitaka1, Mika Ogata1, Masafumi Zaitsu1, Chikako Motomura1, Kazuyo Kuzume1, Toki - hiko Fujino1, Yuchiro Toku1, Masanori Ikeda1, and Hiroshi Odajima1 1West Japan Research Society Pediatric Clinical Allergy, Fukuoka 811-1394, Japan 2Oita University Faculty of Medicine, Oita 879-5593, Japan Background:  In view of the increasing prevalence of food allergies, there has been an associated increase in frequency of  situations requiring an emergency response for anaphylaxis at the home, childcare facilities and educational institutions.",Non-OADS,/arxiv_data1/oa_pdf/56/4f/apa-7-37.PMC5287069.pdf
https://doi.org/10.5415/apallergy.2017.7.1.37 Asia Pac Allergy 2017;7:37-41Original Article,Non-OADS,/arxiv_data1/oa_pdf/56/4f/apa-7-37.PMC5287069.pdf
"Asia Pacific allergy38 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.37INTRODUCTION In association with the increase in number of patients with  food allergies and anaphylaxis [1], the frequency of occasions  requiring emergency care at the home, nursery, kindergarten,  and school has also increased [2].",Non-OADS,/arxiv_data1/oa_pdf/56/4f/apa-7-37.PMC5287069.pdf
Adrenaline auto-injector administration at schools39 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.37The person who administered AAI at the nursery/ kindergarten/school Forty-five (45) physicians had patients who administered the  AAI.,Non-OADS,/arxiv_data1/oa_pdf/56/4f/apa-7-37.PMC5287069.pdf
"Asia Pacific allergy40 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.37junior-high school children, and 4.0% in high school children,  with those having experienced anaphylaxis being 0.6%, 0.4%, and  0.3%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/56/4f/apa-7-37.PMC5287069.pdf
Adrenaline auto-injector administration at schools41 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.37REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/56/4f/apa-7-37.PMC5287069.pdf
"http://apallergy.orgThe impact of age on Pru p 3 IgE production in  Italy Giorgio Ciprandi1,*, Mara De Amici2, Maria Luisa Di Martino3, Fiorella Barocci4, and Paola Comite1 1Allergy and Laboratory Medicine Department, IRCCS-AOU San Martino-IST, 16132 Genoa, Italy 2Department of Pediatrics, Foundation IRCCS Policlinico San Matteo, 27100 Pavia, Italy  3Allergy Lab, Internal Medicine II Unit, AOU Cagliari, 09124 Cagliari, Italy 4Immunohematology and Transfusion Medicine, AO G. Salvini, 20024, Garbagnate Milanese (MI), Italy  Background:  Pollen allergy may be frequently associated with fruit-vegetables: the so-called pollen food syndrome.",Non-OADS,/arxiv_data1/oa_pdf/a9/fa/apa-7-42.PMC5287070.pdf
Hypothesis & Experience Original Article https://doi.org/10.5415/apallergy.2017.7.1.42 Asia Pac Allergy 2017;7:42-47,Non-OADS,/arxiv_data1/oa_pdf/a9/fa/apa-7-42.PMC5287070.pdf
"LTP sensitization and age43 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.42 as hazelnut, walnut, peanut, pine nut: noteworthy these nuts  belong to different botanic species), rice, maize, and vegetables,  mainly tomato and lettuce [3].",Non-OADS,/arxiv_data1/oa_pdf/a9/fa/apa-7-42.PMC5287070.pdf
"Ciprandi G, et al.Asia Pacific allergy44 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.42was described by Tuft and Blumstein in 1942  [10].",OADS,/arxiv_data1/oa_pdf/a9/fa/apa-7-42.PMC5287070.pdf
"LTP sensitization and age45 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.42detected and are available for molecualr diagnostics: Pru p 1, Pru  p 3, and Pru p 4.",OADS,/arxiv_data1/oa_pdf/a9/fa/apa-7-42.PMC5287070.pdf
"Ciprandi G, et al.Asia Pacific allergy46 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.42REFERENCES 1.",OADS,/arxiv_data1/oa_pdf/a9/fa/apa-7-42.PMC5287070.pdf
LTP sensitization and age47 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.42pollen: an in vivo study.,Non-OADS,/arxiv_data1/oa_pdf/a9/fa/apa-7-42.PMC5287070.pdf
"http://apallergy.orgAnaphylaxis caused by honey: a case report  Rita Aguiar1,*, Fátima Cabral Duarte1, Ana Mendes1, Borja Bartolomé2, and Manuel Pereira Barbosa1 1Department Immunoallergology, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, E.P.E, 1649-035 Lisbon, Portugal 2Research and Development Department, Bial-Aristegui, Bilbao 48008, Spain Honey allergy is a very rare, but serious health condition.",Non-OADS,/arxiv_data1/oa_pdf/c0/df/apa-7-48.PMC5287071.pdf
Educational & Teaching Material Case Report https://doi.org/10.5415/apallergy.2017.7.1.48 Asia Pac Allergy 2017;7:48-50,Non-OADS,/arxiv_data1/oa_pdf/c0/df/apa-7-48.PMC5287071.pdf
"Anaphylaxis caused by honey49 apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.48 sesame, rye, barley, maize, wheat, oats, banana, egg, and milk)  were negative.",Non-OADS,/arxiv_data1/oa_pdf/c0/df/apa-7-48.PMC5287071.pdf
"Aguiar R, et al.Asia Pacific allergy50 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.48extract, so this result does not support the assumption that the  56-kDa band identified in honey A (heather honey) would be  a protein derived from bee venom.",OADS,/arxiv_data1/oa_pdf/c0/df/apa-7-48.PMC5287071.pdf
"http://apallergy.org Hypersensitivity to ticagrelor and low response  to clopidogrel: a case report Jing Dai, Shuzheng Lyu*, and Changjiang Ge Department of Cardiology, Capital Medical University Affiliated to Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel   Diseases, Beijing 100029, China Ticagrelor is widely used to treat acute coronary syndrome.",Non-OADS,/arxiv_data1/oa_pdf/e5/7c/apa-7-51.PMC5287072.pdf
Case Report https://doi.org/10.5415/apallergy.2017.7.1.51 Asia Pac Allergy 2017;7:51-53,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/apa-7-51.PMC5287072.pdf
"Dai J, et al.Asia Pacific allergy52 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.1.51Drugs included aspirin, ticagrelor, bisoprolol, and rosuvastatin.",OADS,/arxiv_data1/oa_pdf/e5/7c/apa-7-51.PMC5287072.pdf
"A case of hypersensitivity reaction to ticagrelor 53   apallergy.org https://doi.org/10.5415/apallergy.2017.7.1.51rashes after taking ticagrelor, showing a delayed-type of  hypersensitivity reaction, which is not the usual indication of  ticagrelor desensitization.",Non-OADS,/arxiv_data1/oa_pdf/e5/7c/apa-7-51.PMC5287072.pdf
"This strategy has led to the identi ﬁcation of large number of nuclear proteins from barley (Hordeum vulgare ), thus triggering the creation of a dedicated database called UNcleProt, http://barley.gambrinus.ueb.cas.cz/ .KEYWORDS barley; cell cycle; database; ﬂow-cytometry; localization; mass spectrometry; nuclear proteome; nucleus Introduction The nucleus is a key feature of eukaryotic cells and is characterized by the high complexity and dynamic organization of its components.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"1, 70 –80 http://dx.doi.org/10.1080/19491034.2016.1255391",Non-OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Morex) nuclear protein database (UNcle- Prot, http://barley.gambrinus.ueb.cas.cz/ ) that provides information about the barley nuclear pro-teins that have been identi ﬁed to date.",Non-OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Based on the accuracy of 6 subcellu- lar localization programs tested by Xiong et al., 38 we chose Plant-mPLoc ( http://www.csbio.sjtu.edu.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
cn/bioinf/plant-multi/39and CELLO ( http://cello.life.,Non-OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
The predictionaccuracy for all identi ﬁed barley nuclear proteins was monitored using the subnuclear web server Nuc-Ploc(http://www.csbio.sjtu.edu.cn/bioinf/Nuc-PLoc/ 41).,OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"To date, none of the existingnuclear databases such as the yeast nuclear database, 49 vertebrate nuclear database ( http://npd.hgu.mrc.ac.uk/ user/50,51), rice nuclear database ( http://gene64.dna.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"The identi ﬁed protein sequences were queried against Arabidopsis thaliana, Oryza sativa and Zea mays subsets of the UniProtKB/Swiss-Prot databaseusing the BLASTP algorithm ( http://blast.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
Domain searches were performedagainst CDD database 55utilizing CD search tool in a batch mode ( http://www.ncbi.nlm.nih.gov/Structure/ cdd/wrpsb.cgi ).,OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"UNcleProt database is built on a MySQL v.5.5.46 (http://www.mysql.com ) database, and the web inter- face uses PHP v.5.4.45 ( http://www.php.net ), which makes the database easy to navigate.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"ORCID Nicolas Blavet http://orcid.org/0000-0003-2199-9119 Jan Vr /C19ana http://orcid.org/0000-0001-6171-8516 Jaroslav Dole /C20zel http://orcid.org/0000-0002-6263-0492 Be/C19ata Petrovsk /C19a http://orcid.org/0000-0002-0315-9872 References [1] Guo T, Fang Y. Functional organization and dynamics of the cell nucleus.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"J Exp Bot 2015; 66:1627-40;http://dx.doi.org/10.1093/jxb/erv041 [3] Sutherland HGE, Mumford GK, Newton K, Ford LV, Farrall R, Dellaire G, C /C19aceres JF, Bickmore WA.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Hum Mol Genet 2001;10:1995-2011; PMID:11555636; http://dx.doi.org/10.1093/hmg/10.18.1995 [4] Wente SR, Rout MP.",Non-OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Cold Spring Harb Perspect Biol 2010;2:a000562; PMID:20630994; http://dx.doi.org/10.1101/cshperspect.a000562 [5] Aebi U, Cohn J, Buhle L, Gerace L. The nuclear lamina is a meshwork of intermediate-type ﬁlaments.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Nature 1986; 323:560-4; PMID:3762708; http://dx.doi.org/10.1038/323560a0 [6] Worman HJ, Gundersen GG.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Trends Cell Biol 2006;16:67-9; PMID:16406617; http://dx.doi.org/10.1016/j.tcb.2005.12.006 [7] Graumann K, Bass HW, Parry G. SUNrises on the inter- national plant nucleus consortium.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Nucleus 2013; 4:3-7;PMID:23324458; http://dx.doi.org/10.4161/nucl.23385 [8] Bae MS, Cho EJ, Choi EY, Park OK.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Analysis of the Ara- bidopsis nuclear proteome and its response to cold stress.Plant J 2003; 36:652-63; PMID:14617066; http://dx.doi.org/10.1046/j.1365-313X.2003.01907.x [9] Calikowski TT, Meulia T, Meier I.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"J Cell Biochem 2003; 90:361-78; PMID:14505352; http://dx.doi.org/10.1002/jcb.10624 [10] Bigeard J, Rayapuram N, P ﬂieger D, Hirt H. Phosphory- lation-dependent regulation of plant chromatin andchromatin-associated proteins.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Proteomics 2014;14:2127-40; PMID:24889195; http://dx.doi.org/10.1002/pmic.201400073 [11] Jones AME, MacLean D, Studholme DJ, Serna-Sanz A, Andreasson E, Rathjen JP, Peck SC.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"J Proteomics 2009; 72:439-51; PMID:19245862;http://dx.doi.org/10.1016/j.jprot.2009.02.004 [12] Pendle AF, Clark GP, Boon R, Lewandowska D, Lam YW, Andersen J, Mann M, Lamond AI, Brown JWS,Shaw PJ.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Mol Biol Cell 2005; 16:260-9; PMID:15496452; http://dx.doi.org/10.1091/ mbc.E04-09-0791 [13] Aki T, Yanagisawa S. Application of rice nuclear prote- ome analysis to the identi ﬁcation of evolutionarily con- served and glucose-responsive nuclear proteins.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"JProteome Res 2009; 8:3912-24; PMID:19621931; http://dx.doi.org/10.1021/pr900187e [14] Choudhary MK, Basu D, Datta A, Chakraborty N, Chakraborty S. Dehydration-responsive nuclear prote- o m eo fr i c e( Oryza sativa L.) illustrates protein net- work, novel regulators of cellular adaptation, andevolutionary perspective.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Prote- omics 2013; 13:3478-97; PMID:24133045; http://dx.doi.org/10.1002/pmic.201300284 [16] Khan MMK, Komatsu S. Rice proteomics: recent devel- opments and analysis of nuclear proteins.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Phytochemis-try 2004; 65:1671-81; PMID:15276429; http://dx.doi.org/ 10.1016/j.phytochem.2004.04.012 [17] Li G, Nallamilli BRR, Tan F, Peng Z.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Electrophoresis 2008; 29:604-17; PMID:18203134; http://dx.doi.org/10.1002/elps.200700412 [18] Mujahid H, Tan F, Zhang J, Nallamilli BRR, Pendarvis K, Peng Z.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Proteome Sci 2013; 11:26; PMID:23777608; http://dx.doi.org/10.1186/1477-5956-11-26 [19] Tan F, Li G, Chitteti BR, Peng Z. Proteome and phos- phoproteome analysis of chromatin associated proteinsin rice ( Oryza sativa ).",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Proteomics 2007; 7:4511-27; PMID:18022940; http://dx.doi.org/10.1002/pmic.200700580 [20] Lee BJ, Kwon SJ, Kim SK, Kim KJ, Park CJ, Kim YJ, Park OK, Paek KH.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Biochem Biophys ResCommun 2006; 351:405-11; PMID:17070775; http://dx.doi.org/10.1016/j.bbrc.2006.10.071 [21] Kumar R, Kumar A, Subba P, Gayali S, Barua P, Chakra- borty S, Chakraborty N. Nuclear phosphoproteome of developing chickpea seedlings ( Cicer arietinum L.) and protein-kinase interaction network.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
105:58-73; PMID:24747304; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"J Proteome Res 2006;5:3301-11; PMID:17137331; http://dx.doi.org/10.1021/ pr060147a [23] Pandey A, Chakraborty S, Datta A, Chakraborty N. Proteomics approach to identify dehydration responsivenuclear proteins from chickpea ( Cicer arietinum L).",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Mol Cell Proteomics 2008; 7:88-107; PMID:17921517;http://dx.doi.org/10.1074/mcp.M700314-MCP200 [24] Subba P, Kumar R, Gayali S, Shekhar S, Parveen S, Pan- dey A, Datta A, Chakraborty S, Chakraborty N. Charac- terisation of the nuclear proteome of a dehydration- sensitive cultivar of chickpea and comparative proteomicanalysis with a tolerant cultivar.",Non-OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Proteomics 2013;13:1973-92; PMID:23798506; http://dx.doi.org/10.1002/pmic.201200380 [25] Repetto O, Rogniaux H, Firnhaber C, Zuber H, K €uster H, Larr/C19e C, Thompson R, Gallardo K. Exploring the nuclear proteome of Medicago truncatula at the switch towards seed ﬁlling.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Plant J 2008; 56:398-410; PMID:18643982; http://dx.doi.org/10.1111/j.1365-313X.2008.03610.x [26] Casati P, Campi M, Chu F, Suzuki N, Maltby D, Guan S, Burlingame AL, Walbot V. Histone acetylation and chro-matin remodeling are required for UV-B –dependent transcriptional activation of regulated genes in maize.Plant Cell 2008; 20:827-42; PMID:18398050; http://dx.doi.org/10.1105/tpc.107.056457 [27] Guo B, Chen Y, Li C, Wang T, Wang R, Wang B, Hu S, Du X, Xing H, Song X, et al.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Proteomics2014; 14:1071-87; PMID:24677780; http://dx.doi.org/10.1002/pmic.201300147 [28] Abdalla KO, Rafudeen MS.",Non-OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"J Proteomics 2012;75:2361-74; PMID:22361341; http://dx.doi.org/10.1016/j.jprot.2012.02.006 [29] Abdalla KO, Baker B, Rafudeen MS. Proteomic analy- sis of nuclear proteins during dehydration of the res-urrection plant Xerophyta viscosa .",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Mol Biosyst 2011; 7:773-83; PMID:21132161;http://dx.doi.org/10.1039/C0MB00171F [31] Bancel E, Bonnot T, Davanture M, Branlard G, Zivy M, Martre P. Proteomic approach to identify nuclearproteins in wheat grain.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Front Plant Sci 2015; 6:905; PMID:26579155; http://dx.doi.org/10.3389/fpls.2015.00905 [33] Petrovsk /C19a B, Jer /C19abkov /C19a H, Chamr /C19ad I, Vr /C19ana J, Lenobel R, Urinovsk /C19aJ ,/C20Sebela M, Dole /C20zel J. Proteomic analysis of barley cell nuclei puri ﬁed by ﬂow sorting.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Cytogenet Genome Res 2014; 143:78-86; http://dx.doi.org/10.1159/000365311 [34] International Barley Genome Sequencing Consortium A physical, genetic and functional sequence assembly of thebarley genome.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Nucleic Acids Res 1997; 25:3389-402;PMID:9254694; http://dx.doi.org/10.1093/nar/25.17.3389 [36] Pieper U, Eswar N, Braberg H, Madhusudhan MS, Davis FP, Stuart AC, Mirkovic N, Rossi A, Marti-Renom MA,Fiser A. et al.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Nucleic Acids Res 2004; 32:D217-D222; PMID:14681398; http://dx.doi.org/10.1093/nar/gkh095 [37] Marchler-Bauer A, Derbyshire MK, Gonzales NR, Lu S, Chitsaz F, Geer LY, Geer RC, He J, Gwadz M, HurwitzDI, et al.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Nucleic Acids Res 2015; 43:D222-226; PMID:25414356;http://dx.doi.org/10.1093/nar/gku1221 [38] Xiong E, Zheng C, Wu X, Wang W. Protein subcellular location: The gap between prediction and experimenta- tion.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
Plant Mol Biol Rep 2015; 34:52-61; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Proteins 2006; 64:643-51;PMID:16752418; http://dx.doi.org/10.1002/prot.21018 [41] Shen HB, Chou KC.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Protein Eng Des Sel 2007;20:561-7; PMID:17993650; http://dx.doi.org/10.1093/protein/gzm057 [42] Lys /C19ak MA, /C20C/C19ıhal/C19ıkov/C19a J, Kubal /C19akov/C19aM , /C20Simkov /C19aH , K€unzel G, Dole /C20zel J.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Chromosome Res 1999; 7:431-44; http://dx.doi.org/ 10.1023/A:1009293628638 [43] Vr /C19ana J, Kubal /C19akov/C19aM , /C20Simkov /C19aH , /C20C/C19ıhal/C19ıkov/C19a J, Lys /C19ak MA, Dole /C20zel J.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"J Appl Genet 2011;52:371-90; PMID:21912935; http://dx.doi.org/10.1007/s13353-011-0061-1 [46] Bennett MD, Smith JB.",Non-OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Philos Trans R Soc Lond, B, Biol Sci 1976; 274:227-74; PMID:6977; http://dx.doi.org/10.1098/rstb.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Plant Cell 2011;23:1249-63; PMID:21467582; http://dx.doi.org/10.1105/tpc.110.082537 [48] Mayer KFX, Waugh R, Brown JWS, Schulman A, Langridge P, Platzer M, Fincher GB, Muehlbauer GJ,Sato K, Close TJ, et al.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Bioinformatics 2004;20:1413-5; PMID:15087322; http://dx.doi.org/10.1093/ bioinformatics/bth114 [50] Bickmore WA, Sutherland HGE.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"EMBO J 2002; 21:1248-54; PMID:11889031; http://dx.doi.org/10.1093/emboj/21.6.1248 [51] Dellaire G, Farrall R, Bickmore WA.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Nucleic Acids Res 2003; 31:328-30; PMID:12520015; http://dx.doi.org/10.1093/nar/gkg018 [52] Pijnappel WP, Kolkman A, Baltissen MP, Heck A, Jr, Timmers HM.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Proteome Sci 2009; 7:46; PMID:20034391; http://dx.doi.org/10.1186/1477- 5956-7-46 [53] Tenga MJ, Lazar IM.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"PLoS One 2012; 7:e48722;PMID:23144944; http://dx.doi.org/10.1371/journal.pone.0048722 [55] Marchler-Bauer A, Derbyshire MK, Gonzales NR, Lu S, Chitsaz F, Geer LY, Geer RC, He J, Gwadz M, HurwitzDI, et al.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"Nucleic Acids Res 2015; 43:D222-226; PMID:25414356; http://dx.doi.org/10.1093/nar/gku1221 [56] McCarthy FM, Wang N, Magee GB, Nanduri B, Lawrence ML, Camon EB, Barrell DG, Hill DP, Dolan ME, WilliamsWP, et al.",OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
BMC Genomics 2006; 7:229; PMID:16961921;http://dx.doi.org/10.1186/1471-2164-7-22980 N. BLAVET ET AL.,OADS,/arxiv_data1/oa_pdf/59/9f/kncl-08-01-1255391.PMC5287097.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.NUCLEUS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"1, 17 –33 http://dx.doi.org/10.1080/19491034.2016.1260798",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Cell Biol 2006;172:41-53; PMID:16380439; http://dx.doi.org/10.1083/jcb.200509124 [4] Mejat A, Misteli T. LINC complexes in health and dis- ease.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Nucleus 2010; 1:40-52; PMID:21327104; http://dx.doi.org/10.4161/nucl.1.1.10530 [5] Jaalouk DE, Lammerding J. Mechanotransduction gone awry.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Nat Rev Mol Cell Biol 2009; 10:63-73;PMID:19197333; http://dx.doi.org/10.1038/nrm2597 [6] Wilson KL, Foisner R. Lamin-binding Proteins.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Cold Spring Harb Perspect Biol 2010; 2:a000554;PMID:20452940; http://dx.doi.org/10.1101/cshperspect.a000554 [7] Taylor MR, Fain PR, Sinagra G, Robinson ML, Robertson AD, Carniel E, Di Lenarda A, Bohlmeyer TJ, Ferguson DA, Brodsky GL, et al.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Am Coll Cardiol 2003; 41:771-80;PMID:12628721; http://dx.doi.org/10.1016/S0735-1097(02)02954-6 [8] Bonne G, Leturcq F, Ben Yaou R. Emery-Dreifuss Mus- cular Dystrophy.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Identi ﬁcation of a lamin A/C gene mutation in a Taiwanese family with limb girdle muscular dystrophy and cardiomyopathy.Inter J Cardiol 2010; 145:598-9; PMID:20615561; http://dx.doi.org/10.1016/j.ijcard.2010.06.014 [11] Alastalo TP, West G, Li SP, Keinanen A, Helenius M, Tyni T, Lapatto R, Turanlahti M, Heikkila P, KaariainenH, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Hum Mutat 2015; 36:694-703;PMID:25820511; http://dx.doi.org/10.1002/humu.22793 [12] Guo X, Ling C, Liu Y, Zhang X, Zhang S. A Case of Novel Lamin A/C Mutation Manifesting as AtypicalProgeroid Syndrome and Cardiomyopathy.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Am Heart J 2015;169:587-93; PMID:25819867; http://dx.doi.org/10.1016/j.ahj.2014.12.021 [14] Ara /C19ujo-Vilar D, Lado-Abeal J, Palos-Paz F, Lattanzi G, Band /C19ınM a ,B e l l i d oD ,D o m /C19ınguez-Gerpe L, Calvo C, P /C19erez O, Ramazanova A, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Pacing ClinElectrophysiol 2009; 32:410-5; PMID:19272076; http://dx.doi.org/10.1111/j.1540-8159.2008.02254.x [16] Galant D, Gaborit B, Desgrouas C, Abdesselam I, Ber- nard M, Levy N, Merono F, Coirault C, Roll P, Lagarde A, et al.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Cells2016; 5; PMID:27120622; http://dx.doi.org/10.3390/cells5020021 [17] Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, YoungJB, American Heart A, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Circulation 2006; 113:1807-16; PMID:16567565; http://dx.doi.org/10.1161/ CIRCULATIONAHA.106.174287 [18] Yajima T. Viral myocarditis: potential defense mecha- nisms within the cardiomyocyte against virus infection.Future Microbiol 2011; 6:551-66; PMID:21585262;http://dx.doi.org/10.2217/fmb.11.40 [19] Yajima T, Knowlton KU.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Circulation 2009; 119:2615-24; PMID:19451363; http://dx.doi.org/10.1161/ CIRCULATIONAHA.108.766022 [20] Walker RK, Cousins VM, Umoh NA, Jeffress MA, Taghipour D, Al-Rubaiee M, Haddad GE.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Alcohol Clin Exp Res 2013; 37:1253-60;PMID:23527963; http://dx.doi.org/10.1111/acer.12109 [21] Raj S, Franco VI, Lipshultz SE.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"2014; 16:315; PMID:24748018; http://dx.doi.org/ 10.1007/s11936-014-0315-4 [22] Yoshikawa T, Baba A, Nagatomo Y. Autoimmune mechanisms underlying dilated cardiomyopathy.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Circ J2009; 73:602-7; PMID:19246813; http://dx.doi.org/10.1253/circj.CJ-08-1151 [23] Watkins H, Ashra ﬁan H, Redwood C. Inherited cardiomy- opathies.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"N Eng J Med 2011; 364:1643-56; PMID:21524215; http://dx.doi.org/10.1056/NEJMra0902923 [24] Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O ’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"JAm Coll Cardiol 1999; 34:181-90; http://dx.doi.org/10.1016/S0735-1097(99)00172-2 [26] Vatta M, Mohapatra B, Jimenez S, Sanchez X, Faulkner G, Perles Z, Sinagra G, Lin JH, Vu TM, Zhou Q, et al.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"JAm Coll Cardiol 2003; 42:2014-27; PMID:14662268;http://dx.doi.org/10.1016/j.jacc.2003.10.021 [27] Tsubata S, Bowles KR, Vatta M, Zintz C, Titus J, Muho- nen L, Bowles NE, Towbin JA.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Clin Invest 2000; 106:655-62; PMID:10974018; http://dx.doi.org/10.1172/JCI9224 [28] Franz WM, Cremer M, Herrmann R, Grunig E, Fogel W, Scheffold T, Goebel HH, Kircheisen R, Kubler W,Voit T, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Ann N Y Acad Sci1995; 752:470-91; PMID:7755293; http://dx.doi.org/10.1111/j.1749-6632.1995.tb17457.x [29] Taylor MR, Slavov D, Ku L, Di Lenarda A, Sinagra G, Carniel E, Haubold K, Boucek MM, Ferguson D,Graw SL, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Circulation 2007; 115:1244-51; PMID:17325244; http://dx.doi.org/10.1161/CIRCULATIONAHA.106.644013 [30] Haghighi K, Kolokathis F, Gramolini AO, Waggoner JR, Pater L, Lynch RA, Fan GC, Tsiapras D, Parekh RR, Dorn GW, 2nd, et al.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Am Heart J 2008;156:161-9; PMID:18585512; http://dx.doi.org/ 10.1016/j.ahj.2008.01.026 [32] Pasotti M, Klersy C, Pilotto A, Marziliano N, Rapezzi C, Serio A, Mannarino S, Gambarin F, Favalli V, GrassoM, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Am Coll Cardiol 2008;52:1250-60; PMID:18926329; http://dx.doi.org/10.1016/ j.jacc.2008.06.044 [33] Tesson F, Saj M, Uvaize MM, Nicolas H, Ploski R, Bilinska Z. Lamin A/C mutations in dilated cardiomy-opathy.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Cardiol J 2014; 21:331-42; PMID:24846508;http://dx.doi.org/10.5603/CJ.a2014.0037 [34] van Weerd JH, Christoffels VM.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
Develop-ment 2016; 143:197-210; PMID:26786210; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Meta-analysis of clinical charac- teristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?J Mol Med 2005; 83:79-83; PMID:15551023; http://dx.doi.org/10.1007/s00109-004-0589-1 [37] Brodt C, Siegfried JD, Hofmeyer M, Martel J, Rampersaud E, Li D, Morales A, Hershberger RE.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
Circ Res 1998;83:580-93; PMID:9742053; http://dx.doi.org/10.1161/ 01.RES.83.6.580 [40] Marian AJ.,Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Pathogenesis of diverse clinical and patho- logical phenotypes in hypertrophic cardiomyopathy.Lancet 2000; 355:58-60; PMID:10615904; http://dx.doi.org/10.1016/S0140-6736(99)06187-5 [41] Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, BurbanM, et al.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"107:2227-32; PMID:12707239; http://dx.doi.org/ 10.1161/01.CIR.0000066323.15244.54 [42] Marston S, Copeland O, Jacques A, Livesey K, Tsang V, McKenna WJ, Jalilzadeh S, Carballo S, Redwood C,Watkins H. Evidence from human myectomy samplesthat MYBPC3 mutations cause hypertrophic cardiomy-opathy through haploinsuf ﬁciency.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Circ Res 2009; 105:219-22; PMID:19574547; http://dx.doi.org/10.1161/ CIRCRESAHA.109.202440 [43] van Dijk SJ, Dooijes D, dos Remedios C, Michels M, Lamers JM, Winegrad S, Schlossarek S, Carrier L, ten Cate FJ, Stie-nen GJ, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Cardiovasc Res 1999; 44:20-36;PMID:10615387; http://dx.doi.org/10.1016/S0008-6363(99)00213-8 [45] Seidman JG, Seidman C. The genetic basis for cardio- myopathy: from mutation identi ﬁcation to mechanistic paradigms.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Cell 2001; 104:557-67; PMID:11239412; http://dx.doi.org/10.1016/S0092-8674(01)00242-2 [46] Kirschner SE, Becker E, Antognozzi M, Kubis HP, Francino A, Navarro-Lopez F, Bit-Avragim N,Perrot A, Mirrakhimov MM, Osterziel KJ, et al.Hypertrophic cardiomyopathy-related beta-myosinmutations cause highly variable calcium sensitivitywith functional imbalances among individual mus- cle cells.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Am J Physiol Heart Circ Physiol 2005; 288:H1242-51; PMID:15550524; http://dx.doi.org/10.1152/ajpheart.00686.2004 [47] Knollmann BC, Kirchhof P, Sirenko SG, Degen H, Greene AE, Schober T, Mackow JC, Fabritz L, PotterJD, Morad M. Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventric-ular tachycardia and Ca2 C-dependent action potential remodeling.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Circ Res 2003; 92:428-36; PMID:12600890; http://dx.doi.org/10.1161/01.RES.0000059562.91384.1A [48] Huke S, Knollmann BC.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Mol Cell Car-diol 2010; 48:824-33; PMID:20097204; http://dx.doi.org/10.1016/j.yjmcc.2010.01.011 [49] Bers DM, Guo T. Calcium signaling in cardiac ven- tricular myocytes.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Ann N Y Acad Sci 2005; 1047:86-98; PMID:16093487; http://dx.doi.org/ 10.1196/annals.1341.008 [50] Robinson P, Grif ﬁths PJ, Watkins H, Redwood CS.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Circ Res 2007; 101:1266-73; PMID:17932326; http://dx.doi.org/10.1161/CIRCRESAHA.107.156380 [51] Kataoka A, Hemmer C, Chase PB.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Computational simu- lation of hypertrophic cardiomyopathy mutations introponin I: in ﬂuence of increased myo ﬁlament calcium sensitivity on isometric force, ATPase and [Ca2 C]i. J Biomech 2007; 40:2044-52; PMID:17140583; http://dx.doi.org/10.1016/j.jbiomech.2006.09.026 [52] Smith GA, Dixon HB, Kirschenlohr HL, Grace AA, Metcalfe JC, Vandenberg JI.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Biochem J 2000; 346 Pt 2:393-402; PMID:10677358; http://dx.doi.org/10.1042/bj3460393 [53] Ashra ﬁan H, Redwood C, Blair E, Watkins H. Hyper- trophic cardiomyopathy:a paradigm for myocardialenergy depletion.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Trends Genet 2003; 19:263-8;PMID:12711218; http://dx.doi.org/10.1016/S0168-9525(03)00081-7 [54] Blair E, Redwood C, Ashra ﬁan H, Oliveira M, Broxholme J, Kerr B, Salmon A, Ostman-Smith I, Watkins H. Mutations in the gamma(2) subunit ofAMP-activated protein kinase cause familial hypertro-phic cardiomyopathy: evidence for the central role ofenergy compromise in disease pathogenesis.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Hum MolGenet 2001; 10:1215-20; PMID:11371514; http://dx.doi.org/10.1093/hmg/10.11.1215 [55] Mercuri E, Brown SC, Nihoyannopoulos P, Poulton J, Kinali M, Richard P, Piercy RJ, Messina S, Sewry C, Burke MM, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Muscle Nerve 2005;31:602-9; PMID:15770669; http://dx.doi.org/10.1002/mus.20293 [56] Nikolova V, Leimena C, McMahon AC, Tan JC, Chandar S, Jogia D, Kesteven SH, Michalicek J, Otway R, Verheyen F, et al.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Clin Invest 2004; 113:357-69; PMID:14755333; http://dx.doi.org/10.1172/JCI200419448 [57] Sen-Chowdhry S, McKenna WJ.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Curr Opin Cardiol 2008; 23:38-45; PMID:18281826; http://dx.doi.org/ 10.1097/HCO.0b013e3282f2c96e [58] Sen-Chowdhry S, Morgan RD, Chambers JC, McKenna WJ.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Ann Rev Med 2010; 61:233-53;PMID:20059337; http://dx.doi.org/10.1146/annurev.med.052208.130419 [59] McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F. Diag- nosis of arrhythmogenic right ventricular dysplasia/car-diomyopathy.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Br Heart J 1994; 71:215-8;PMID:8142187; http://dx.doi.org/10.1136/hrt.71.3.215 [60] Tabib A, Loire R, Chalabreysse L, Meyronnet D, Miras A, Malicier D, Thivolet F, Chevalier P, Bouvagnet P.NUCLEUS 29",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Circulation 2003;108:3000-5; PMID:14662701; http://dx.doi.org/10.1161/01.CIR.0000108396.65446.21 [61] Kirchhof P, Fabritz L, Zwiener M, Witt H, Schafers M, Zellerhoff S, Paul M, Athai T, Hiller KH, Baba HA, et al.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Circulation 2006; 114:1799-806; PMID:17030684; http://dx.doi.org/10.1161/CIRCULATIONAHA.106.624502 [62] Asimaki A, Syrris P, Wichter T, Matthias P, Saf ﬁtz JE, McKenna WJ.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Am J Hum Genet 2007; 81:964-73;PMID:17924338; http://dx.doi.org/10.1086/521633 [63] Protonotarios N, Tsatsopoulou A. Naxos disease and Carvajal syndrome: cardiocutaneous disorders thathighlight the pathogenesis and broaden the spectrum ofarrhythmogenic right ventricular cardiomyopathy.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Cardiovasc Electro-physiol 2005; 16:927-35; PMID:16101641; http://dx.doi.org/10.1111/j.1540-8167.2005.40842.x [65] Sen-Chowdhry S, Syrris P, McKenna WJ.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Clin Invest 2006;116:2012-21; PMID:16823493; http://dx.doi.org/ 10.1172/JCI27751 [67] MacRae CA, Birchmeier W, Thierfelder L. Arrhythmo- genic right ventricular cardiomyopathy: moving towardmechanism.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Clin Invest 2006; 116:1825-8;PMID:16823481; http://dx.doi.org/10.1172/JCI29174 [68] Larsen MK, Nissen PH, Berge KE, Leren TP, Kristensen IB, Jensen HK, Banner J. Molecularautopsy in young sudden cardiac death victims with suspected cardiomyopathy.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"EMBO J 2006; 25:3275-85; PMID:16858403;http://dx.doi.org/10.1038/sj.emboj.7601230 [71] Arimura T, Helbling-Leclerc A, Massart C, Varnous S, Niel F, Lacene E, Fromes Y, Toussaint M, Mura A M ,K e l l e rD I ,e ta l .M o u s em o d e lc a r r y i n gH 2 2 2 P - Lmna mutation develops muscular dystrophy anddilated cardiomyopathy similar to human striatedmuscle laminopathies.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Hum Mol Genet 2005;14:155-69; PMID:15548545; http://dx.doi.org/10.1093/hmg/ddi017 [72] Muchir A, Pavlidis P, Decostre V, Herron AJ, Arimura T, Bonne G, Worman HJ.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Clin Invest 2007;117:1282-93; PMID:17446932; http://dx.doi.org/10.1172/JCI29042 [73] Muchir A, Shan J, Bonne G, Lehnart SE, Worman HJ.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Hum Mol Genet 2009; 18:241-7; PMID:18927124; http://dx.doi.org/ 10.1093/hmg/ddn343 [74] Wu W, Shan J, Bonne G, Worman HJ, Muchir A. Pharmacological inhibition of c-Jun N-terminalkinase signaling prevents cardiomyopathy caused bymutation in LMNA gene.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Biochim Biophys Acta2010; 1802:632-8; PMID:20388542; http://dx.doi.org/10.1016/j.bbadis.2010.04.001 [75] Wu W, Muchir A, Shan J, Bonne G, Worman HJ.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Circula-tion 2010; 123:53-61; PMID:21173351; http://dx.doi.org/10.1161/CIRCULATIONAHA.110.970673 [76] Muchir A, Reilly Sa, Wu W, Iwata S, Homma S, Bonne G, Worman HJ.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Cardio-vasc Res 2012; 93:311-9; PMID:22068161; http://dx.doi.org/10.1093/cvr/cvr301 [77] Choi JC, Wu W, Muchir A, Iwata S, Homma S, Worman HJ.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Sci Transl Med 2012; 4:144ra02; ; http://dx.doi.org/10.1126/scitranslmed.3003875 [79] Muchir A, Wu W, Sera F, Homma S, Worman HJ.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"452:958-61; PMID:25218145; http://dx.doi.org/ 10.1016/j.bbrc.2014.09.020 [80] Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, Atherton J, Vidaillet HJ, Jr., Spudich S,De Girolami U, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
N Engl J Med 1999; 341:1715-24; PMID:10580070; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Hum Mol Genet 2005; 14:2167-80;PMID:15972724; http://dx.doi.org/10.1093/hmg/ddi221 [82] Nguyen-Tran VT, Kubalak SW, Minamisawa S, Fiset C, Wollert KC, Brown AB, Ruiz-Lozano P, Barrere-Lemaire S, Kondo R, Norman LW, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Cell 2000; 102:671-82; PMID:11007485; http://dx.doi.org/10.1016/S0092-8674(00)00089-1 [83] Cattin M-E, Bertrand AT, Schlossarek S, Le Bihan MC, Skov Jensen S, Neuber C, Crocini C, Maron S, Lain /C19eJ , Mougenot N, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Ann Neurol 2008; 64:177-86; PMID:18551513; http://dx.doi.org/10.1002/ana.21417 [85] Cattin ME, Ferry A, Vignaud A, Mougenot N, Jacquet A, Wahbi K, Bertrand AT, Bonne G. Mutation in laminA/C sensitizes the myocardium to exercise-inducedmechanical stress but has no effect on skeletal musclesin mouse.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Ann Neu-rol 2000; 48:170-80; PMID:10939567; http://dx.doi.org/10.1002/1531-8249(200008)48:2%3c170::AID- ANA6%3e3.0.CO;2-J [87] Wang Y, Herron AJ, Worman HJ.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Pathology and nuclear abnormalities in hearts of transgenic miceexpressing M371K lamin A encoded by an LMNAmutation causing Emery-Dreifuss muscular dystrophy.Hum Mol Genet 2006; 15:2479-89; PMID:16825283;http://dx.doi.org/10.1093/hmg/ddl170 [88] Lu D, Lian H, Zhang X, Shao H, Huang L, Qin C, Zhang L. LMNA E82K mutation activates FAS and mitochon- drial pathways of apoptosis in heart tissue speci ﬁctransgenic mice.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"PLoS One 2010; 5:e15167; PMID:21151901; http://dx.doi.org/10.1371/journal.pone.0015167 [89] Mounkes LC, Kozlov S, Hernandez L, Sullivan T, Stewart CL.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Nature 2003; 423:298-301;PMID:12748643; http://dx.doi.org/10.1038/nature01631 [90] Zuela N, Zwerger M, Levin T, Medalia O, Gruenbaum Y.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Cell Sci 2016; 129:1781-91;PMID:27034135; http://dx.doi.org/10.1242/jcs.184309 [91] Ramos FJ, Chen SC, Garelick MG, Dai DF, Liao CY, Schreiber KH, MacKay VL, An EH, Strong R, LadigesWC, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"SciTransl Medi 2012; 4:144ra03; http://dx.doi.org/10.1126/scitranslmed.3003802 [92] Nikolova-Krstevski V, Leimena C, Xiao X-H, Kesteven S, Tan JC, Yeo LS, Yu Z-Y, Zhang Q, Carlton A, Head S,et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Mol Cell Cardiol 2011; 50:479-86; PMID:21156181; http://dx.doi.org/10.1016/j.yjmcc.2010.12.001 [93] Chen SC, Kennedy BK, Lampe PD.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Exp Cell Res 2013;319:888-96; PMID:23261543; http://dx.doi.org/10.1016/j.yexcr.2012.12.014 [94] Frock RL, Chen SC, Da D-F, Frett E, Lau C, Brown C, Pak DN, Wang Y, Muchir A, Worman HJ, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"PloS One 2012; 7:e42918; PMID:22905185; http://dx.doi.org/10.1371/journal.pone.0042918 [95] Wolf CM, Wang L, Alcalai R, Pizard A, Burgon PG, Ahmad F, Sherwood M, Branco DM, Wakimoto H,Fishman GI, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Mol Cell Cardiol 2008;44:293-303; PMID:18182166; http://dx.doi.org/10.1016/j.yjmcc.2007.11.008 [96] Chandar S, Yeo LS, Leimena C, Tan J-C, Xiao X-H, Nikolova-Krstevski V, Yasuoka Y, Gardiner-Garden M,Wu J, Kesteven S, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Circulat Res 2010; 106:573-82; PMID:20019332; http://dx.doi.org/10.1161/CIRCRESAHA.109.204388 [97] Cupesi M, Yoshioka J, Gannon J, Kudinova A, Stew- art CL, Lammerding J. Attenuated hypertrophicresponse to pressure overload in a lamin A/C hap-loinsuf ﬁciency mouse.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Mol Cell Cardiol 2010; 48:1290-7; PMID:19913544; http://dx.doi.org/10.1016/j.yjmcc.2009.10.024 [98] Zwerger M, Jaalouk DE, Lombardi ML, Isermann P, Mauermann M, Dialynas G, Herrmann H, Wallrath LL,NUCLEUS 31",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Hum Mol Genet 2013; 22:2335-49; PMID:23427149; http://dx.doi.org/10.1093/hmg/ddt079 [99] Bhattacharjee P, Banerjee A, Banerjee A, Dasgupta D, Sengupta K. Structural alterations of Lamin A protein in dilated cardiomyopathy.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Biochemistry 2013; 52:4229- 41; PMID:23701190; http://dx.doi.org/10.1021/bi400337t [100] West G, Gullmets J, Virtanen L, Li SP, Keinanen A, S h i m iT ,M a u e r m a n nM ,H e l i oT ,K a a r t i n e nM ,Ollila L, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"PLoS One 2013; 8:e83410;PMID:24386194; http://dx.doi.org/10.1371/journal.pone.0083410 [102] Lammerding J, Fong LG, Ji JY, Reue K, Stewart CL, Young SG, Lee RT.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Biol Chem 2006;281:25768-80; PMID:16825190; http://dx.doi.org/10.1074/jbc.M513511200 [103] Lammerding J, Schulze PC, Takahashi T, Kozlov S, Sullivan T, Kamm RD, Stewart CL, Lee RT.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Cell Biol 2005; 170:781-91; PMID:16115958; http://dx.doi.org/10.1083/jcb.200502148 [105] Lammerding J, Lee RT.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Novartis Found Symp 2005; 264:264-73; discussion 73–8; PMID:15773759; http://dx.doi.org/10.1002/ 0470093765.ch18 [106] Lammerding J, Schulze PC, Takahashi T, Kozlov S, Sullivan T, Kamm RD, Stewart CL, Lee RT.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Clin Invest 2004;113:370-8; PMID:14755334; http://dx.doi.org/ 10.1172/JCI200419670 [107] Siu CW, Lee YK, Ho JC, Lai WH, Chan YC, Ng KM, Wong LY, Au KW, Lau YM, Zhang J, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Aging (Albany NY) 2012; 4:803-22; PMID:23362510; http://dx.doi.org/10.18632/aging.100503 [108] De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C ,A m i e lJ ,B o c c a c c i oI ,L y o n n e tS ,S t e w a r tC L , Munnich A, Le Merrer M, et al.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Science 2003; 300:2055; PMID:12702809; ht tp://dx.doi.org/10.1126/ science.1084125 [109] De Sandre-Giovannoli A, Levy N. Altered splicing in prelamin A-associated premature aging phenotypes.Prog Mol Subcell Biol 2006; 44:199-232;PMID:17076270; http://dx.doi.org/10.1007/978-3-540- 34449-0_9 [110] De Sandre-giovannoli AD, Cau P, Navarro C, Amiel J, Lyonnet S, Stewart CL, Munnich A, Merrer ML, Le N.Lamin A Truncation in Hutichnson-Gilford Progeria.Science 2003; 300:21702; http://dx.doi.org/10.1126/science.1084125 [111] Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, et al.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Nature2003; 423:293-8; PMID:12714972; http://dx.doi.org/10.1038/nature01629 [112] Shackleton S, Smallwood DT, Clayton P, Wilson LC, Agarwal aK, Garg a, Trembath RC.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
J Med Genet 2005; 42:e36; PMID:15937076; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Circulation2010; 121:2200-10; PMID:20458013; http://dx.doi.org/10.1161/CIRCULATIONAHA.109.902056 [114] Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB, Gruenbaum Y, Khuon S,Mendez M, Varga R, et al.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"ProcNatl Acad Sci U S A 2004; 101:8963-8; PMID:15184648;http://dx.doi.org/10.1073/pnas.0402943101 [115] Liu Y, Rusinol A, Sinensky M, Wang Y, Zou Y. DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A. J Cell Sci 2006;119:4644-9; PMID:17062639; http://dx.doi.org/10.1242/jcs.03263 [116] Liu Y, Wang Y, Rusinol AE, Sinensky MS, Liu J, Shell SM, Zou Y.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Involvement of xeroderma pigmen-tosum group A (XPA) in progeria arising fromdefective maturation of prelamin A. FASEB J 2008; 22:603-11; PMID:17848622; http://dx.doi.org/ 10.1096/fj.07-8598com [117] Liu B, Wang J, Chan KM, Tjia WM, Deng W, Guan X, Huang JD, Li KM, Chau PY, Chen DJ, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"NatMed 2005; 11:780-5; PMID:15980864; http://dx.doi.org/10.1038/nm1266 [118] Misteli T, Scaf ﬁdi P. Genome instability in progeria: when repair gets old.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
Nat Med 2005; 11:718-9; PMID:16015360; http://dx.doi.org/10.1038/nm0705-71832 D. BRAYSON AND C. M. SHANAHAN,OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Arterioscler Thromb Vasc Biol 2010;30:2301-9; PMID:20798379; http://dx.doi.org/10.1161/ATVBAHA.110.209460 [121] Gerhard-Herman M, Smoot LB, Wake N, Kieran MW, Kleinman ME, Miller DT, Schwartzman A,Giobbie-Hurder A, Neuberg D, Gordon LB.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
Hyperten-sion 2012; 59:92-7; PMID: 22083160; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Sci Transl Med 2011; 3:106ra7-r a7; http://dx.doi.org/ 10.1126/scitranslmed.3002847 [123] Pend /C19as AM, Zhou Z, Cadi ~nanos J, Freije JMP, Wang J, Hultenby K, Astudillo A, Wernerson A, Rodr /C19ıguez F, Tryggvason K, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"An accumulation of non-farnesylatedprelamin A causes cardiomyopathy but not progeria.Hum Mol Genet 2010; 19:2682-94; PMID:20421363;http://dx.doi.org/10.1093/hmg/ddq158 [125] Brodsky GL, Bowersox JA, Fitzgerald-miller L, Miller LA, Maclean KN.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Biochem Biophys Res Commun 2007; 356:872-9; PMID:17389141; http://dx.doi.org/10.1016/j.bbrc.2007.03.062 [126] Cattin ME, Muchir A, Bonne G. ’State-of-the-heart ’of cardiac laminopathies.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Curr Opin Cardiol 2013; 28:297-304; PMID:23455585; http://dx.doi.org/10.1097/HCO.0b013e32835f0c79[127] Lu JT, Muchir A, Nagy PL, Worman HJ.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Dis Models Mech 2011; 4:562-8; PMID:21810905;http://dx.doi.org/10.1242/dmm.006346 [128] Scharner J, Figeac N, Ellis JA, Zammit PS.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Gene Ther 2015; 22:503-15; PMID:25832542; http://dx.doi.org/10.1038/gt.2015.8 [129] Lee JM, Nobumori C, Tu Y, Choi C, Yang SH, Jung HJ, Vickers TA, Rigo F, Bennett CF, Young SG, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"J Clin Invest 2016; 126:1592-602;PMID:26999604; http://dx.doi.org/10.1172/JCI85908 [130] Gordon LB, Kleinman ME, Miller DT, Neuberg DS, Giobbie-Hurder A, Gerhard-Herman M, Smoot LB, Gordon CM, Cleveland R, Snyder BD, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Circulation 2016;134:114-25; PMID:27400896; http://dx.doi.org/10.1161/CIRCULATIONAHA.116.022188 [132] Ibrahim MX, Sayin VI, Akula MK, Liu M, Fong LG, Young SG, Bergo MO.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Science 2013; 340:1330-3; PMID:23686339;http://dx.doi.org/10.1126/science.1238880 [133] Larrieu D, Br itton S, Demir M, Rodriguez R, Jackson SP.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"Science 2014;344:527-32; PMID:24786082; http://dx.doi.org/10.1126/science.1252651 [134] Rankin J, Auer-Grumbach M, Bagg W, Colclough K, Nguyen TD, Fenton-May J, Hattersley A, Hudson J,Jardine P, Josifova D, et al.",OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
Am J Med Genet Part A 2008;146A:1530-42; PMID:18478590; http://dx.doi.org/10.1002/ajmg.a.32331NUCLEUS 33,Non-OADS,/arxiv_data1/oa_pdf/a6/29/kncl-08-01-1260798.PMC5287098.pdf
"1, 34 –45 http://dx.doi.org/10.1080/19491034.2016.1252893",Non-OADS,/arxiv_data1/oa_pdf/49/ae/kncl-08-01-1252893.PMC5287099.pdf
Curr Opin Cell Biol 2006; 18:108-16;PMID:16364623; http://dx.doi.org/10.1016/j.ceb.2005.12.004 [2] Kamei H. Relationship of nuclear invaginations to peri- nuclear rings composed of intermediate ﬁlaments in MIA PaCa-2 and some other cells.,OADS,/arxiv_data1/oa_pdf/49/ae/kncl-08-01-1252893.PMC5287099.pdf
"Cell Structure Func-tion 1994; 19:123-32; PMID:7954871; http://dx.doi.org/10.1247/csf.19.123 [3] Malhas A, Goulbourne C, Vaux DJ.",OADS,/arxiv_data1/oa_pdf/49/ae/kncl-08-01-1252893.PMC5287099.pdf
